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SCOPE OF THE THESIS 
The evolution of life can only be understood as the loom of more efficient ways to replicate genetic 
material. The development of intricate processes of gene regulation control has allowed the 
emergence of more elaborated life forms. In the first half of Chapter 1 of this thesis, I introduce the 
basis of transcription regulation in the context of evolution. On the second half, I discuss how 
transcription regulation mechanisms can explain complex processes in animal development such as 
the formation of the brain.  
Chapters 2 to 4 contain the experimental work performed during the course of my PhD studies where 
the general scope has been the application of state of the art biochemistry technologies to the field of 
transcription regulation and neurodevelopment. Chapter 2 involves the study of the core 
transcription regulatory machinery. The Mediator complex has acted as a bridge for my neuroscience 
background to cross to the chromatin world, where we have expanded the general understanding of 
the Mediator interactome and its genomic localization. Moreover, it has provided new paths to 
explore in further research. One example is Chapter 3, where I characterize the role of Cggbp1, a 
Mediator-interacting transcription factor involved in neural commitment. Exploiting updated 
protocols of stem cells culture and differentiation, I could follow the role of Cggbp1 in the dynamic 
model of neural induction. Having seen the early neural induction events described in Chapter 3 and 
to the more biochemistry focus studies in neural progenitors in Chapter 2; it seems fitting that 
Chapter 4 of my thesis focuses in neurons, a terminal point of differentiation in the neural lineage. In 
this last chapter, we present an epigenetic map of the phenomenon of neuronal maturation, which is 
very important for neurons but surprisingly understudied. Also related to my experimental work are 
worth mentioning 2 other publications (reported in my CV at this thesis addendum) where I could 
contribute with the biochemistry skills learned during my PhD studies. 
In the final Chapter of this thesis (Chapter 5), I summarize the results of the experimental research 
described in Chapters 2 to 4. In addition, I present preliminary experimental data of new potential 
projects.  
In summary, we have combined biochemistry and molecular cell techniques with the study of neural 
development, providing notable contributions to the general understanding of how transcription is 
regulated but also discover new factors involved in transcriptional regulation. 
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Chapter 1 
INTRODUCTION 
Prologue 
The science of biology is the study of life. Many disciplines, ranging from the morphological 
description and classification of species in the taxonomy field, to the study of organic chemical 
reactions seen in biochemistry, are branches of biology that each study living organisms.  
But what do we call a living organism? What is life? These questions have been the subject of 
discussion between scientists for centuries and continues to arise as our knowledge and 
understanding expand1. The current concept of life may not be far from the one used by the National 
Aeronautics and Space Administration (NASA) as “a self-sustained chemical system capable of 
undergoing Darwinian evolution”. However, the development of new research fields such as 
synthetic biology and artificial intelligence has made the boundaries of the definitions of life 
dimmed2, and I would suggest an even more minimalistic idea such as “life is an evolving self-
sustaining system”.  
The last short sentence presents two key concepts that will echo through this introduction. The first 
one, “self-sustention” refers to the autonomy of the replication of the organism, while the second one, 
“evolution”, alludes to the transmission of heritable traits by the aforementioned Darwinian natural 
selection which could lead to the appearance of new organisms3. With these two pillars I will attempt 
to summarize my molecular neuroscience studies starting from the simplicity of the first life forms on 
earth towards the development of the brain, adding one layer of complexity at a time. 
The origin of life and the central dogma of biology 
After the formation of the Earth and the condensation of the oceans around 4 billion years ago4, the 
first organic molecules started to appear from inorganic reactions with the energy from the sun 
and/or volcanic activity filling the oceans with a vast and chaotic spectrum of monomers and 
polymers in a stage termed “primordial soup”5.  Several studies have demonstrated the production of 
both amino acids6 and nucleotides7, building blocks of modern life forms, under prebiotic reactions 
mimicked under laboratory conditions. 
In this progressively changing chemical environment, complex molecules were created and destroyed 
continuously depending on the affinity of their small components and other favorable conditions 
such as compartmentalization within lipid vesicles and local concentrations at sea shores, crystals, ice 
sheets or metal precipitates at deep-sea vents8–10. There is an ongoing debate about the exact chemical 
nature of the first pre-living organism, but its main characteristic are clear, i.e. the ability to self-
replicate11. In other words, the origin of life would have been molecules with the capacity to catalyze 
the chemical reactions needed to create a new molecule with the same capacity and as result, 
preserving and propagating its identity in the anarchical mix of reactions ongoing in the primordial 
soup. To accomplish this, in addition to the catalytic activity per se, which many other molecules 
perhaps had acquired before, the first life forms would have been the template themselves, carrying a 
piece of information (what we know today as genes) needed to assemble the right components to 
carry out the replication reaction12.  
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It is important to notice that an exact copy of the molecule would not have been essential to continue 
the replication chain as long as its “daughter” had retained the same ability. Therefore, several 
variants of the original structure would have appeared (alleles) and coexisted. Some of these 
molecules would have changed their template (genotype) so much that they had developed 
differential traits (phenotype) such as the speed of replication, the accuracy on reading the template, 
their structural stability, or even starting to carry information for several genes. In short, the evolution 
arms race would have started, as one type of molecule would have tried to outcompete the others 
and/or compartmentalize it in each cell of multi-cellular organisms, as a more capable system to 
transmit its information.  
From this ancestor “replication” wars, one particular system rose victorious. The power of this design 
relayed on a first very stable molecule that could contain several genes, individually encoding into 
smaller templates which at the end would be processed to produce the functional molecules13. This 
design was so fitting that became the base of all other subsequent living forms until now and 
constitutes the central dogma of biology, which explains the flow of genetic information within a 
biological system14 (Figure 1). 
The ultimate molecule then comes as deoxyribonucleic acid (DNA)15 and usually consists of two 
antiparallel polymer strands coiled around each other to form a double helix16,17. The monomer 
building blocks are nucleotides, each of them composed by three molecules: a five-carbon sugar 
(deoxyribose in the case of DNA), at least one phosphate group and one of four nitrogenous bases, 
guanine (G), adenine (A), cytosine (C), or thymine (T).The order in which these four bases are stacked 
to form the strand formulates a letter code18 (Figure 2). Why there is a four letter only alphabet in 
DNA is intriguing as some laboratories have accomplished to synthesize and coordinate new artificial 
bases into native DNA and it suggested to be a hint to the first choices in replication evolution19.  
In addition, in the double strand selective pairing (or complementarity) between the letters occurs, 
where the purine bases G and A form 3 and 2 hydrogen bonds to the pyrimidine bases C and T, 
respectively. The duplication of the information in two strands provides a very stable and at the same 
time direct way to replicate the molecule as a single strand can become the template for the synthesis 
of the complementary counterpart20. 
Through the process called transcription, the letters in the DNA encode for the formation of a very 
similar yet different molecule, the ribonucleic acid (RNA) by a protein named RNA polymerase21. 
RNA molecules tend to be single-stranded; their nucleotides contain ribose, as well as the same bases 
except thymine that is replaced by uracil (U). Despite single-stranded RNA being less stable, its 
properties allow it to gain specific activities22. For example, RNA molecules can have catalytic 
properties representing a paradigm where genotype and phenotype are found in the same molecule. 
In fact, a strongly supported theory suggests RNA molecules as the true origin of life, before DNA 
was established as the main genotype carrier23.  
1 
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Figure 1 | The central dogma of biology 
The normal flow of biological information: DNA can be copied to DNA (DNA replication), DNA 
information can be transferred into mRNA (transcription), and proteins can be synthesized using the 
information in mRNA as a template (translation). Proteins are the major effectors in all steps.  
Next, RNA is used as an intermediate template to produce the final step on the process, the synthesis 
of proteins24. These polymers are different from DNA and RNA as they are composed of amino acids. 
It is in this last step, that the 4-letter alphabet is translated, whereby 3 letters are read in combination 
into 1 out of 22 possible amino acids; different 3-letter combinations can result in the same amino acid 
(the concept of degeneration of the code), and 1 and 3 of such combinations provide a signal to the 
system for respectively starting and stopping the incorporation of amino acids during synthesis of 
proteins.  
Amino acids differentiate between one another by their side chains, which contain specific atom 
groups and grant them different chemical properties. Again, the sequence into which amino acids are 
arranged in the polypeptide (called primary structure) will be essential as the order of the side chains 
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folding of the protein (tertiary structure) and even the formation of multi-protein complexes 
(quarternary structure). The preeminent characteristic of proteins is the expansion of the complexity 
of structural conformation possibilities (also called protein domains) by going from the 4 nucleotides 
to 22 amino acid combinations.  
Part I. Evolving genes, evolving transcription 
As hinted before, the DNA of the latest universal common ancestor (LUCA) of modern organisms 
must have carried several genes to code for the proteins needed to carry out the essential process of 
replication. Probably, either by copying mistakes, by the integration of viral genomes by horizontal 
gene transfer25 or by (sometimes incomplete) genome duplication and conversion during evolution, it 
would have also developed extra genes coding for proteins that had become beneficial in their 
primitive environment. Examples would be those regulating compartmentalization, the caption of 
nutrients across lipid-based membranes, the metabolism of some molecules for either energy or 
limiting intermediate substrates, etc26. 
Promoters and general transcription factors 
One of the first mechanisms that appeared to regulate transcription would have been promoters. 
Even the genes of “simple” bacteria contain combinations of DNA sequence elements (cis-regulatory 
elements) pointing to the transcription start point (TSS). Close-proximity short sequences serve to 
recruit DNA recognition proteins (trans-regulatory elements) such as general transcription factors, 
which aid the RNA polymerase to initiate transcription. While in bacteria this function is restricted to 
variants of a single protein (σ factor28), the intricacy of transcription increased in more complex 
organisms (such as eukaryotes). Notably, promoter modularity expanded both in sequences forming 
the core promoter and in general transcription factors29.  
While storing information into one single-strand of DNA to expand protein functionality would have 
been helpful, a selective transcription of each of the genes would also have been favored. Hence, the 
first mechanisms of transcription would have appeared at the beginning especially to maximize 
resources and separate pieces of information, but later to coordinate responses to  signals27. 
Transcription activators and repressors 
An early evolutionary innovation in transcription was the ability to switch on or off some of the 
functions of the organism. Thus, some trans-regulatory elements evolved to recognize and bind 
specific sequences (or DNA motifs) to select which genes to regulate. By definition, transcription 
factors (TFs) are proteins containing one or more DNA-binding domains (DBD) and they are often 
classified based on sequence similarity, structural folding of their DBDs and/or the DNA sequence 
they bind to. Examples of transcription factor families are basic helix-loop-helix (bHLH) factors, 
characterized by a motif of two α-helices (one of them with basic aminoacids) connected by a loop; 
zing finger (Znf) factors, which contain multiple finger-like protrusions that make contacts with their 
1 
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target nucleic acid using zinc or other metals ions to stabilize their folding; or homodomain factors, 
composed of three alpha helixes, with helices 2 and 3 forming a helix-turn-helix (HTH) structure30. 
Figure 2 | Range of characteristic sizes of the compaction states of DNA 
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TFs can either activate or repress transcription, depending on their protein functionality, allowing the 
modulation of transcriptional output in response to certain extracellular cues linked to cascades of 
intracellular signals. One of the first described examples is the bacterial lactose (Lac) operon, a two-
part control mechanism ensuring that the proteins involved in lactose metabolism are only expressed 
when lactose is available (by constitutive action of a repressor) and there is not a better source of 
energy such as glucose (activator dependent on a signal molecule)31,32.  
As I will mention below, the increases in the number of regulatory proteins in general and of TFs in 
particular is connected to phenotypic innovations and the evolution of more complex unicellular and 
multicellular organisms. 
Histones, chromatin and DNA remodeling complexes 
An inherent problem in the process of scaling up information storage is the limitation in structure, 
size and space-time accessibility33. As good as the retention of increasing numbers of genes may seem, 
there is a functional limit where it may become impractical to have an extreme long strand of DNA, 
roaming inside the cell (even if looping and coiling of naked DNA occurs34). In addition, too much 
available information at the same time makes coordination of genome control difficult25,35. Thus, 
another already early evolutionary innovation in gene regulation was the targeted compaction of 
DNA. Achaea, a microorganism phylum originally classified as bacteria, differs from the latter by 
containing innovative genes, especially in the regulation of transcription and translation. Among 
them, several Achaea have genes encoding for histones, positively charged proteins with the ability to 
interact with the negatively charged DNA, and fold it around them34,36.  
The term chromatin refers to the DNA in coordination with other molecules such as proteins or RNA. 
In more modern life forms called eukaryotes, the nucleosome is the basic unit of chromatin 
packaging37,38. It consists of a histone octamer core composed by two times the histone proteins H2A, 
H2B, H3 and H4 that wraps 146 base pairs plus a short DNA segment as linker39. Short-range 
interactions within an array of nucleosomes, mediated in part by the addition of histone H1, form 
chromatin fibers. Further compaction (by supposed rosettes) would organize the whole strand of 
DNA into (each of) the compacted chromosome(s) (Figure 2).  
However, chromatin compaction may very well not have emerged to solve the size limitation in the 
evolutionary process of genomic scaling, but rather – and more importantly to add a layer of gene 
regulation by dictating which parts of the DNA are accessible to being transcribed. As a consequence, 
together with the aforementioned nucleosome-based packaging, new regulatory components for 
efficiently defining the compaction state of specific genomic regions would have emerged. Through 
evolution, a wide collection of these chromatin remodelers would arise following the different 
strategies to regulate chromatin. For example, in eukaryotes several groups of proteins act together, 
i.e. in complexes, which in an ATP-dependent fashion remove, slide or exchange nucleosomes40.  
Although some of these processes and the needed components were already present in Achaea, the 
real expansion of chromatin remodeling began with the evolution of histones themselves, in 
1 
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particular by means of providing them with a protruding tail that are accessible on the outside the 
nucleosome41. These histone tails mediate inter-nucleosome interactions, but more importantly serve 
as more accessible sites to biochemically modify the nucleosome. New chromatin remodelers with 
enzymatic activity that catalyzes the covalent modification of polypeptides (post-translation 
modifications, PTMs) provide a means to alter the physico-chemical properties of histone tails 
depending on the groups conjugated to them and the position of the modification42. For example, 
adding acetyl groups to H3 at its lysine 27 (H3K27ac) would negate positive charges on histones, 
thereby disrupting the attraction of H3 to DNA43. As a consequence, these more relaxed chromatin 
regions (referred to as euchromatin) are more accessible for transcription to take place. 
Heterochromatin44 on the other hand refers to more densely packed regions of DNA which commonly 
associate with silencing of gene transcription , involving tri-methylation of H3 at its lysine 9 
(H3K9me3)45.  
Figure 3 | Epigenetic landscape of (A) heterochromatin and (B) euchromatin 
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The palette of PTMs at histone tails, or histone code, co-determines the activity of a certain genomic 
region46. Histone modifications, together with nucleosome remodeling, DNA methylation and various 
non-coding RNAs constitute the major mechanisms of alter gene expression without altering the 
DNA sequence itself. The study of the heritable transmission of such modulations to daughter cells 
isknown as epigenetics47.  
In addition to the regulation by chromatin remodelers (acting as writers or erasers), other proteins 
have evolved to read these histone modifications. Thus, their function became dependent not on the 
DNA sequence itself, but to previous actionof writers/erasers.Therefore, they outreach to all regions 
with a certain type of modification42 (Table 1).   
Table 1 | Histone post-translation modificationsand enzymes and their main role in gene transcription 
Modification Histone Position Enzyme Function in transcription 
Methylation 
H3 
K4 Mll1-4, Set1A,b Activation 
K9 
Suv39h, G9a, HMTase I, 
ESET, SETBD1 Activation (me1), Repression (me3) 
K27 E(Z) Activation (me1), Repression (me3) 
K36 HYPB, Smyd2, NSD1 Activation and internal gene initiation repression 
K79 Dot1L Activation (me1, me2, me3) 
H4 K20 PR-Set7, SET8 Activation (me1), Repression (me3) 
Acetylation 
H3 
K27 CBP Activation 
K56 Asf1+Rtt109 Activation 
H4 K16 hMOF Activation 
H2A.Z K14 SAGA (yeast) Activation 
Argenine 
Methylation 
H3 
R2 (Asymmetric) PRMT6 Repression 
R8 (Symmetric) PRMT5 Repression 
R17 (Asymmetric) PRMT4 (Carm1) Activation 
R26 (Asymmetric) PRMT4 (Carm1) Activation 
H4 
R3 (Symmetric) PRMT5, PRMT7 (mono me) Repression 
R3 (Asymmetric) PRMT1, PRMT6 Activation 
H2A 
R3 (Symmetric) PRMT5, PRMT7 (mono me) Repression 
R3 (Asymmetric) PRMT1, PRMT6 Activation 
Phosphorylation H3 S10 Snf1 (yeast) Activation 
Ubiquitination 
H2A K119 hPRC1L Repression 
H2B K120 UbcH6, RNF20/40 Activation 
1 
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Multicellularity and long-range regulatory elements 
The increase in response flexibility evolved by transcription regulatory networks(TRNs), which 
allowed ancestral unicellular organisms to develop the ability to induce different life cycle states 
tobetter adapt to changes in the environment. In order to orchestrate these radical changes in 
phenotype via using differential gene expression, their DNA sequence had to incorporate more cis-
regulatory elements. In other words, one cell would contain the information to transform to a 
different type as well as the switches to activate this transition.  
At the same time, either by selection forces (i.e. predation and the limitation of nutrients, increased 
global oxygen levels among others48)  some unicellular organisms, after being replicated, would 
behave as colonies by starting to aggregate, thereby creating the first multicellular organisms 
(metazoans)49,50.  
Until this point, the percentage of protein-encoding sequences in the genome of the first life forms 
was quiet high, fostering “useless” sections of DNA between genes may very well have been 
disadvantageous27. With the innovation of different cellular states and multicellular coordination, 
more cis-regulatory elements would then have to be developed, driving genome expansion. Hence, 
not only promoters, but pieces further away from the transcription start site (TSS) would then play a 
major role in gene regulation50.  
Enhancers or silencers are short regions of the genome that contain specific motifs for transcription 
factors and act as activation/repression switches for a gene (or sometimes a set of genes)that can be 
located over great distance51. As seen before in Figure 3, such elements are characterized by certain 
chromatin features. Although promoters have been recently suggested to act as long-range enhancers 
for other genes52, enhancers are the main distant regulatory elements that have expanded the spatio-
temporal transcription potential of the genome. This extension further allowed the evolution of more 
complex organisms, multiplying the number of cell types and developmental steps. As a result, the 
genome of these organisms started to be filled by non-protein coding regions, many acting as cis 
regulatory elements, to the point that the actual protein coding sequence only accounts for less than 
the 10% of the total DNA sequence in humans50. 
Chromatin loops, topology domains and insulators 
As mentioned above, DNA within the cell is compacted and folded. Even in bacteria, there are 
proteins involved in the folding and coiling of the DNA, creating a consistent and organized genomic 
architecture53.  
However, with the introduction of long-range regulatory elements, the conformation of the chromatin 
ceases to play a structural role only, but also starts to actively function as a further layer of 
transcriptional regulation. Besides the topologically associated domains (TADs; also seen in bacteria), 
which are static regions within the DNA where contacts are frequent, a great number of dynamic 
loops within TADs are observed in eukaryotes54,55. In fact, this observation consolidated one of the 
21
proposed models on how enhancers influence transcription at far distance, by looping into the 
promoter region56.  
Nonetheless, chromatin looping not only facilitates contacts; it can also negate the reach of enhancers 
or silencers by isolating them in a different domain. This phenomenon is mediated by insulators, with 
proteins such as CTCF that serve to set boundaries between genomic domains. Insulators can also act 
as barriers separating and stabilizing different chromatin states57.  
Figure 4 | Enhancer activation and promoter recognition 
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Figure 5 | Steps of transcription in an active promoter 
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Box 1. Chromatin regulatory macro-domains 
The need to coordinate complex genetic programs and the expansion in chromatin regulation 
mechanisms lead to the appearance of chromatin macro-domains, large regulatory modules involved 
in the fine-tuning of complex transcriptional output. Some of these prominent regulatory structures 
have been known for a long time. However, with the development of new epigenetic techniques and 
bioinformatic analysis, new regulatory features are being discovered along with their mechanisms of 
action and their role in global transcriptional regulation. Some of these “special” chromatin features 
include: 
DNA methylation valleys (DMVs): large regions (>3 kb) devoid of methylation that are often located 
in proximity to promoters of early developmental genes. Part of their mechanism of action is based on 
a rich GC content and a high association with special chromatin regulatory complexes, such as 
Polycomb type repressors58. 
H3K4me3 broad domains: regions among the top-5% domains with broadest H3K4me3 span. Mainly 
associated to promoters, they present high levels of paused RNA polymerase, which correlates with 
low transcription variability. In addition, these broad domains are relevant to to cell identity genes 
(factors required to establish and maintain the cell lineage)59. 
Locus Control Regions (LCRs): a combination of regulatory elements, mainly enhancers, that are 
capable of activating an entire gene locus even when placed in a totally different position in the 
genome. The first LCR to be identified was in the β-globin locus60.  
Clusters of open regulatory elements (COREs), stretch enhancers and super enhancers: the same as 
LCRs, these clusters of enhancers were identified by independent groups using genome-wide 
approaches. Back in 2011, using a combination of DNaseI and FAIRE sequencing approaches, COREs 
were identified in 7 different cell types61. Gene annotation to COREs already revealed that these broad 
domains were associated to cell-type identity genes. In 2013, a study integrating several histone 
modification profiles and expression data from 10 cell lines, identified a similar subset of regulatory 
elements termed stretch enhancers as they display extended lengths in epigenetic marks62. In the same 
year, the concept of super enhancers was proposed63. Defined by Mediator complex occupancy (or as 
seen in other studies by other transcription coactivators or epigenetic marks) and using a pre-defined 
list of stitched enhancers, the super enhancer label is assigned to the top most-enriched proportion of 
domains that surpasses an arbitrary defined threshold (i.e. dictated by the slope of a plot). As seen in 
stretch enhancers, super enhancers are associated to cell identity genes; they are found to be enriched 
in disease single nucleotide polymorphisms (SNPs).  
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Part II. The Swiss Army knife of transcription 
Discovery of the Mediator complex 
The eukaryotic rise of promoter complexity together with the expansion of general transcription 
factors acting at long distance enhancers was followed by the emergence of the Mediator complex 
(Table 2)64.  
Table 2 | Genomic features and evolutionary innovations in the kingdoms of life. Adapted from 64 
The first indications of the existence of Mediator came from studies on RNA polymerase II  (RNA Pol 
II) transcription in yeast (reviewed by one of its discovers in 65). Trying to decipher which components
were limiting for the reaction of transcription, Kornberg’s group showed in 1990 that adding 
activators, general transcription factors and polymerase was not sufficient to reach maximum 
transcription levels. It was only when a different fraction of yeast extract was added that the reaction 
Bacteria Archaea Protists and fungi Eukaryotes 
(E. coli) Average (S. cerevisae) Land plants (A. Thaliana) 
Drosophila  
(D. Melanogaster) 
Human 
(H. Sapiens) 
Stimated genome size (bp) 4,6 million 1,5-4 million 12 million 157 million 165 million 3 billion 
Protein-coding genes 3200 2000-5000 6000 25000 13000 20000 
% of non protein-coding genome 25,5 ~20 5-50 70 86,8 98,8 
General Transcription Factors Sigma factor Ancient TBP, TFII factors 
TBP, TFII 
factors TBP, TFII factors TBP, TFII factors TBP, TFII factors 
Core promoter elements - TATA, BRE TATA, INR* TATA, BRE, INR, MTE, Y-patch 
TATA, BRE, INR, 
MTE, 
TATA, BRE, INR, 
MTE, CpG 
Histones Ancient Ancient + + + + 
Histone tails - - + + + + 
Chromatin looping Architectural Architectural Architectural /Functional 
Architectural 
/Functional 
Architectural 
/Functional 
Architectural 
/Functional 
Chromatin remodelling Minimal Minimal + + + + 
Mediator complex - - + + + + 
HE
AD
 
MED6 - - + + + + 
MED8 - - + + + + 
MED11 - - + + + + 
MED17 - - + + + + 
MED19 - - + ++ + + 
MED20 - - + ++ + + 
MED22 - - + ++ + + 
M
ID
D
LE
 
MED1 - - + ? + + 
MED4 - - + + + + 
MED7 - - + + + + 
MED9 - - + + + + 
MED21 - - + + + + 
MED31 - - + + + + 
TA
IL
 
MED2/29 - - + + + + 
MED3/27 - - + + + + 
MED5/24 - - + ++ + + 
MED14 - - + + + + 
MED15 - - + ++++ + + 
MED16 - - + + + + 
MED23 - - - + + + 
N
.A
 
MED25 - - - + + + 
MED26 - - - - + + 
MED28 - - - + + + 
MED30 - - - + + + 
KI
N
AS
E MED12 - - - + + ++ 
MED13 - - + + + ++ 
CDK8 - - + + + ++ 
CYCC - - + ++ + ++ 
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was accomplished. This activity was named Mediator as it was hypothesized that would contain the 
scaffold connecting the rest of the transcription machinery66.  
Parallel studies such as the one from Young’s group found a multi-subunit complex associated with 
the C-terminal domain (CTD) of RNA polymerase II (RNA Pol II) although in that time it was not 
related to Mediator due to the co-presence of TBP and only 2% of the total yeast polymerase, not 
taking into account that the association could be transitory67.  
The biggest breakthrough came one year later with the purification of the complex in yeast, where 16 
subunits of the Mediator were identified. Besides the function in transcription activation, it was 
shown that the purified complex stimulated basal transcription by 10-fold and potentiated CTD 
phosphorylation by at least 30-fold68.  
Further studies highlighted the general role of Mediator in virtually all yeast transcription units69 and 
a Mediator cycle model was proposed where it would associate with RNA Pol II holoenzyme in a 
preinitiation complex (PIC), potentiate CTD phosphorylation that would start transcription and 
elongation, be released from RNA Pol II and re-start the cycle70.  
Early hints on the evolutionary conservation of Mediator came from the purification of the complex in 
mammals as a coactivator of nuclear hormone receptors71 and interestingly, by the electron 
microscopy observations that, besides differences in sequence, both yeast and mouse Mediator 
complexes folded in a similar way together with RNA Pol II holoenzyme72.  
Composition and Structure 
More than 30 subunits compose the Mediator complex in higher eukaryotes, with a combined mass of 
more than 1 MDa. From the early electron microscopy studies to chemical protein crosslink and mass 
spec approaches73, followed by the most recent cryo-electron microscopy (cryo-EM) experiments74, 
many groups have attempted to solve the structure of this macro-complex and to understand the 
mechanism of its binding to the transcription machinery.  
What is known so far is that Mediator subunits constitute four modules; a head domain and middle 
domain tightly bound with a more flexible tail at the base, plus a kinase module that can reversibly 
associate with the rest of the complex. Nowadays a unified nomenclature for Mediator subunits is 
used, established after the discovery of Mediator counterparts across species75. The subunits for each 
module in yeast include MED6, MED8, MED11, MED17, MED18, MED19, MED20, and MED22 in the 
head module; MED1, MED4, MED7, MED9, MED10, MED21, and MED31 in the middle module; and 
MED2, MED3, MED5, MED14, MED15, and MED16 in the tail module. Human Mediator subunits 
MED27, MED24 and MED29 are structural homologs of yeast MED3, MED5, and MED2, respectively. 
Further work on mammalian Mediator lead to the identification of additional subunits MED28, 
MED29, MED30, MED23, MED24, MED25, MED26, and MED27. The kinase domain in yeast is 
composed of MED12, MED13, CDK8 and Cyclin C (in mammals additional paralogs MED12L, 
MED13L and CDK19 have been found).  
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Although its presence is widely conserved across the eukaryotic lineage, the protein sequence and the 
complex subunit composition present high variation76. For example, seven Mediator subunits are 
unique to Arabidopsis (named MED32, MED33a, MED33b, MED34, MED35, MED36, and MED3777) 
and some eukaryotic lineages completely lack the kinase module64 (Table 2). 
In the context of transcription evolution, as new chromatin factors emerged it was equally important 
to coordinate them to the pre-existing transcription apparatus. Indeed, through the course of 
evolution, the Mediator complex adapted to recognize new partners by the appearance of new 
subunits, but also through elongation and mutation of existing ones. Most variation in structure 
resides in intrinsic disordered regions (IDR), which are abundantly found in the middle and tail 
modules, and proven to be domains of protein interaction and as target for PTMs78.   
Based on the rapid evolution of these IDRs a specific inhibitor with affinity to the fungal MED15 
subunit has been developed. This inhibitor disrupts the binding of a transcription factor which is key 
of the drug resistance pathway in fungi, but has no effects on human MED15 interactions with host 
transcription factors79. Hence, further research on species-specific Mediator differences could provide 
effective approaches to target eukaryotic pathogens (by disrupting specific IDR-TF interactions) not 
only focusing on human medicine but also in biotic stresses in plants (such as Mediator-IDRs based 
pesticides).   
Recent structural studies, in particular the two publications of the 3.4-Å crystal structure and 4.4-Å 
cryo-EM map, have resolved most of the quaternary structure of the head-middle core complex and 
greatly expand our knowledge on the dynamics of subunit conformation. For example, MED14 acts as 
a backbone where subunits from the head and middle assemble in addition to its contacts with the tail 
of the complex. As a consequence, its span over all modules makes MED14 essential for the 
documented structural shifting of the complex. MED17 serves as the major interface of the head 
module with MED14. The remaining subunits of the head module assemble in a conformation 
consisting of a connector neck with a jaw, part of which is movable and connects to RNA Pol II. 
Several subunits of the middle module interact with MED14 nicely complementary to its shape and 
forming a more rigid structure termed as hook, hinge, connector, knob, and plank. Both studies 
coincide that the middle knob and head neck domains of Mediator lock the CTD of RNA Pol II, 
triggering the further interaction of Mediator plank and the RNA Pol II subunit Rbp1. Due to its high 
mobility and disorder, only low resolution structures exist of middle subunit MED1 and the tail. 
Interestingly, the tail has proven not to be completely essential to the core Mediator although its 
presence is key for binding to DNA-binding transcription factors. Finally, a high resolution structure 
of the kinase module is currently missing, but it is hypothesized that it docks to the Mediator middle 
hook domain via MED13 (Figure 6). 
Functions of Mediator 
In addition to its aforementioned role in PIC assembly and RNA Pol II transcription initiation, the 
Mediator complex serves a wide range of functions, with most of them in transcriptional activation76.  
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Figure 6 | Subunit localization within the Mediator complex. Adapted from yeast studies74,80,81 
Often after metazoan transcription initiation, RNA Pol II pauses after 30-60 nucleotides via the action 
of NELF and DSIF complexes and resumes transcription via a process called pause-release, a rate-
limiting step dependent on elongation factors such as CDK982. Until recent studies, the specific 
localization and function of MED26 subunit was poorly described in part due to its inconsistent 
appearance in Mediator purifications. Meanwhile, MED26 has been identified as the link between 
transcription initiation and elongation; it serves as docking for the super elongation complex (SEC), 
switching Mediators binding from general transcription factors to elongation factors83,84. Moreover, 
CDK8 kinase activity is important for the recruitment of SEC to a different subset of genes, suggesting 
a parallel mechanism of elongation that depends on the target. Possibly, CDK8-SEC may play a role in 
early pause-release events when the gene has just been activated, with MED26-SEC ruling steady 
transcription afterwards85.  
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Roles in transcription termination have been also proposed, in particular via MED18. Both in yeast 
and plants, MED18 binding has been found at gene termination regions showing impairments in 
expression upon Med18 depletion86,87. 
From affinity purification of MED23 together with mass spectrometry analysis, a link with splicing 
factors of the hnRNP family was made88. Although association with the RNA processing machinery 
has to be taken with a grain of salt due to Mediator’s function in elongation, this new role of Mediator 
will have to be taken into account in further studies. 
Due to its ability to bind RNA Pol II at promoters via its core domains and transcription factors 
mainly via its tail module (an updated list of them can be found in 89), the Mediator complex has often 
been suggested to act as a bridge between enhancers and promoters. However, only recent studies 
where the genome binding of different Mediator subunits was sequentially studied showing that a 
single Mediator complex simultaneously contacts enhancers and promoters, finally provided the 
mechanistic prove to this model90. 
Mediator has meanwhile also been implicated in long-range interactions by helping Cohesin to 
promote the looping necessary for gene activation91;in addition, looping is essential for MED18-
mediated termination of transcription92. More importantly, a recent study in yeast indicates that the 
chromatin-bound fraction of Mediator occupies chromosomal interacting domain boundaries 
suggesting a more prominent role of Mediator in high-order genome structure93.  
Another complexity emerged with the inclusion of enhancer RNAs (eRNA) or activating ncRNAs 
(ncRNA-a), which is related not only to looping, but also to the transcription of non-coding RNAs 
(ncRNA) and the structure of Mediator. Although there is some controversy as to whether they are 
the same, it is clear that Mediator is involved in the transcription of ncRNA, which fold in a 
tridimensional molecular structure, aiding Mediator-mediated looping and potentiating the 
transcription of its target loci94.  
Due to its strategic location and exceptional size, the Mediator complex also constitutes a platform for 
coactivator recruitment. To date, more than 550 protein-protein interactions have been accounted for 
the human Mediator complex (according to Biogrid database). Well known chromatin regulators such 
as EP300-CBP, CHD1, the TRRAP complex and the SAGA complex interact with Mediator89,95,96,97. 
Recently, CARM1 (coactivator-associated arginine methyltransferase 1), also known as PRMT4 
(protein arginine N-methyltransferase 4) has been found in a high-throughput affinity purification 
based screen using MED9 as bait98. Although many of these complexes associate to TFs, the 
scaffolding effect of Mediator should be also considered for their recruitment. Nevertheless, the 
interaction of TFs with Mediator is required for the structural shift of the latter, allowing the 
recruitment of coactivators96,99.  
Along with interactors involved in direct chromatin regulation, Mediator has also been found to be 
post-translation modified by an increasing range of proteins. As previously mentioned, Mediator 
IDRs contain abundant sites for PTM and other studies show how signaling cascades converge on 
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these PTMs, affecting Mediator function in various ways. Global proteomics approaches have 
uncovered several PTMs on Mediator100, but very few mechanistic studies have as yet been . 
Nonetheless, MED1 phosphorylation mediated by MAPK/ERK101 or PI3K/AKT102 pathways appears 
important for MED1 association to the complex, looping and PIC assembly. In addition, work from 
Grosveld’s lab suggests that CDK9 phosphorylates MED1/9 (unpublished data). MED13 and MED13L 
appear to be phosphorylated and then degraded via the E3-ubiquitin ligase FBW7 mediated 
ubiquitylation, compromising the recruitment of the kinase module to the complex103. CARM1 not 
only acts as a histone modifier (see above), but has the ability to Arginine-methylate other proteins 
such as EP300/CBP104, but also MED12105 (see also this PhD thesis). A new working model on Mediator 
cycle of transcription implies degradation of not only the recruiting TFs, but also of the tail subunits 
of Mediator at enhancers80. As examples, yeast MED3 tail subunit was found to be degraded after 
CDK8 phosphorylation106 and MED15 was found to be destabilized by TRIM11107.  
In contrast to its function in transcription activation, Mediator has also been related to repression and 
silencing of expression, mainly accredited to the CDK8-kinase module based on its independent 
actions from the core. First, it was shown that in human cells Mediator containing the kinase-module 
repressed transcription108. In addition, mutations in the kinase-module resulted in gene expression 
upregulation 109,110,111. As mentioned, CDK8 kinase activity regulates transcription factor degradation, 
another example being Notch intracellular domain at enhancers112. Finally, the kinase module 
subunits interact with chromatin repressors such as G9a histone (H3K9) methyltransferase113, PRMT5 
(a histone arginine methyltransferase114) and the Polycomb repression complex (PRC)115. Along these 
lines,  intriguing studies relate Mediator to pericentromeric heterochromatin, hypothetically via a 
MED26-HP1 interaction116, and to telomere maintenance110,117,118.  
Finally, Mediator has been linked to the DNA-damage response (DDR). Indeed, MED17 recruits the 
DNA repair protein RAD2 to the genome and MED17 mutants result in increased DNA-damage 
sensitivity to cells119.  
Mediator in development and disease 
Subsequent to the recruitment by transcription factors and its interactions with epigenetic regulators, 
the Mediator complex plays crucial physiological roles. Aberrant function of MED1, MED12, MED21, 
MED23, MED24, MED31, and CDK8 subunit leads to embryonic lethality89. In addition, genetic 
screens to identify regulators of embryonic stem cell (ESC) state identified a long list of Mediator 
subunits as essential for OCT4 mRNA expression, encoding a TF master regulator of embryonic cell 
pluripotent state91.  
Other subunits, when mutated, display a defined phenotype due to aberrant interactions. such as 
MED19/26-REST in neurogenesis120, MED1 in adipogenesis121,MED14122 as interactor of PPARγ, 
GATA1-dependence on MED1123,124, MED15-Smad2/3/4 in mesoderm development125, the link of SOX9 
and MED12126 and MED25127 in chondrogenesis, MED12-SOX10 in oligodendroglia128 and MED23-
RUNX2 in bone development129. 
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Extensive studies of Mediator complex have also been carried out in plants. Besides roles in plant 
development, the idea of Mediator as a hub of transcription really shines in the coordination of 
signaling cascades in this eukaryotic kingdom. Many studies place Mediator as the nexus of many 
hormone-mediated responses to both abiotic stress (such as cold and drought), but also in the defense 
response to plant pathogens130.  
Many human diseases have an origin in Mediator dysfunction131. Not surprisingly, many of the 
Mediator-associated diseases have a developmental component. Remarkably, Mediator subunit gene 
mutations are a frequent cause of neurodevelopmental disorders, including X-linked intellectual 
disability (MED12132), microcephaly (MED17133), congenital retinal folds and intellectual disability 
(CDK19 haplo-insufficiency134), Charcot-Marie-Tooth disease (CMTD) and eye-intellectual disability 
syndrome (MED25135,136) and intellectual disability (MED23137). Together with intellectual disability 
and developmental delay, MED13L haplo-insufficiency syndrome features cardiac congenital 
defects138. Also affecting the heart, a chromosome deletion involving MED15 has been shown to cause 
cardiac conotruncus defects139. 
The correct fine-tuning of transcription is essential for cell homeostasis, and slight alterations can lead 
to malignancy. As central operator in transcription, the Mediator complex has the potential to play 
important roles in oncogenesis140. Indeed, many genes encoding for Mediator subunits have been 
found to be misregulated in cancer141, but few mechanistic studies have been published. For example, 
the very well described MED1 interaction with nuclear hormone receptors142 explains its implication 
to androgen143 and estrogen144 dependent tumorigenesis. In addition to that, the role in modulation of 
Wnt/beta-catenin145 signaling could explain in many cases Mediator´s implication in 
tumorigenesis146,147. Finally, the oncogenic role of the CDK8-kinase module148 could be targeted with 
the recent development of CDK8/19 inhibitors149. 
Part IV. Let’s get neural 
In addition to the described increase in transcription complexity, the expansion of genes involved in 
cell-cell communication and cell adhesion allowed the diverse evolution of metazoans and their wide 
radiation150. The innovation in signaling systems (biochemical pathways and their nuclear 
interpretation resulting in genomic transcriptional responses) granted the ability to generate more 
sophisticated body structures. This way, in early metazoans endodermal cells give rise to an internal 
digestive epithelium; the ectoderm, originally forming a protective epithelium towards the 
environment; and as a result of endoderm-ectoderm interaction, the induction from ectoderm of 
mesoderm, a mesenchymal layer between the other two151, giving rise to many cell types of may later 
tissues and organs.  
Neurons are ancient 
Even prior to the presence of mesoderm in the animal kingdom, a specialized cell type of the 
ectoderm (and in some cases endoderm) made its appearance, the neuron. Until that point, the chase 
of other organisms as a source of energy may have happened by sensing nutritional, chemical, light or 
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temperature gradients, basic processes that could be achieved by sensory cilia152. However, together 
with the formation of multicellular organisms, predation may have pushed the development of new 
fast and highly coordinated sensing-response strategies153. Neurons are specialized and high-energy 
demanding cells with the role of transmitting signals via chemical and/or electrical reactions to other 
neurons or other cells. Their shape can vary but they share common features such as the soma, the 
main body of the cell containing the nucleus; dendrites, cellular extensions acting in signal inputs, 
and axons, the principal projections acting as connection fibers and commonly acting in output 
signaling. The synapse is the contact structure between neurons (or between neurons and non-
neuronal cells) where chemical neurotransmitters are exchanged154. The establishment of synapses 
(synaptogenesis) requires a complex machinery of proteins acting as synthesizers, releasers, 
transporters, receptors and modulators. Interestingly, a basic neural genetic toolkit is already present 
in more ancient organisms such as choanoflagellates, unicellular organisms closely related to the first 
metazoans155 and it has been proposed that multicellularity and gene duplications unlocked their 
potential to form the first synaptic structures in evolution.  
From hundreds of neurons to millions 
Soon in metazoan evolution the appearance of an embryonic region capable of generating a nervous 
system was selected in order to integrate and coordinate neuronal networks across the body. 
Particularly in symmetric bilaterians, the nervous system became internalized, anteriorized and 
concentrated in a mass termed brain and a connecting web of nerve cords156. Early evolutionary 
examples of the first bilaterians with brain are nematodes such Caenorhabditis elegans which contain 
302 neurons in the whole body, and its study has helped the general understanding in eukaryotic 
development and neurophysiology157.  
Gene duplication is a major evolutionary mechanism as it provides new copies of genes that can 
diverge to acquire new functions158. Vertebrate genomes contain multiple paralogs of many genes of 
the fruit fly (Drosophila melanogaster). Such is the case of the Hox genes which invertebrates have a 
single Hox cluster corresponding to four human and mouse equivalent A-D HOX clusters, although 
the duplications are not perfect159.Notably, the number of coding sequences in vertebrate genomes 
does not scale proportionally to their increased length, indicating that – as illustrated above – many if 
not most of the duplicated genes were lost. However, and quite interestingly, there is a 
disproportional retention of genes involved in developmental processes and neural activity. This 
increase in the genetic toolkit in addition to the refinement of cis-regulatory regions coincides with the 
appearance of the first vertebrates (chordates) almost 500 million years ago160.During the course of 
evolution this combination allowed  the expansion of the nervous system both in size and 
complexity161. 
From an egg to a brain, study of neural development 
As brains became larger, the number of neurons and their connectivity also increased, allowing also 
animals to adapt to more diverse environments and facilitating their radiation. This phenomenon of 
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evolutionary encephalization is more patent since the emergence of placental mammals 100-150 million 
years ago. The forebrain began to expand rapidly, producing additional cortical subdivisions and 
more complex neural networks167. 
BOX 2. The mouse as a model organism 
Nowadays many different eukaryotic species are used in research ranging from the unicellular yeast, 
a wide range of plants, small worms and flies to bigger vertebrates such as fish, frogs, mice and rats, 
guinea pigs or even monkeys and apes. All of them are powerful model organisms to study in vivo 
biological process that can be, always with certain bias, extrapolated to the human physiology. The 
use of model organisms has been fundamental for the advance of not only our general understanding 
of biology but to great improvement in medicine of the past centuries162.  
Mice have been formally studied since the beginnings of the 20th century. Their resemblance to the 
human physiopathology and development, their small size and easy handling and relative short life 
cycle have fomented its use as a model organism. Currently mice account for more than 60% of all 
vertebrate models used in research with more than 7 million exemplars used each year only in the 
European union (stats from 2011163). In 2002, its genome became the first mammalian one completely 
sequenced, and with the sequencing of the human genome a year later; it was shown to share around 
80% of the same protein coding genes164. Due to their high similarity to humans, mice often provide 
good models to study and understand human physiology and complex genetic diseases. 
Furthermore, the development of genetic engineering has allowed the creation of mice carrying 
specific mutations to mimic different phenotypes and up to this date there are more than 41000 
different mice strains165. Nonetheless, mice are used not only as research models but also as producers 
of therapeutic agents such as antibodies, which with recent technologies have reach the milestone of 
humanized monoclonal peptides166.  
But how is this intricate structure that we called brain formed? As hinted before, the answer relies on 
the tight spatio-temporal combination of genes and regulatory signals that shapes the development of 
the organism from its starting point, the fertilized egg or zygote.  
Embryonic stem cells, mothers of all cells 
Indeed, at the moment of the fertilization of an oocyte by a spermatocyte, yieldingthe 1-cell zygote, all 
the genetic information to generate, maintain and reproduce the new organism is already contained 
within the zygote. In mammals, this developmental plan starts already while the zygote and the 
arising cleavage-stage embryos travels to the uterus (for implantation). In the mouse, it takes about 
2.5 embryonic days (E2.5) to generate a mass of 8-16 cells named morula. Between 16-32 cells the first 
developmental decision is taken as cells of the morula after compaction have to provide the embryo 
with cells that will become the proper embryo on the one hand and on the other hand, cells needed 
for implantation of the early (E3.5) and then late (E4.5) blastocyst. The net result is the formation in 
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the (cavitated) blastocyst of asymmetrically distributed inner cell mass (ICM) cells (at the embryonic 
pole of the blastocyst) and the trophectoderm cells surrounding the entire blastocyst, respectively. 
Interestingly, not only transcription factors play a role as chromatin modifiers such as CARM1 may 
also be essential for this process168.  
Until this point ICM cells have the potential to give rise to all of the cell types of the future embryonic 
and adult body, just like this is achieved in the mouse embryo by gastrulation, which starts at E6.5. 
Hence the term embryonic stem cells (ESCs), the cell culture derived counterparts of ICM cells of the 
pre-implantation blastocyst, for their pluripotency allows them to generate all cells for the 
development of the organism.  
Indeed, ESCs can be isolated from pre-implantation blastocyst stage mouse embryos and  their 
pluripotent state can be maintained in well-defined cell culture conditions169. This enables their 
expansion and, using different cell culture conditions, their differentiation along the three germ layers 
and cells derived thereof170. Undifferentiated ESCs can be modified by genetic engineering and then 
transplanted back to a non-compacted morula or injected into a forming blastocyst from an acceptor 
embryo giving rise to chimeric mice, which after appropriate crossing can generate full genetically 
modified organisms171. Moreover, the ability to expand ESCs in high numbers and differentiate them 
to particular cell types with high or sufficient efficiency has been fundamental for the development of 
new cell-based therapeutic strategies in regenerative medicine172. Thus, the study of ESCs, based on 
initial crucial work with mouse ESCs, has attracted a lot of attention not only due to its human clinical 
potential, but also – and important for this PhD thesis - as an excellent cell model to study 
transcriptional regulation during development. 
One of the major fields in ESCs research is the study of the extrinsic and intrinsic signaling systems 
and resulting pathways that govern the self-renewal and (the meanwhile various) pluripotency states 
of these cells. For example, the inhibition of glycogen synthase kinase 3 (GSK3) by Wnt signaling 
supports ESC self-renewal and, together with the block of the FGF pathway   inhibition of ERK, 
constitutes a 2-inhibitor (2i) cocktail widely used in cell cultures. On top of that, LIF, a product of the 
trophoectoderm, signals to ESCs via the LIFR and the downstream STATs, supporting self-renewal, 
hence many protocols opt to culture ESCs in serum/LIF conditions. However, ESCs cultures with 
serum/LIF seem more heterogeneous, resembling more the ICM cells of the late blastocyst, and are 
not identical to the 2i-mediated ground state170,173. 
The integration of the aforementioned LIF, FGF, Wnt and likely BMP (present in serum) extrinsic 
signals converges to the nucleus where the action is taken by downstream transcription regulators. 
Among them, Oct4, Sox2 and Nanog constitute a well-described transcription factor core system that 
is key to pluripotency acquisition and maintenance, and acts via auto-regulatory feedback loops. The 
study of these factors has led to the discovery of many others acting with them174 and the genomic 
characterization of the epigenetic landscape of ESCs have expanded the core TFs to include others 
such as Klf4, Esrrb and Prmd14175. One of the most notable accomplishments in the study of ESCs 
transcription has been the use of Oct4/Sox2/cMyc/Klf4 TFs in order to reprogram somatic cells to i.e. 
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induced pluripotent stem cells (iPSCs)176. Although the process is not very efficient, it provides 
circumvention to the ethical problems of obtaining human embryonic tissues. Such iPSCs represent 
the opportunity to develop therapeutic strategies using cell systems derived from patient-own cells177.  
Another particularity of ESCs is their epigenetic landscape. Due to their ground-state in development 
and their potential to differentiate to the three main lineages, ESCs chromatin seems to be more 
permissive than more mature cells. Instead of strong defined heterochromatin silenced regions, many 
developmental genes in ESCs appear to be repressed in a less sturdy manner showing a poised state 
with activation marks. These bivalent domains are characterized by the histone mark H3K27me3 and 
they are regulated by the repression of Polycomb group (PcG) of protein complexes, PRC1 and 
PRC2178,179. Hence, the specific de-repression of some of these genes casts the path that the cell will 
take into its final lineage. Most bivalent genome domains shift to a single state upon differentiation, 
although bivalent domains can also rise in several steps of development when the cell is at a 
crossroad of determination180.  
Neural ectoderm and neural stem cells 
Even before implantation to the uterus, the second lineage specification begins to take place within 
the ICM cells to separate them in epiblast, which will compose the mesoderm and ectoderm; and 
hypoblast (or primitive endoderm) which will give rise to the visceral and parietal endoderm. A 
round of division later, around E4,5 a cavity starts to form in a process called gastrulation and the 
embryo starts to reorganize into a multilayered structure181 (Figure 7A). 
The nervous system originates from the induced neuroectoderm, which around E7.5 as a thickened, 
but flat neural plate wherein all cells have the potential to become neural cell types, but they will not 
all do so, as Delta-Notch signaling will provoke lateral inhibition in these cells; furthermore, the 
neural plate matures via patterning in anterior-posterior direction. FGF secreted from the anterior 
neural ridge (ANR) plays an important role in this, while the neural plate is also flanked by neural 
crest cells and the ectodermal placode cells, which can only arise at intermediate concentrations of 
BMP, whereas BMP activity has to be avoided in the neural plate itself. In response to signals between 
this neuroepithelium (NE) of the neural plate and surrounding tissues, also a longitudinal groove 
forms along the neural plate (referred to as the process of neurulation) and, at different points, the 
neural plate will display hinges around which it curves on itself to give rise to the neural tube. 
This developing neuroepithelium will generate most of the neurons and the non-neuronal cells (glial 
cells) of the CNS182. At the start of gastrulation, cells from any part of the ectoderm can still develop as 
either epidermis or neural tissue. Here is where morphogenetic positional signals produced both from 
within and outside the ectoderm play a crucial role in the process of neural induction (Figure 7A).  
One of the most prominent signals in this stage of development is BMP, the production of which in 
Xenopus progressively concentrates in the ventral and lateral mesoderm and acts as a ventralizer of 
mesoderm, dose-controlled mesoderm patterning factor, epidermis promoting factor and neural 
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induction inhibitor. In the mouse its antagonism (by molecules such as Noggin, Chordin and 
Follistatin, and the Wnt/Nodal/BMP antagonist Cerberus) is not sufficient to induce neural fate183. 
Figure 7 | Early steps in mouse embryogenesis 
A. From fertilization to embryonic day 8 (E8); Note that embryonic stem cells can be isolated from the inner cell 
mass of the blastocyst to establish cell culture models. Around E6.5 the process of gastrulation starts (triangles 
indicate morphogen signaling, yellow line indicates the primitive line). B. Process of neural tube 
formation (triangles indicate morphogen signaling).  
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Indeed, FGFs produced by the prospective neural cells, acting as neural inducer proteins possibly by 
a direct effect in preventing BMP transcription in the mouse anterior visceral endoderm (AVE) and 
embryonic ectoderm184. However, lateral epiblast cells in close vicinity have been claimed to be 
insensitive to the FGF gradient. Consequently, it has been shown that Wnt signaling is also a critical 
determinant of non-neural fate as its continued signaling blocks the FGF response185 (Figure 7B).  
While the neural tube is formed, it is at the same time subdivided into discrete territories according to 
the levels of morphogens (and neural-promoting antagonists) generated by several signaling centers. 
In addition to the anterior(rostral)/posterior(caudal) patterning established by BMP, FGF and Wnt 
gradients, a dorsal/ventral axis settles during neurulation and in the closed neural tube with the 
action once more of BMPs, this time secreted by the roof plate of the neural tube; and Sonic hedgehog 
(SHH), secreted in large amounts from the notochord and in the most ventral part (non-neural cells; 
floor plate) of the neural tube. Furthermore, along the neural tube the paraxial mesoderm also 
influences the neural tube anterior-posterior patterning in the trunk region of the embryo by the 
generation of retinoic acid (RA), which is essential for the development of the medial segments of the 
neural tube that give rise to the hindbrain and the spinal cord. The interplay between these gradients 
is not only fundamental for the proper patterning of the CNS, but also for the specification of the 
neuronal sub-types along the dorsal-ventral axis of the neural tube that will give rise to interneurons 
and motor neurons, respectively, from cell progenitors. Only with the study of the proper signaling 
within and to the CNS it has been possible to generate specific neuronal populations in cell culture186.  
The combination of dosed signals and their interplay triggers the activation of cell-intrinsic factors 
that regulate the competence of the neural ectoderm. For example, SHH signaling is integrated by the 
vertebrate Gli family (GLI1-3) of TFs acting early in neural plate formation187. Very similar to Gli 
protein domains, the Zic family is involved in neuroectoderm differentiation after BMP 
inhibition188,189. In addition to Zic family proteins, the BMP antagonism is mediated in part by (likely) 
anti-BMP-Smad action of Zeb2, a multifunctional DNA-binding transcription factor that is needed 
intact for activation of neurogenesis genes such as Sox1-2and also acts in BMP-sensitive neural crest 
cells190,191.  
Derepression of neural genes by the degradation of pluripotency factors and differentiation blockers 
is also a well described mechanism of neural induction. For example, REST neuronal repressor 
already starts being degraded in the transition from ESCs to the neural commited progenitors 
allowing the expression of neural induction transcription factors like Ascl1 while repressing terminal 
neuronal differentiation192. Another case is the down regulation of neural tissue relevant miRNAs that 
e.g. target Zeb2 and Pax6 TFs during neural induction and the loss of ESCs pluripotency193. Finally, 
many poised genes resolve into an active state by the regulation of Polycomb-mediated repression 
and the action of chromatin modifiers such as demethylase JMJD3 (also known as KDM6B), which 
removes H3K27me3 marks of neural genes194. 
Following the exit from pluripotency to neural commitment  Sox2, which is already present in ESCs, 
has been shown to be bound to poised neural enhancers195. In fact, the whole SoxB1 family of 
37
transcriptions factors act early in neural induction. Sox1 expression starts as soon as the appearance of 
the neural plate and is downregulated after neural tube formation, hence it may be a marker of early 
neural induction196. Sox3, another early marker, is expressed promptly in the ectoderm and it has been 
shown to co-occupy Sox2-bound genomic regions in neural-induced cells195. Together with other TFs 
such as Geminin and Zic2, Sox2 and Sox3 are essential for the maintenance of an immature 
proliferating state of neuroepithelial cells (NE cells).  
Thus, NE cells are neural stem cells (NSCs) and start to appear in the ventricular zone (VZ) of the 
neural tube as early as E8.5 in the mouse, dividing mostly symmetrically to rapidly expand the stem 
cell pool. The correct regulation of their expansion and survival is vital to achieve a suitable nervous 
system. In fact, disorders affecting the NSCs pool lead to major neurodevelopmental disorders such 
as microencephaly, where the exhaustion of self-renewing NSCs leads to smaller brains often 
associated with intellectual disability in various human syndromes197.  
NSCs can be isolated from mouse embryos and, by applying the right culture conditions (adding 
growth factors like FGF and EGF), can be expanded while retaining their multipotent capacity198. The 
in vitro culture of NSCs has widened the possibilities for their study, notably at the biochemistry level, 
given insights in the chromatin landscape dictating their physiology199–201. The transcriptional 
networks regulating NSCs are enriched for basic helix-loop-helix (bHLH) factors such as factors of the 
Hes, Id, Olig and NeuroD families as well as other E-box binding proteins such as E2-2 (Tcf4). Their 
mRNA expression vary according to the signaling they receive, depending on their localization across 
the developing CNS202. This dynamic regulation of the level of expression of these neural genes also 
determines the future fate of NSC progeny. The antagonistic action between Hes and Id self-renewal 
factors against the proneural differentiation effects of NeuroD1, Ascl1 and Ngn2 appears to 
oscillate203, keeping the progenitor state in a fragile equilibrium until single-fate determination factors 
take control.  
The most anterior part of the neural tube termed as telencephalon will give rise to a significant part of 
the human brain, the cerebral cortex, believed to endow mammals with the ability to perform 
complex tasks. Around E10 NE cells in this part of the embryo transit into a new NSC type, the radial 
glial cells (RGCs). RGCs define the architecture of the entire future neural tube as their soma and 
basal body lie in the VZ and a long radial process extends from their cell body to the pial surface of 
the (rapidly broadening) neural tube. While both NE cells and RGCs express the neural progenitor 
marker Nestin, RGCs also contain the specific markers Glast, Blbp and Rc2, and later Pax6204. Different 
populations of RGCs have been described, but in general terms it has been shown that RGCs undergo 
symmetric and asymmetric cell divisions, not only expanding the numbers of NSCs, but also 
generating more differentiated neuronal cells205. 
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Neurogenesis 
The onset of neurogenesis in the mouse cortex starts around E10-11 with the asymmetric divisions of 
RGCs, which will give rise to post-mitotic neurons or intermediate progenitors, which move to the 
subventricular zone (SVZ) (Figure 8).  
The neurogenesis switch seems to be triggered in vivo by many cues that break the exclusive 
expanding progenitor state of the neuroepithelium and favors the transition to neuron- producing 
RGCs. Besides Notch signaling (through Hes family of transcription factors206), Pax6 and FoxG1 seem 
to be directly involved in the NE to RGCs transition together with the action of FGF (Fgf10 expression 
starting around E10 in the VZ)207. The BMP role is complex as after its initial neural-inhibitory activity 
it seems to be involved subsequently in blocking neurogenesis and promote astrogliogenesis208. RA 
produced by the meninges (mesenchymal layers that surround the CNS and act as protection and 
exchange layers) is also fundamental to cortical neurogenesis209.   
The intrinsic effectors of all these extrinsic signals are generally termed proneural genes as they 
activate neuronal terminal differentiation or (in the mouse, subsequent gliogenesis). As already 
mentioned, bHLH factors such as the Neurogenin family and Ascl1, can induce rapid and full 
neuronal differentiation. Interestingly, both Ngn2 and Ascl1 have the capacity to directly reprogram, 
including in vivo, other differentiated cells into neurons210,211, denoting a pioneer master regulatory 
effect. Downstream this wave of early proneural genes, a wide range of secondary factors such as 
those of the Dlx, NeuroD, SoxC (Sox4 and Sox11) families, together with Tbr2 settles the neuronal 
fate212. Besides the downregulation of progenitor functions, several of these proneural transcription 
factors later target genes involved in cell-adhesion, axon guidance, guided cell migration, cell shape 
changes and synapse formation, preparing the newborn neurons first to reach their correct 
destination and later develop an arborized axon projecting structure213. 
In addition, cell cycle control is decisive during CNS development214. First, NSCs undergo rapid 
divisions with the need to tightly control the mitotic apparatus. On the other hand, the birth of post-
mitotic neurons is linked with the exit from the cell cycle, establishing them in an undefined G0 phase. 
Hence, many transcription factors also target cell cycle regulators like cyclinD1 (ccnd1) and CDK 
inhibitor p21215–217.  
As neurons are born from RGCs or intermediate progenitors in the SVZ, an essential process of 
lamination into layers starts. RGCs provide the pillars where newly generate neurons migrate from 
the VZ/SVZ into the cortical plate forming eventually, as time proceeds and the brain cortex grows in 
thickness, an “inside-out” gradient of maturation. The correct migration of the different neuronal 
populations into layers is regulated not only by the contact with RGCs but a wide range of signaling 
molecules. For example, the earliest-formed cortical neurons that generate the outer layer I, termed 
preplate, express Reelin, an extracellular matrix molecule essential for the correct positioning of 
newborn neurons218. Meanwhile, it has been shown that TFs such as Zeb2, also an E-box binding TF, 
in the upper layers signal in a non-cell autonomous fashion back to the stem cells in the VZ by 
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regulating (as a transcriptional repressor) the levels of neurotrophins and FGF ligands that time 
neurogenesis and gliogenesis, respectively219.  
Figure 8 | Mouse central nervous system development
Telencephalic development is highlighted apart. Note that several cell culture models can be established by 
isolating specific parts of the brain in different windows of time. 
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While neurons born in the dorsal part of the telencephalon (pallium) occupy their designated layers 
by radial migration and the neurons formed are pyramidal, excitatory neurons, the inhibitory 
GABAergic interneurons, which compose around 20% of total neurons in the cortex, migrate 
tangentially from subpallial structures (termed ganglionic eminences) along well-defined paths to 
invade and later integrate radially into the cortical neuron network220.  
As seen, such migration is fundamental to many phases and locations of the nervous system 
development and its impairment is accordingly the cause of several brain diseases221. Many molecules 
that direct migration can act as attractants or repulsers first for the whole cell but also later for its 
projections. Among them, Netrin, Ephrin and Semaphorin families have a central role222. 
Fascinatingly, mutations in the Integrator complex, which is involved in metazoan RNA Pol II pause-
release among other functions223, also produce cortical migration defects, insinuating specific roles in 
development for the general transcription machinery224. In addition to that, large numbers of neurons 
die by programmed cell death during the first steps of brain maturation in a competition process for 
establishing the proper connections. Axon guidance molecules and the final connection with 
synapses, accompanied by the action of neurotriphins such as BDNF, dictate the survival of post-
mitotic neurons225.  
According to the time of generation and their positioning, neurons from each layer and region of the 
cortex are influenced by specific signal inputs determining the specific cocktail of proneural genes 
that define their neuronal sub-type identity. First, RGCs at the VZ/SVZ are identified with Pax6, 
FoxG1 plus Emx2 and Lhx2. In addition, intermediate progenitors in the SVZ expressed Cux1-2 and 
Tbr2. Later, upper layer markers are Cux1-2, Mef2c, Brn1-2 (Pou3f3/Pou3f2, respectively) while Sox5, 
Foxp2, Fezf2 and Tbr1 represent deep layer markers226,227.  
After the process of embryonic neurogenesis that mostly takes place between E11-16 in the mouse, a 
major switch in RGCs occurs as they start producing macroglia, which are different subtypes of non-
neural cells. Macroglia are involved in the homeostatsis of neurons in processes such as metabolic 
support, myelinization of the axons, signaling in neuronal migration and maturation, brain repair 
after damage, immune reaction response (in combination with the microglia of mesodermal origin) 
and even on synaptic communication228.  
The switch to gliogenesis, time wise, is also highly regulated by proneural genes as many of them act 
as glial lineage blockers. Hence, the downregulation of genes such Ngn2 is the first step of gliogenesis. 
It has been shown that neural intermediate progenitors and early born neurons signal the 
surrounding cells via the Notch pathway229, which in coordination with JAK/STAT signaling, lead 
Nuclear Factor IA (Nfia), Olig2 and SoxE family (Sox8, Sox9 and Sox10) to promote glial specification. 
Zeb2 is needed for the correct timing and extent of gliogenesis in the developing brain and for 
counteract inhibitory effects of BMP (and Wnt) action in myelinogenesis219,230.  
41
BOX 3. Seahorse of memory, the hippocampus 
Buried deep within the medial temporal lobe lays the hippocampus. Although residing in the 
telencephalon, its network is organized quite differently from that found in the cortex. With all 
principal cells in a single layer and the synaptic inputs to well defined dendritic lamina, the 
hippocampus has become the major model to study neurophysiology. In addition, its capacity to 
survive sliced in vitro for long periods of time have revolutionized the field of electrophysiology.  
Furthermore, its abundance of pyramidal neurons has selected the hippocampus as a good source of 
homogenous neurons frequently used to study plasticity, pharmacological effects and intracellular 
features. Hence, the hippocampus is one of the most widely studied regions of the brain not only for 
its central role in memory and its dysfunction in Alzheimer’s disease but also as a model of synaptic 
plasticity.  
On top of this, the extraordinary discovery of the hippocampus as one of the few sources of new 
neurons in the adulthood (together with the SVZ in humans, plus the olfactory bulb in mice), has 
pushed the study of the hippocampus to new frontiers231. 
Neural maturation 
The generation and migration of neurons to their predetermined locations are only the first steps in 
the developing brain. Right after birth, post-mitotic neurons are far from being functional. Instead, 
neurons will endure a long process of neural maturation that will keep ongoing even postnatally. 
Interestingly, the same post-mitotic cell that is round-shaped at birth will first have to mold into a 
migrating format in order to reach its destination but later will suffer major morphological changes to 
develop the synaptic structure. Thus, neurons switch from the expression of cell movement and 
guidance receptor proteins to synapse machinery and axon guidance, accompanied also by changes in 
genes involved in metabolic control232.  
Once neurons integrate to their destinations and establish connections via their axon and dendrites, 
specific transcriptional pathways regulate the processing of information. The connectivity of the CNS 
is flexible in order to be able to achieve processes such as memory and learning233. This synaptic 
plasticity can be achieved due to the transcriptional control of genes that regulate synaptic formation 
via cascades triggered by synaptic activity.  
Calcium is the major intracellular molecule of synaptic activity as its influx to the neuron is regulated 
by channels that depend on membrane depolarization. Calcium is recognized by sensors such as 
kinases CamKI-II which activate by phosphorylation the transcription factor CREB, which in turn 
quickly induces the immediate-early genes c-Jun and c-Fos. These three factors together with MEF2 
and NPAS4 control the activity-dependent transcription of a wide number of activity-regulated 
genes234. Nevertheless many other transcription factors have been suggested to be involved as well, 
i.e. SRF, ELK, NFAT, NFkB, DREAM, NeuroD, SP4 and CREST235.  
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Perhaps the gene Bdnf (encoding Brain-derived neurotrophic factor) is the best reference of activated 
targets upon synaptic activity. Secreted BDNF has a central role in neuronal survival, dendritic 
growth and synaptic development. At the molecular level, the regulation of its multiple isoforms, the 
peptide maturation and secretion have been a focus of incessant interest in neuroscience236. Besides 
Bdnf, other targets such Arc, Homer-1a and Zif268 genes and encoded actors consolidate synapses and 
help the long-term potentiating of connections237.  
Interestingly many of these activity responses start to take effect intermittently before neurons do 
fully mature. In fact, synaptic activity is crucial for the survival and maturation of the neural cell, and 
neural maturation can only be understood in the context of synaptic activity238.  
As seen, the TRN governing differentiation and functionality of matured neurons have been 
molecularly explored in depth and continuously receive attention. However, the transition period 
representing the maturation from early post-mitotic phase to a fully arborized neuron remains still 
poorly understood. While differentiation and synapse formation seem to be highly extrinsic regulated 
processes, maturation seems to be more cell-intrinsic239–241.  
Indeed, there is abundant evidence pointing to a major autonomous switch in chromatin regulation 
happening in a short window of time during neuron development. One of the earliest indications that 
neurons transform their chromatin landscape was the observation of changes in the location, size, and 
number of nuclear structures such as chromocenters and nucleoli during their maturation242. More at 
the biochemical level, it was shown that neurons present shorter nucleosomal repeat length and lower 
levels of histone H1 than glia, suggesting a genome-wide lineage-specific regulation of chromatin243. 
More recent epigenetic studies have revealed a shift from hypo to hyper DNA methylation during 
neural maturation. DNA methylation at cytosines mediated by methyltransferases such as Dnmt 
family is a very dynamic phenomenon across development. Interestingly, while most methylation in 
the embryo occurs at CpG, during maturation neurons present significant methylation at non-CpG 
sites244. Methylation of the DNA is a powerful mechanism of epigenetic repression due to its 
recognition by methyl-CpG-binding domain (MBD) proteins that in turn recruit corepressors such 
histone deacethylases (HDACs)245. In CNS development, one of most studied MBDs is methyl-CpG-
binding protein 2 (MeCP2) as its mutation causes Rett syndrome, a progressive neurodevelopmental 
disorder and one of the most common causes of mental retardation in females246. Its role in repression 
has been widely studied247. For example, its phosphorylation after synaptic activity allows the 
derepression of the Bdnf gene248.  
One of the latest breakthroughs in neuronal epigenetics has been the discovery of an enrichment of 5-
hydroxymethylcytosine (5hmC) in the developing CNS249,250. Previously thought to be just an 
intermediate in the demethylation processes mediated by TET family proteins, it has been shown to 
play a physiological role in neurons. More specifically, 5hmC increases during neuronal maturation 
accumulating at active neural-specific gene bodies250.  Fascinatingly, MeCP2 Rett mutations impair the 
binding to 5hmC rather than to 5mC thus revealing a new role for MeCP2 in transcription 
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activation251. With the previous observation that MeCP2 competes with linker histone H1in vitro252, 
and that MeCP2 is nearly as abundant as the histone octamer only in neurons253, a model has been 
postulated where MeCP2 largely substitutes for histone H1 and is distributed throughout the 
genome; at heterochromatin, acting as a suppressor but also at euchromatin, where its binding to 
5hmC would favor transcription254. Hence, MeCP2 seem to be a central epigenetic regulator during 
neuron maturation.  
Nonetheless, a transcription factor response during neuronal maturation is missing. While other 
epigenetic mechanisms like micro RNAs could explain MeCP2 post-transcriptional regulation255–257, a 
sequential regulation of transcription factors could be expected, starting from early post-mitotic 
phases and switching to synaptic active states.  
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ABSTRACT 
Mediator complex regulates transcription by connecting enhancers to promoters. High Mediator 
binding density defines super enhancers, which regulate cell-identity genes and oncogenes. Protein 
interactions of Mediator may explain its role in these processes but have not been identified 
comprehensively. Here we purified Mediator from neural stem cells (NSCs) and identified 75 novel 
protein-protein interaction partners. We identified super enhancers in NSCs and show that Mediator-
interacting chromatin modifiers colocalize with Mediator at enhancers and super enhancers. 
Transcription factor families with high affinity for Mediator dominate enhancers and super enhancers 
and can explain genome-wide Mediator localization. We identified E-box transcription factor Tcf4 as a 
key regulator of NSCs. Tcf4 interacts with Mediator, colocalizes with Mediator at super enhancers 
and regulates neurogenic transcription factor genes with super enhancers and broad H3K4me3 
domains. Our data suggest that high binding-affinity for Mediator is an important organizing feature 
in the transcriptional network that determines NSC identity. 
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INTRODUCTION 
The Mediator complex is a complex of ~ 30 subunits that is important for transcriptional regulation 
and is conserved from yeast to human1–4. The Mediator complex provides communication between 
active enhancers and promoters by interacting with proteins that bind to either of these two classes of 
regulatory DNA elements4–6. Accordingly, identified Mediator-interacting proteins include many 
transcription factors, RNA polymerase II (RNApol2) and transcription elongation factors7. Recently, 
Mediator content was used to rank enhancers in embryonic stem cells (ESCs) and enhancers with the 
highest Mediator content were postulated as super enhancers (SEs)8, a class of enhancers that 
regulates key genes in cell identity and oncogenes8–10. Related enhancer types such as stretch 
enhancers and anti-pause enhancers were described independently11,12. There is debate on whether 
SEs act mechanistically different from typical enhancers13. Arguments in favor of the functional 
distinction of SEs is their ability to drive high levels of transcription and their selective sensitivity to 
inhibitors of Brd4, a chromatin-binding protein enriched at SEs10,14,15. Besides Mediator and Brd4, a 
number of chromatin modifiers, such as Ep300, Chd7, Smc1a (Cohesin complex) Brg1 (SWI-SNF 
complex), Chd4 (NuRD complex) and Kdm1a (LSD1 complex), were found to be enriched at SEs9. In a 
recently proposed model, the constituent enhancers of an SE and their regulated promoter(s) would 
group together to form a phase-separated assembly16. Such an assembly would rely on interactions 
between transcriptional and chromatin regulators16.  
Cell-type specific master TFs colocalise with Mediator at SEs8,9. However, evidence for interactions 
between master TFs and Mediator, which would underpin their role in recruiting Mediator to SEs, is 
scarce. For example, among SE-binding master TFs Oct4, Sox2 and Nanog (ESCs), Pu.1 (pro-B cells), 
MyoD (Myotubes) and C/EBPα (Macrophages)8, Mediator interactions were only detected in 
immunoprecipitations of Sox2 and C/EBPα and these were with single Mediator subunits17,18. Also 
our understanding of the recruitment of the above chromatin modifiers to enhancers and SEs and 
their subsequent maintenance at high levels at SEs is far from complete. Mediator was shown to 
interact with SE-enriched chromatin modifiers Cohesin19and Crebbp20, suggesting that Mediator 
could, in principle, provide an anchoring role at enhancers, SEs and the proposed phase-separated 
assemblies. 
To investigate the relevance of Mediator interactors in defining enhancers and SEs, we purified the 
Mediator complex from neural stem cells (NSCs) and identified its protein-protein interaction 
partners by mass spectrometry. To prevent recording interactions that are mediated via 
DNA/chromatin, we purified Mediator from non-treated nuclear extracts, nuclear extracts treated 
with nuclease benzonase and nuclear extracts treated with ethidium bromide to disrupt protein-DNA 
interactions and only took interactions with Mediator complex that were not affected by these 
treatments. Our resulting Mediator interactome contains 95 proteins of which 75 are novel Mediator-
interacting proteins. Subsequently, we performed Mediator ChIP-seq in NSCs and defined SEs in 
NSCs by their Mediator content. Remarkably, we find that the three most frequent motifs in SEs are 
bound by multiple members of the small set of TFs that we identified as Mediator interactors in NSCs. 
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We show that one of these TFs, Tcf4, regulates a set of key NSC transcription factor genes with SEs 
and broad H3K4me3 domain-containing promoters. High Mediator affinity therefore appears an 
important characteristic of master TFs. Our Mediator interactome contains many known enhancer-
binding chromatin modifiers and we show that Mediator-interacting chromatin modifiers Jmjd1c and 
Carm1 bind genome-wide to enhancers and SEs. Together this suggests thathigh Mediator binding 
affinity selects proteins that play important roles in establishing and maintainingenhancers and SEs to 
facilitate the regulation of cell identity.  
RESULTS 
Purification of the Mediator complex from neural stem cells 
We generated a mouse neural stem cell line expressing FLAG-tagged Med15 (F-Med15 NSCs) to 
enable the purification of the Mediator complex by our FLAG-affinity protocol, which combines high 
efficiency and low background21 and was extensively validated in the past for accuracy by 
independent immunoprecipitations of endogenous proteins21,22. F-Med15 NSCs and parental NSCs 
were grown to large scale and nuclear extracts prepared (see Methods). We were interested in 
proteins that can bind to the Mediator complex relying solely on protein-protein interactions and not 
being mediated via chromatin, which may co-purify with a chromatin-binding factor such as the 
Mediator complex. We reasoned that proteins interacting with Mediator by protein-protein 
interaction would not show a reduced interaction efficiency when treating the nuclear extract with the 
DNA-RNA digesting enzyme Benzonase or with ethidium bromide (EtBr), which intercalates in the 
DNA and disrupts protein-DNA interactions, as compared to untreated nuclear extracts (Figure 1A). 
The used nuclear extract preparation procedure23 aims to minimize the amount of DNA/chromatin in 
the extract by gently douncing the nuclei as a method for lysis. Nevertheless, remnants of 
DNA/chromatin do get released from the nuclei into the extract (Figure 1B, Untreated). Addition of 
benzonase completely removed chromatin/DNA from the extract. (Figure 1B, compare Benzonase to 
Untreated). We purified the Mediator complex by FLAG-affinity from nuclear extracts treated with 
Benzonase, with EtBr or not treated, as well as from parental NSCs as a control. Purified Mediator 
samples and control samples were analyzed by mass spectrometry to identify the proteins present in 
these samples. We selected proteins that were specific for Mediator samples and that did not go down 
in abundance (less than 2-fold drop in emPAI score) when comparing purifications from nuclear 
extracts treated with Benzonase or EtBr, to purifications from untreated extracts (see Methods). To be 
included in our final list of Mediator-interacting proteins (Figure 1C, Table S1), selected proteins also 
had to be specifically present in an independent replicate of the Mediator purification from 
Benzonase-treated nuclear extract (Table S1). 
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Figure 1 | Mediator complex interactome in neural stem cells 
(A) Schematic representation of Mediator complex purifications from neural stem cells (NSCs) expressing 
Med15-FLAG. Mass spectrometry results of the three conditions were compared to select proteins that do not 
decrease in abundance upon treatments as chromatin-independent Mediator complex interactors. IP, 
immunoprecipitation. MS, Mass spectrometry. (B) Agarose gel with DNA from untreated NSC nuclear extract 
or nuclear extract treated with Benzonase or Ethidium Bromide, as indicated. DNA size markers (M) are 
indicated. (C) Interactome of the Mediator complex in NSCs. Novel Mediator interaction partners are in red, 
known Mediator interaction partners are in grey. Thickness of the edges gives an indication of the relative molar 
protein quantity observed in the purified Mediator complex samples. See also Table S1. 
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A Mediator interactome in neural stem cells 
We identified 119 Med15-interacting proteins from the four FLAG-Med15 purifications (Figure 1C, 
Table S1), of which 24 proteins are core-subunits of the Mediator complex, leaving 95 proteins that we 
postulate as Mediator complex-interacting proteins. The vast majority of these Mediator-interacting 
proteins, 75 proteins, was not previously identified as binding to Mediator and would therefore be 
novel Mediator interactors (Figure 1C, indicated in red). A number of well-known constituents of 
enhancers such as Ep300, Chd7, LSD1 complex, NuRD complex and SWI-SNF complex24–27 were 
identified as interactors of Mediator (Fig. 1C, Table S1). Cohesin subunit Smc1a19 was identified, 
whereas Cohesin subunit Smc3 and Cohesin loader Nipbl were observed in 3 out of 4 Mediator 
purifications and are therefore not part of the final Mediator interactor list (Table S1). Ep300, Crebbp, 
Chd7, Kdm1a (LSD1 complex), Chd4 (NuRD complex), Smc1a (Cohesin) and Brg1 (SWI-SNF 
complex) were recently shown, like Mediator, to have higher binding densities at super enhancers 
(SEs) in embryonic stem cells, as compared to typical enhancers9. Other transcriptional activators and 
repressors interacting with Mediator included Ncoa1-2, the COMPASS complex, Integrator complex, 
TRRAP complex and N-CoR complex (Figure 1C). We identified histone demethylase Jmjd1c and 
arginine demethylase Carm1 as Mediator interactors. Carm1 was recently identified to bind Med9 in a 
high throughput interaction screen28. We independently confirmed the interactions of Jmjd1c and 
Carm1 with Mediator by reverse co-immunoprecipitations with Carm1 antibodies (Figure 2A) and 
Jmjd1c antibodies (Figure 2B). Prominent Mediator interactor categories not directly related to 
transcription were mRNA binding proteins, often functioning in post-transcriptional events, and 
protein modifiers (Figure 1C).  
Mediator has been identified as a co-activator of many DNA sequence-specific transcription factors, 
often nuclear hormone receptors29,30. We identified 16 DNA sequence-specific transcription factors 
(TFs) of which 14 are novel Mediator interactors (Fig. 1C), including NFI TFs Nfia and Nfib, Sox2 and 
E-box TFs Tcf4 and Tcf12. The majority of these TFs have an important function in the regulation of 
NSCs (Figure 2C). To test whether detected Mediator-interacting TFs are the highest expressed TFs in 
NSC, which could explain their detection by mass spectrometry, we plotted the 16 detected TFs 
against the 600 highest expressed TFs (by RNA-seq) in our NSCs. We find that Mediator-interacting 
TFs are not the highest expressed TFs in NSCs (Figure 2D). This suggests that the detection of our 
Mediator-interacting TFs is primarily related to their high binding-affinity for Mediator, as compared 
to many other, not detected, TFs.  
Brd4 has been shown to strongly colocalise with Mediator at enhancers and promoters. Despite our 
high sensitivity of detecting Mediator interactors, we did not detect Brd4 in any of our FLAG-Med15 
purifications (Table S1 and data not shown). We also did not detect Jmjd6 and Nsd3, functional 
interaction partners of Brd415,31, in any purification.  
In conclusion, we expanded the Mediator interactome with many transcription-associated factors and 
our experimental set-up suggests that these interactions are independent of chromatin.  
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Figure 2 | Mediator complex interactor validation 
(A) Immunoprecipitation (IP) of Carm1 and Med12 by a Carm1 antibody from NSC nuclear extract. Western 
blots are probed with the indicated antibodies. Control IP by rabbit IgG and 5% input are also shown. (B) 
Immunoprecipitation (IP) of Jmjd1c and Med12 by Jmjd1c antibody from NSC nuclear extract. Western blots are 
probed with the indicated antibodies. Control IP by rabbit IgG and 5% input are also shown.(C) Function in 
neural development of identified Mediator-interacting transcription factors in NSCs. References are provided in 
the Methods.(D) mRNA levels in NSCs of Mediator-interacting transcription factors (TFs) and the Top 600 
highest expressed TFs in NSCs. The average emPAI scores, a semi-quantitative mass spectrometry-based 
measure of molar amounts,in the 4 Mediator complex purifications is shown for Mediator–interacting TFs.  
Mediator-based super enhancers in neural stem cells 
High Mediator content is a defining feature of so-called super enhancers (SEs)8. SEs have not been 
defined yet in NSCs. We identified SEs in NSCs by ranking NSC enhancers, which were previously 
defined by the presence of the H3K27ac mark and Ep30032, by their Med1 ChIP signal using the ROSE 
algorithm 8,9. Accordingly, we identified 445 SEs in NSCs and assigned the 9436 remaining enhancers 
as typical enhancers (Figures 3A and 3B, Table S2). Transcription factors encoded by genes near top 
SEs include Mediator interactors Nfia, Tcf4, Sox2 and Sall3 (Figure 3B). We find that active genes near 
SEs (SE genes) in NSCs are, on average, several fold higher expressed than genes near typical 
enhancers (Figure 3C). 
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Figure 3 | Super enhancers in neural stem cells 
(A) Distribution of Med1 ChIP-seq signal (total reads) in enhancer regions in NSCs. 445 enhancers regions in the 
right upper quadrant are postulated as super enhancers. Examples of genes near super enhancers and the super 
enhancer rank are indicated. (B) Top 25 super enhancers (SEs) in NSCs, ranked by Mediator content, and their 
nearest active gene (left panel). Top 25 active transcription factor genes nearest to SEs (Right panel). SE rank is 
indicated. Genes encoding transcription factors that we identified as Mediator interactors are red-shaded. (C) 
Distribution of mRNA expression in NSCs of active genes nearest to SEs and active genes nearest to typical 
enhancers,but not nearest to SEs. Whiskers represent ultimate range. Significanceof the difference in mRNA 
levels between two gene categories was assessed by student T test (***;p<0.001) (D) Most frequent transcription 
factor DNA motifs in Mediator binding sites at typical enhancers and SEs. Motif frequency is indicated as the 
percentage of all Mediator binding sites at typical enhancers or SEs that harbour this motif. See also Table S2.  
DNA motif enrichment analysis revealed that E-box, NFI and SOX motifs were the first, second and 
third most frequent TF DNA binding motifs in Mediator peaks, both within typical enhancers and SEs 
(Figure 3D). These motifs were also previously observed in NSC enhancers defined by H3K27ac and 
Ep30032. Interestingly, TFs that can bind these motifs are well represented within the select group of 
TFs that we find interacting with Mediator, with Tcf4 and Tcf12 binding E-box motifs, Nfia and Nfib 
binding NFI sites and Sox2 binding SOX sites. In summary, we identified SEs in NSCs and find that 
the E-box motif is the most frequently occurring motif in Mediator peaks within typical enhancers 
and SEs in NSCs.  
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Genome-wide overlap of Mediator and its interaction partners outside promoters 
The identification of Mediator binding sites in NSCs allowed us to probe its genome-wide overlap 
with identified Mediator interaction partners. We first focused on Mediator-interacting transcription 
factors, which with their sequence-specific DNA binding capacity would be candidates for Mediator-
recruitment to the genome. Using published ChIP-seq data sets for TFs Nfia and Nfib (combined 
ChIP-seq; NFI) and Sox232, we found that binding sites of NFI and Sox2 highly overlap with Mediator 
binding sites outside promoters, including at typical enhancers and SEs (Figure 4A). Using our Tcf4 
ChIP-seq data set33, we show that Tcf4 has an even higher overlap with Mediator outside promoters, 
at typical enhancers and at SEs (Figure 4A), consistent with the finding that the E-box is the most 
frequent TF motif at Mediator binding sites in enhancers and SEs in NSCs (Figure 3D). The sum of 
binding sites of Tcf4, Sox2 and NFI (T+S+N) covers nearly 80% of all Mediator binding sites outside 
promoters and over 80% of Mediator binding sites within typical enhancers and SEs (Figure 4A). The 
combined binding sites of representatives of three TF families that we find interacting with Mediator, 
could therefore potentially account for nearly all recruitment of Mediator outside promoters in NSCs. 
Examples of the overlap of Mediator with Mediator-interacting TFs are shown in Figures 4B and 4C.  
Subsequently, we investigated the overlap of Mediator with interacting chromatin modifiers. We 
performed ChIP-seq for identified Mediator-interactors arginine methylase Carm1 and H3K9 
demethylase Jmjd1c. We found that Carm1 and Jmjd1c highly overlap with Mediator outside 
promoters, at enhancers and at SEs (Figure 4A). Chromatin remodeler Chd7 is known to bind 
enhancers in ES cells34 and indeed overlaps with Mediator at enhancers and SEs in NSCs (Figures 4A). 
As expected, RNApol2 and its associated Integrator complex35 show a high overlap with Mediator at 
promoters (Figures 4A). Polycomb protein Cbx8 and insulator protein Ctcf, which we never found 
interacting with Mediator, show low genome overlaps with Mediator (Figure 4A). Examples of the 
overlap of Mediator with interacting chromatin modifiers are shown in Figures 4B and 4C. As 
expected, we also find high overlaps between Mediator-interacting TFs and Mediator-interacting 
chromatin modifiers (Figure 4D). We conclude that Mediator shows high binding site overlap at 
enhancers and SEs with interacting TFs Tcf4, NFI and Sox2 and with interacting chromatin modifiers 
Jmjd1c, Carm1 and Chd7. 
Genes with super enhancers and broad H3K4me3 promoters in NSCs are enriched for neurogenic 
transcriptional regulators 
Recently genes with broad H3K4me3 domains at their promoters were identified36,37, including in 
NSCs36. The top 5% of broadest H3K4me3 domains in promoters (here abbreviated as broad 
promoters) associated with cell identity genes36 and tumor-suppressor genes37. Mechanistically, broad 
promoters have increased rates of transcription elongation and higher transcriptional consistency36,37 
and show enhanced DNA looping interactions with SEs38, compared to their typical counterparts. We 
found that the complete sets of SE genes and broad promoter genes in NSCs both have Transcription 
Regulation as their lead Gene Ontology (GO) category (Figure 5A and Table S3). 
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Figure 4 | Binding site overlap of Mediator complex and its interactors 
(A) Percentage overlap of genome-wide binding sites of Mediator (Med1) with Mediator interactors Tcf4, Sox2, 
NFI (Nfia + Nfib), Carm1, Jmjd1c, Chd7, Ep300, Integrator complex (Ints11 subunit), and RNApol2 in NSCs. 
Cbx8 and Ctcf were not identified as Mediator interactors and serve as negative controls. Percentages overlap of 
binding sites, as determined by ChIP-seq, are indicated. T+S+N, sum of the binding sites of Tcf4, Sox2 and NFI. 
TSS, within 1 kb of a transcription start site. (B) Overlap of binding sites of Mediator (Med1) with binding sites 
of Mediator interactors at the Myc locus in NSCs. ChIP-seq tracks for the indicated proteins and histone 
modifications at the Myc gene are shown. The Myc SE in the adjacent (inactive) Pvt gene is indicated with a red 
bar. Range of reads per million per base pair is indicated on the y-axis. Scale bar is indicated (C) Overlap of 
binding sites of Mediator (Med1) with binding sites of Mediator interactors at the Myc locus in NSCs. ChIP-seq 
tracks for the indicated proteins and histone modifications at the Myc gene are shown. The Myc SE in the 
adjacent (inactive) Pvt gene is indicated with a red bar. Range of reads per million per base pair is indicated on 
the y-axis. Scale bar is indicated (D) Overlap of binding sites of Mediator (Med1) with binding sites of Mediator 
interactors at the Rad51c locus in NSCs. ChIP-seq tracks for the indicated proteins and histone modifications at 
the Rad51c gene are shown. The Rad51c SEs in the adjacent (inactive) Tex10 gene are indicated with red bars. 
Range of reads per million per base pair is indicated on the y-axis. Scale bar is indicated. 
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Transcriptional regulator genes within the SE category showed neurogenesis as the only significant 
GO term, whereas transcriptional regulator genes within the broad promoter category included 
neurogenesis as one of three significant GO terms (Figure 5A and Table S3). The observed enrichment 
in transcriptional regulators acting in neurogenesis is in line with the association with cell identity 
genes that has been postulated for genes with SEs8,9 or genes with broad promoters36. We find that 
genes with broad promoters partially overlap with SE-associated genes in NSCs (Figure 5B). Genes 
with SEs and broad promoters (SE+Broad) strongly enrich for transcriptional regulators acting in 
neurogenesis (Figure 5B, Tables S3 and S4). Remarkably, both left-over categories of genes, genes with 
broad promoters but without SEs (Broad-SE) and genes with SEs but without broad promoters (SE-
Broad) lose transcriptional regulators acting in neurogenesis as a GO term, whereas SE-Broad genes 
lose Transcriptional Regulation as a GO term altogether (Figure 5B, Table S3). Indeed, Mediator-
interacting TFs Tcf4, Sox2, Sall3, Nfia and Nfib, as well as other well-known neural TFs including 
Olig1-2, Pou3f1, Pou3f3 and Npas3 and oncogene Myc have broad promoters and SEs (Table S4). We 
find that SE+Broad genes are, on average, higher expressed than SE-Broad genes or Broad-SE genes, 
even when comparing the top 100 of each category (Figure 5C). We conclude that in NSCs, genes with 
both SEs and broad H3K4me3 promoters account for the association of the separate categories of SE 
genes and broad promoter genes with transcriptional regulators acting in neurogenesis. Broad 
promoters and SEs appear to act synergistically to give higher expression in NSCs, as compared to 
genes with only one of these regulatory elements. 
Binding of Mediator and its interaction partners at promoters 
We investigated transcriptional regulators binding around promoters of Broad+SE genes. We found 
that Broad+SE genes had higher and broader promoter signals for H3K4me3, RNApol2 and Integrator 
than SE-Broad and Broad-SE genes (Figure 5D).  
Figure 5 (in next page) | Mediator complex and its interactors at promoters  
(A) Predominant Gene Ontology terms for genes with broad H3k4me3 promoters and for active genes nearest to 
SEs (SE genes) in NSCs. Numbers of genes in each category are indicated between brackets. 
(B) Overlap of genes with broad H3K4me3 promoters and SE genes in NSCs. Venn diagram with the two 
categories of genes, their overlap and their predominant Gene Ontology terms is shown. Numbers of genes in 
each category are indicated between brackets. (C) Distribution of mRNA levels in NSCs of the different 
categories of active genes. Box plots based on RNA-seq data are shown. Broad-SE, broad H3K4me3 promoter 
genes not nearest to SE. SE-Broad, SE genes without broad H3K4me3 promoter. SE+Broad , SE genes with broad 
H3K4me3 promoter. Typical, genes nearest to a typical enhancer but not nearest to an SE and without a broad 
H3K4me3 promoter. mRNA levels of all genes and top 100 genes within each category are shown. Statistically 
significant differences between groups are indicated as separate letters above the box plots, as assessed by 
student T tests comparing all gene subsets (lower case letters) or top 100 subsets (upper case letters).p<0.001 
except for B, p<0.05.If the letters are the same, the difference between these groups is not significant. (D) ChIP-
seq density plots around promoters of the different categories of genes for the indicated factors and histone 
modifications. Mean ChIP-seq density (y-axis) and distance to TSS (x-axis) are shown. (E) Overlap of binding 
sites of Med1 with binding sites of Mediator interactors at the Hes1 broad H3K4me3 promotor area in NSCs. 
ChIP-seq tracks for the indicated proteins and histone modifications at the Hes1 gene are shown. Range of reads 
per million per base pair is indicated on the y-axis. Scale bar is indicated. See also Figure S1 and Tables S3 and 
S4. 
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Mediator complex binding to promoters has not yet been analyzed genome-wide at broad promoters 
or genes nearest to SEs. We found that Mediator has a much higher and broader ChIP signal at 
Broad+SE genes than at SE-Broad, Broad-SE and typical genes (Figure 5D). Interestingly, we observed 
the same for Mediator interactors T+S+N, Jmjd1c, Carm1 and Chd7 (Figure 5D). The shape of 
Mediator signal tracked closely to that of its interactors with a shoulder upstream of the TSS and a 
long tail into the gene (Figure 5D). As the SE+Broad definition appears to select for genes with the 
broadest and highest H3K4me3 signal (Figure 5D), we also tested the top 100 SE+Broad, top 100 SE-
Broad and top 100 Broad-SE genes to have more equal signals. Indeed top 100 SE+Broad and top 100 
Broad-SE have more similar H3K4me3 signals (Figure S1A) and showed more similar signals for 
Mediator and its interactors at the TSS and upstream of the TSS. However, Mediatorand its interactors 
have a higher signal downstream of the TSS in SE+Broad genes, as compared to all other categories. 
Top 100 SE-Broad genes have a narrower signal for all these factors (Figure S1A). The close similarity 
between the Mediator signal and the signals of its interactors Tcf4, Sox2, NFI, Jmjd1c, Carm1 and 
Chd7 is also apparent at individual broad promoter regions (Figures 5E and S1B). Top 100 SE+Broad 
promoters have more RNApol2 and Integrator signal than top 100 Broad-SE and top 100 SE-Broad 
promoters (Figure S1A), suggesting more efficient recruitment of RNApol2 and Integrator as a 
potential explanation for their higher expression (Figure 5C). We conclude that broad promoters have 
higher and broader signals for Mediator that is closely tracked by all its tested interacting factors. 
Tcf4 regulates neurogenic transcription factor genes with super enhancers and 
broad H3K4me3 promoters 
Tcf4 showed the highest overlap with Mediator at enhancers and SEs of the tested Mediator-
interacting TFs (Figure 4A) prompting us to further investigate a possible role of Tcf4 in regulating 
genes near SEs. We find that Tcf4 content followed Mediator content at enhancers and SEs (Figure 
6A).  
To test to what extent Tcf4 regulates genes with or without SEs and/or broad H3K4me3 promotors, 
we used our RNA-seq data set from RNA isolated 44 hours after Tcf4 knock-down or control knock-
down in NSCs33. We found that Tcf4 depletion down-regulates nearly two-thirds of all SE+Broad 
genes (Figure 6B) and also has the strongest down-regulating effect on SE-containing genes (Figure 
6C). Genes without SEs, either Broad-SE genes or genes with typical enhancers, are significantly less 
affected by Tcf4 depletion (Figure 6C). This suggests that Tcf4 predominantly regulates genes via SEs. 
Indeed, Tcf4 is present on nearly all SEs of SE+Broad genes (Figure 6D). Tcf4-bound and activated 
SE+Broad genes include 15 transcription factor genes (Figure 6E) of which Bahcc1, Hes1,Myc, Nfib, 
Sall1 and Sall3, Olig2, Thra and Npas3 encode known regulators of neural progenitors and/or 
neurogenesis 36,39–44.Tcf4 protein has protein-protein interactions in NSCs with 6 TFs that are part of 
this set of Tcf4-activated TF genes, including Nfib and Olig233 (Figure 6E). This allows for a potential 
feed-forward circuit (Figure 6E) where Tcf4 maintains the expression of its own co-factors, which then 
subsequently may aid Tcf4 in the regulation of other target genes and its own expression. In line with 
this possibility, NFI and Olig2 colocalize with Tcf4 and Mediator on SEs in all 15 TF genes, for 
example at the Olig2 gene (Figure 6F), the Sall3 gene and the Notch1 gene (Figure S2). Tcf4, Mediator, 
2 
Chapter 2 | A Mediator-centered transcriptional network defining NSCs
72
NFI and Olig2 also co-localise at the SE in the Tcf4 gene itself (Figure 6G). Nfib expression has the 
second-best spatial-temporal correlation (0.56 Pearson coefficient) with Tcf4 expression in pre-natal 
development of the mouse brain (out of 1104 genes45 and the second best spatial temporal correlation 
(0.90 Pearson coefficient)with TCF4 in pre-natal human brain development (out of 19700 genes)46, 
suggesting that a Tcf4-Nfib co-regulatory partnership could be widespread in mammalian brain 
development. 
DISCUSSION 
A Mediator interaction network of enhancer- and promoter-binding proteins 
We have expanded the protein-protein interaction network of the Mediator complex with many 
proteins and complexes that reside at enhancers, super enhancers or promoters and thereby 
established the potential of the Mediator complex as a major interaction hub at enhancer-promoter 
assemblies. 
Figure 6 (in next page) | Tcf4 regulates neurogenic transcription factor genes with super enhancers and 
broad H3K4me3 promoters. 
(A) Tcf4 signal at enhancers ranked by Med1 content.  Tcf4 ChIP-seq read content (in green) is plotted against at 
enhancers ranked by Med1 ChIP-seq read content (in red).Enhancers in the right upper quadrant are super 
enhancers, analogous to Figure 3A. (B) Percentages of down-regulated genes in the different categories upon 
Tcf4 knock-down in NSCs.Broad-SE: broad H3K4me3 promoter genes not nearest to SE. SE-Broad: SE genes 
without broad H3K4me3 promoter. SE+Broad: SE genes with a broad H3K4me3 promoter. Typical, genes 
nearest to a typical enhancer but not nearest to an SE and without a broad H3K4me3 promoter. Counted down-
regulated genes are at least 1.5-fold down-regulated. Percentages of down-regulated genes in all genes and top 
100 genes within each category are shown.Statistically significant differences between groups are indicated as 
separate letters in the pie charts, p<0.001as assessed by student T tests.If the letters are the same, the difference 
between these groups is not significant. (C) Changes in mRNA levels of the different categories of genes upon 
Tcf4 knock-down versus control knock down in NSCs. Log2 fold change, based on RNA-seq data, is shown. 
Error bars indicate the standard error of the mean (SEM) based on the RNA-seq triplicates. Statistically 
significant differences between groups are indicated as separate letters below the box plots, p<0.001as assessed 
by student T tests.  (D) Percentage of SEs of SE+Broad genes in NSCs bound by Tcf4. SEs nearest to SE+Broad 
genes with or without significant Tcf4 binding sites, as determined by ChIP-seq, were counted. (E) Model of a 
Tcf4-driven feed-forward transcriptional circuit of SE+Broad TF genes in NSCs. 15 SE+Broad TF genes bound at 
their SE by Tcf4 and activated by Tcf4 are indicated. Tcf4 also binds its own SE. TF proteins encoded by 6 target 
genes also interact with Tcf4 protein and may aid in transcriptional regulation by Tcf4. (F) Overlap of binding 
sites of Tcf4 and Med1 with binding sites of Tcf4-interactors Olig2 and NFI at the Olig2 locus in NSCs. ChIP-seq 
tracks for the indicated proteins at and around the Olig2 gene are shown. The Olig2 SE is indicated with a red 
bar. Range of reads per million per base pair is indicated on the y-axis. Scale bar is indicated. (G) Overlap of 
binding sites of Tcf4 and Med1 with binding sites of Tcf4-interactors Olig2 and NFI at the Tcf4 locus in NSCs. 
ChIP-seq tracks for the indicated proteins at the Tcf4 gene are shown. The Tcf4 SE, inside the Tcf4 gene, is 
indicated with a red bar. Range of reads per million per base pair is indicated on the y-axis. Scale bar is 
indicated. (H) Model of SE-Broad H3K4me3 promoter assemblies. TFs at SE constituents and the Broad 
H3K4me3 promoter recruit high levels of Mediator complex to SE-Broad assemblies. In turn, Mediator recruits 
high levels of protein-protein interaction partners such as the RNApol2 complex, Integrator and chromatin 
modifiers. This would result in efficient pause-release of RNApol2 and high but TF-regulated levels of 
transcription. See also Figure S2. 
73
CE
G
A B
Tcf4 signal at enhancers
5000
10000
15000
2000 4000
Ranked enhancers by Med1 
6000 80000
0
10
00
0
20
00
0
30
00
0
40
00
0
M
ed
1 
si
gn
al
 a
t e
nh
an
ce
rs
F
H
60
70
210
70
5 kb
Med1
Tcf4
NFI
Olig2
Olig2
60
70
210
70
25 kb
Med1
Tcf4
NFI
Olig2
Tcf4
Sox8
Sall3
Bahcc1
Npas3
Notch1
Hes1
Hlx
Myc
Sall1
Klf9
Cxxc5
Nfib
Ahdc1
Thra
Olig2
Tcf4
Tcf4
Sox8
Sall3
Ahdc1
Olig2
Nfib
Cxxc5
<      <      <      <      <       <       <      < <      <      <      <      <       <       <      <          <      <      <      <      <      <      <      <       <       <      <
<
Broad H3K4me3
promoter
SE constituent 
Transcription factors
Chromatin modifiers
RNA Pol II
Mediator complex
Gene 
D
32%
  b
51%
 ac
63%
  c
45%
  a
95%
Broad-SE SE-Broad SE+Broad Typical
Top 100
Broad-SE
Top 100
SE-Broad
Top 100
SE+Broad
Tcf4 binding to SEs
of SE+Broad genes
45 % 54% 62%
Lo
g2
 fo
ld
 c
ha
ng
e 
in
 m
R
N
A 
le
ve
ls
Broad
-SE
SE
-Broad
SE
+Broad
Top 100
Broad-SE
Top 100
SE-Broad
Top 100 
SE+BroadTypical
-0.8
-0.7
-0.6
-0.5
-0.4
-0.3
-0.2
-0.1
0.0
b
c c
a
2 
Chapter 2 | A Mediator-centered transcriptional network defining NSCs
74
Mediator binds to enhancers and promoters in close proximity to many other proteins. We believed 
that chromatin-independent protein-protein interactions of purified Mediator complex, as identified 
by their detection by mass spectrometry, would be the best indicator of its recruitment capacity. 
Despite our stringent criteria, 20 years of research on the Mediator complex since its discovery by 
several labs29,47–49 and progressing high throughput interaction studies28,50, we find that 75 of our 95 
identified Mediator interactions are novel.  
Identified Mediator interactors can be broadly divided into DNA sequence-independent proteins, 
mostly chromatin modifiers, and sequence-specific transcription factors. The latter category of 
Mediator interactors would represent potential Mediator recruitment factors. Indeed, NF-kappaB 
subunit RelA, one of the two known Mediator interactors among the 16 identified transcription 
factors, recruits Mediator to activate transcription51. Whereas Mediator-interacting transcription 
factors would be more specific for NSCs (see next paragraph), the Mediator-interacting chromatin 
modifiers and other proteins are mostly ubiquitously expressed and would have general relevance for 
transcriptional regulation.Supporting this suggestion, our Mediator interactor screen discovered two 
major enhancer binding proteins. We observed and independently confirmed interactions between 
Mediator and arginine methylase Carm1 and  putative H3K9 demethylase Jmjd1c. Carm1 is a highly 
studied enzyme and best known in transcriptional regulation as a co-activator of nuclear receptors 
and NF-kappaB and was shown to act at individual promoters52,53. We find that Carm1 is a genome-
wide enhancer binding protein in NSCs that closely co-localizes with Mediator. Jmjd1c was identified 
as a co-activator of the tumor-inducing fusion gene AML1-ETO and shown to be recruited by AML1-
ETO to target gene promoters where it lowers the levels of the repressive mark H3K9me254. We show 
that Jmjd1c marks enhancers genome-wide in NSCs, together with Mediator, where it may perform a 
similar enzymatic role to maintain enhancer activity.  
A recent analysisis9 showed that chromatin modifiers Brd4, Ep300, Crebbp, Chd7, SWI-SNF complex, 
LSD1 complex, Cohesin complex and NuRD complex colocalise with Mediator at enhancers and have 
an increased binding density at SEs, similar to the Mediator complex. With the exception of Brd4, we 
find that all the above chromatin modifiers as Mediator interactors, which may suggest that Mediator 
interaction aids in their recruitment to enhancers and SEs. The apparent correlation of having protein-
protein interactions with Mediator and co-localizing with Mediator on the genome would predict that 
other observed Mediator interactors of unknown genomic location also reside at enhancers or 
promoters. This remains to be tested.   
Mediator-interacting transcription factors define the epigenetic landscape in NSCs 
We performed Mediator ChIP-seq to identify SEs in NSCs. We find that Mediator-defined SEs in 
NSCs have as their most frequent TF motifs E-box, NFI and SOX, similar to NSC enhancers in 
general32. Nfia, Nfib, Sox2, Tcf4, and Tcf12, which can bind one of these motifs, are among the small 
set of 16 TFs that we identified as Mediator interactors. This shows a remarkable synchrony between 
Mediator-binding TFs and prominent enhancer motifs in NSCs. Our identified Mediator-binding TFs 
are not the highest expressed TFs in NSCs, suggesting that they have a higher binding affinity for 
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Mediator than other TFs. The above set of TFs may therefore define enhancers and SEs in NSCs by 
having high affinity for Mediator and thereby being effective at recruiting Mediator and its interactors 
to its binding sites. This would suggest Mediator affinity as an important organizing feature in 
establishing the enhancer landscape in a given cell type. Indeed, the sum of the binding sites of Tcf4, 
Sox2 and Nfi represents nearly all Mediator binding sites at enhancers, and outside promoters in 
general, and can therefore explain genome-wide Mediator recruitment outside promoters in NSCs. 
Relative promoter occupancy of Mediator has not been analysed genome-wide in higher eukaryotes, 
to our knowledge. We find that Mediator has higher and especially broader binding signals at 
promoters with a broad H3K4me3 signal, a class of promoters that was recently discovered36,37.Tcf4, 
Sox2 and Nfi show relatively weak occupancy at promoters in general. However, their binding is 
enhanced at broad promoters and Mediator follows closely their binding pattern in our genome-wide 
plots, as well as at individual broad promoters. We find that Mediator-interacting chromatin 
modifiers,such as Carm1 and Jmjd1c, also track Mediator binding at promoters. Relative enrichment 
of transcription factors at broad promoters was observed before in different cell types36,37. Our results 
suggest that broad promoters may act like proximal enhancers in recruiting TFs, which in turn can 
recruit Mediator and its interactors. The close resemblance of the Mediator genome-wide binding 
sites with the binding sites of its interacting TFs is highly suggestive of Mediator recruitment by these 
TFs. 
Tcf4 is part of a regulatory circuit of neurogenic transcription factors that regulate NSC identity 
We find that Tcf4 preferentially regulates SE-containing genes in NSCs, including a set of neurogenic 
transcription factor genes that have SEs and broad promoters. Intriguingly, we find that a number of 
the TFs encoded by these genes have protein-protein interactions with the Tcf4 protein. Some of these 
Tcf4-interacting TFs co-localize with Tcf4 at SEs in this set of target genes, as well as on the Tcf4 gene 
itself, suggesting a feed-forward circuit that maintains the expression of these TFs in NSCs. Feed-
forward circuits of key TFs in embryonic stem cells (ESCs), such as Oct4, Sox2, Nanog, Esrrb and Klf4, 
were shown to regulate pluripotency and follow the same above criteria8,55,56. Analogous to the ESC 
TF circuit, many of the TFs in our NSC circuit are essential for NSC self-renewal or their neuronal 
differentiation capacity. Together, this suggests that we have uncovered a TF circuit that would be 
central to the regulation of NSC identity. TCF4 heterozygosity in humans leads to Pitt Hopkins 
syndrome with severe intellectual disability57,58, whereas SNPs in the TCF4 locus were among the first 
significant schizophrenia risk variants to be discovered59 and are the most significant schizophrenia 
risk SNPs to date60. These genetic data suggest that TCF4 plays an important role in brain 
development and needs to be tightly regulated to prevent neurodevelopmental disease. Our TF 
circuit may facilitate this regulation. 
Mediator complex as a recruitment hub that facilitates the regulation of cell identity genes 
Mediator complex binding signal was used as one parameter to postulate SEs8, which were 
subsequently shown to regulate cell identity genes and oncogenes in many cell types(8–10. More 
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recently, promoters with a broad H3K4me3 domain were postulated to regulate cell identity genes36,37. 
As was shown before in other cell types36,37, we find that SE genes and Broad genes partially overlap 
in NSCs. However, we show that the link to neurogenic transcriptional regulators in SE genes and 
Broad genes in NSCs is derived from neurogenic transcriptional regulator genes in the overlap of 
both categories; genes that have both SEs and broad promoters. This suggests that, at least in NSCs, 
SE+Broad genes represent a special category of genes that is strongly linked to cell identity. These 
SE+Broad genes have high recruitment of Mediator at their SEs (by definition) and we find that they 
also recruit high levels of Mediator to their promoters. Increased promoter levels of Mediator are also 
observed at broad promoters without surrounding SEs may therefore be recruited by Mediator-
interacting TFs, which we also find enriched at broad promoters. SEs were recently shown to have 
increased 3D interactions with broad promoters, as compared to typical promoters38. We find that 
SE+Broad genes in NSCs are the category of genes with highest levels of RNApol2 and Integrator at 
their promoters. Integrator complex associates with RNApol2 and plays an important role in the 
transcription-initiation and pause-release of RNApol235. The efficient recruitment of RNApol2 and 
Integrator at SE+Broad genes thereby provides an explanation for our observation that this category 
of genes has the highest expression in NSCs.  
All together this fits into a model (Figure 6H) where Mediator is recruited by Mediator-interacting 
TFs to both SEs and Broad promoters. These elements then form relatively stable enhancer-promoter 
assemblies that have high local concentrations of Mediator and its co-recruited protein-protein 
interaction partners, including RNApol2, Integrator and chromatin modifiers. Such assemblies would 
provide an optimal environment for the efficient pause-release of high quantities of RNApol2 and 
thereby combine the high transcriptional consistency and the high transcriptional efficiency that have 
been shown for broad promoters and SE genes, respectively8,9,36. SE-broad promoter assemblies and 
our identified Mediator interactions could provide ideal building blocks for the phase-separated 
complexes that have been recently proposed to drive robust transcription of cell identity genes in 
mammals16.  
METHODS 
Purification of the Mediator complex from neural stem cells            
NS-5 neural stem cells (NSCs) were derived from 46C embryonic stem cells61 and cultured, as 
described62 and regularly tested for mycoplasma contamination and for authenticity by expressed 
NSC markers Pax6, Sox2 and Nestin22. NSC lines with stable expression of C-terminally FLAG-tagged 
Med15 were created by electroporation with pCAG promoter-driven plasmids containing Med15 
cDNA and puromycin selection for individual clones with moderate expression of the tagged 
proteins, as compared to endogenous levels 33,22. Nuclear extract was prepared from NSCs expressing 
FLAG-Med15 and from control NSCs23. FLAG-tagged Mediator complex was purified from 1.5 ml 
nuclear extract, equivalent to 2*108 NSCs, by FLAG-affinity purification, as described22,64. Mediator 
complex purifications were performed from nuclear extract with Benzonase (150U per ml nuclear 
extract) added or Ethidium bromide (50 μg per ml) added at the start of the 3-hour incubation period 
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of the anti-FLAG antibody beads with the nuclear extract. Alternatively, Mediator complex 
purification was performed from untreated nuclear extract. In one experiment, Mediator complex 
purifications were performed from nuclear extracts treated with Benzonase, Ethidium bromide or 
untreated nuclear extract, together with a control purification from nuclear extract from control NSCs. 
In a second, independent, experiment, Mediator complex was purified from nuclear extract treated 
with Benzonase, together with a control purification. Control purifications were from nuclear extract 
treated with benzonase. All purifications are shown in Table S1. 
Identification of proteins by mass spectrometry was as described64. Peptide spectra from purified 
Mediator samples or control sample were searched against UniProt release 2012-11 for protein 
identification. Initial inclusion criteria for Mediator-interacting proteins are similar to those as 
described before64. In short, 1) A minimal Mascot score of 50, 2) At least 5-fold enrichment by emPAI 
score in the Mediator purified sample over the control sample. emPAI score is an estimate of the 
quantity of the identified protein in the purified protein sample, based on the number of peptide 
spectra identified by MS, normalized for the number of peptides that theoretically should be 
identifiable for that protein65. 3) At least 3-fold enrichment by Mascot score in the mediator purified 
sample over the control sample. Of note, of the 95 identified Mediator complex interactors, only 13 are 
also detected in any of the two control samples (Table S1). Subsequently, recorded Mediator 
interactors cannot be 2-fold lower or more in emPAI score in the Mediator complex purification from 
purifications from nuclear extracts treated with Benzonase or Ethidium bromide, as compared to a 
parallel Mediator complexpurification from untreated nuclear extract. Finally, Mediator interaction 
partners are only included in the final list (Table S1) if they are specifically present in all 4 Mediator 
complex purifications. Mediator interaction partners were defined as novel if they did not appear as 
identified by Affinity Capture or Reconstituted Complex in BioGRID, the most comprehensive 
protein-protein interaction database66. Interaction network graphics were made with Cytoscape67. 
Thickness of the edges in the interaction network (Figure 1C) gives an indication of the relative molar 
protein quantity (based on emPAI score) in purified Mediator complex samples with 4 categories of 
thickness; emPAI> 1.5, thickest edge, 0.75<emPAI ≤ 1.5, one but thickest edge, 0.25<emPAI ≤0.75,  one 
but thinnest edge, emPAI<0.25, thinnest edge. 
Immunopreciptations 
Immunoprecipitations of Jmjd1c or Carm1 were performed from 1 ml of NSC nuclear extract using 
10μg of Jmjd1c antibody (Merck Millipore #17-10262, or 10μg Carm1 (Cell Signaling Technology 
#12495) or 10μg of control rabbit IgG (Santa Cruz #sc-2027), exactly as described(van den Berg et al., 
2010). Resulting western blots were probed with the same antibodies and Med12 antibody (Bethyl 
Laboratories #A300-774A). 
Mediator-interacting TFs 
References for function in neural development. Yy168, Nfia69, Sox270, Nfib71, Sall336, Tcf1272, 73, Rela74,75, 
Tcf476,77. TF mRNA levels in our NSCs are from our RNA seq data on our wild-type NSCs33. 
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Chromatin immunoprecipitation combined with high-throughput sequencing (ChIP-seq) 
We adapted protocols previously described 8,33,78. 1.5 × 108 NSCs were used per chromatin 
immunoprecipitation (ChIP). Cells were collected in 1xPBS and crosslinked first with 2 mM 
disuccinimidylglutarate (Thermo Fisher Scientific, Waltham, MA, USA) solution for 45 min and then 
1% formaldehyde solution for 15 min at room temperature. Cells were washed twice with 1X PBS and 
flash frozen in liquid nitrogen. Chromatin was prepared for sonication with 20 mM Tris-HCl pH8, 150 
mMNaCl, 2 mM EDTA, 0.1% SDS, 1% Triton X-100. We used 15 cycles of 30 seconds ON, 30 seconds 
OFF on a Bioruptor Pico sonication device (Diagenode Cat# B01060001) to shear chromatin to 150-
200bp fragments. The resulting chromatin extract was incubated overnight at 4°C with 100ul of Dynal 
Protein G magnetic beads that had been pre-incubated with 10 μg of the appropriate antibody. We 
used the following antibodies: Med1 (Bethyl Labs #A300-793A), Carm1 (Cell Signaling Technology 
#12495), Jmjd1c (Merck Millipore #17-10262), IgG (Normal Rabbit IgG: Santa Cruz #sc-2027). Beads 
were washed 1X with the sonication buffer, 1X with 20 mM Tris-HCl pH8, 500 mM NaCl, 2 mM 
EDTA, 0.1% SDS, 1%Triton X-100, 1X with 10 mM Tris-HCl pH8, 250 mM LiCl, 2 mM EDTA, 1% 
NP40 and 1X with TE containing 50 mM NaCl. Bound complexes were eluted from the beads in 50 
mM Tris-HCl, pH 8.0, 10 mM EDTA and 1% SDS by heating at 65°C for 1 hr with occasional vortexing 
and crosslinking was reversed by overnight incubation at 65°C. ChIP-seq sample preparation and 
sequencing on Illumina GAII or HiSeq2500 (San Diego, CA, USA) platforms was performed at the 
Erasmus MC Center for Biomics, as described79. 
Genomic data analyses 
All ChIP-seq data sets were mapped to the mouse mm9 reference genome using Bowtie v0.12.780, 
where we used a seed length of 36 in which we allowed a maximum of two mismatches. If a read had 
multiple alignments only the best matching read was reported. ChIP-seq data sets with multiple 
replicates were merged. Duplicated reads were removed. MACS46 v1.4.2 was used for peak calling 
using default settings, using IgG ChIP-seq as background control for our Med1, Carm1, Jmjd1c, Tcf4, 
Olig2 and Chd7 ChIP-seq data. For external ChIP-seq data sets either IgG ChIP-seq or sequenced 
chromatin input was used as background control. For histone modifications we used HOMER 
findPeaks81 using -region -size 1000 -minDist 2500 parameters. Genomic datasets that are reported 
and/or used in this study are summarized in Table S5. The accession number for the data reported in 
this paper is GEO: GSE109043.  
Enhancers in mouse NSCs were defined with the same criteria as described previously82 but recalling 
Ep300 and H3K27ac peaks using HOMER, function REGION, and using Bedtools83 to generate 
overlaps between Ep300 peaks and H3K27ac peaks. SEs were identified using the ROSE algorithm8, 
ranking defined enhancers by Med1 ChIP-seq signal. 435 super enhancers were identified and the rest 
were assigned as typical enhancers. Plotting was performed using hockeyfunction in R. We used the 
already described list of mouse NSCs broad H3K4me3 promoters36. 
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For mRNA levels in our mouse NSCs, we used our published RNA sequencing data set33 consisting of 
three replicates to calculate the mean mRNA expression levels. Super enhancer (SE) genes and typical 
enhancer genes are defined as the closest active gene, RKPM > 0.5 in our NSC RNA-seq data33, to an 
SE or a typical enhancer, respectively. 
Motif analyses were performed using HOMER81 and selecting the most frequent motifs found at 
Med1 binding sites at SE constituents and typical enhancers. 
For genome-wide binding site overlaps, we used the 5000 most significant binding sites for each 
factor to determine the percentage of overlap between two factors. Two binding sites were considered 
overlapping if their summits were within 200 bp. Promoters were defined as the regions within 1.5 kb 
of a transcription start site (TSS). Top 5000 peaks from Mediator and its interactors were separated in 
the TSS, nonTSS, typical enhancer and super enhancer categories and the percentage of overlap 
recalculated for each subset. 
Generation of histograms documenting ChIP-seqsignal density at specific sets of promoters in the 
NSC genome was performed by HOMER annotatePeaks with 10bp bins and 12000bp around the TSS. 
By default, HOMER normalizes the output histogram such that the resulting units are per bp per 
peak, on top of the standard total mapped tag normalization of 10 million tags. For each promoter, 
directionality was extracted from TSS annotation and each subset was split between plus or minus 
strand. Subsequently, split lists were then remerged taking into account directionality to finally 
calculate the ChIP-signal density values. Enhancer-annotated expressed genes not present on the 
super enhancer gene list or the broad H3K4me3 promoter gene list were used as typical genes. 
Gene Ontology analyses on the different gene categories were performed using DAVID version 6.784 
using default categories. SE genes are defined as the closest active gene, RKPM > 0.5 in our NSC 
RNA-seq data33, to an SE. Broad H3K4me3 genes are defined as having the top 5% broadest H3K4me3 
domains36. Additionally, we performed GO ontology biological process analysis of the transcription 
regulators found in each subset. Benjamini-corrected p-value was used for ranking Gene Ontology 
terms. 
Tcf4-regulated genes were derived from an RNA-seq. experiment performed in triplicate 48 hours 
after Tcf4 shRNA-transfection or control shRNA-transfection in mouse NSCs33. Gene expression 
values with significant triplicates were assigned to the different subsets. The effect ofTcf4 knock down 
was indicated by plotting the mean fold change vs the scrambled shRNA condition for each subset.  
Data availability 
Genomic datasets that are reported and/or used in this study are summarized in Table S5. The 
accession number for the data reported in this paper is GEO: GSE109043 (link for reviewers: 
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109043 token inwbuwianjozjud).  
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Figure S1 |  Mediator complex and its interactors at promoters, related to Figure 5 
(A) ChIP-seq density plots around top 100 promoters of Broad+SE genes, top 100 Broad-SE genes, top 100 SE-
Broad genes and all typical genes for the indicated factors and histone modifications. Mean ChIP-seq density (y-
axis) and distance to TSS (x-axis) are shown. (B) Overlap of binding sites of Med1 with binding sites of Mediator 
interactors at the Bahcc1 broad H3K4me3 promotor area NSCs. ChIP-seq tracks for the indicated proteins and 
histone modifications at the Hes1 gene are shown. Range of reads per million per base pair is indicated on the y-
axis. Scale bar is indicated. 
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Figure S2 | Tcf4 and its interactors at super enhancers and broad H3k4me3 promoters, related to Figure 6 
(A) Overlap of binding sites of Tcf4 and Med1 with binding sites of Tcf4-interactors Olig2 and NFI at the Sall3 
locus in NSCs. ChIP-seq tracks for the indicated proteins at the Sall3 gene are shown. The Sall3 SE is indicated 
with a red bar. Range of reads per million per base pair is indicated on the y-axis. Scale bar is indicated. (B) 
Overlap of binding sites of Tcf4 and Med1 with binding sites of Tcf4-interactors Olig2 and NFI at the Notch1 
locus in NSCs. ChIP-seq tracks for the indicated proteins at the Notch1 gene are shown. The Notch1 SE is 
indicated with a red bar. Range of reads per million per base pair is indicated on the y-axis. Scale bar is 
indicated. 
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Mediator complex 10
G3X8S4 Med15 29 30 29 0 35 0 31 7,03 7,37 6,70 0,00 36,51 0,00 14,40 1927 1971 1939 0 2489 0 2082
Q9CQA5 Med4 10 10 8 0 7 0 9 4,99 3,72 3,72 0,00 2,71 0,00 3,79 508 498 394 0 337 0 434
Q9DB40 Med27 13 14 12 0 10 0 12 4,01 4,54 3,10 0,00 2,35 0,00 3,50 623 752 649 0 661 0 671
Q9R0X0 Med20 6 6 6 0 8 0 7 3,46 2,31 2,31 0,00 4,18 0,00 3,07 294 286 303 0 497 0 345
Q9DAY7 Med8 9 9 9 0 9 0 9 2,39 2,39 2,82 0,00 2,82 0,00 2,61 364 450 440 0 458 0 428
Q921D4 Med6 9 8 9 0 11 0 9 2,07 2,07 2,07 0,00 4,06 0,00 2,57 414 403 449 0 528 0 449
A2ABV5 Med14
Mediator of RNA polymerase II transcription subunit 15
Mediator of RNA polymerase II transcription subunit 4
Mediator of RNA polymerase II transcription subunit 27
Mediator of RNA polymerase II transcription subunit 20
Mediator of RNA polymerase II transcription subunit 8
Mediator of RNA polymerase II transcription subunit 6
Mediator of RNA polymerase II transcription subunit 14 35 35 38 0 45 0 38 1,56 1,81 1,68 0,00 2,93 0,00 2,00 1907 1808 1909 0 2270 0 1974
Q920D3 Med28 4 5 4 0 5 0 5 1,45 1,92 1,45 0,00 1,92 0,00 1,69 182 209 175 0 252 0 205
Q9CXU0 Med10 5 4 3 0 3 0 4 2,02 1,42 0,94 0,00 0,94 0,00 1,33 246 234 146 0 133 0 190
Q62276 Med22 4 5 3 0 3 0 4 1,43 1,91 1,04 0,00 0,71 0,00 1,27 196 268 186 0 179 0 207
Q8VCD5 Med17 16 19 16 0 20 0 18 1,21 1,57 1,32 0,00 2,13 0,00 1,56 825 974 820 0 1169 0 947
Q9CZ82 Med18 4 4 4 0 8 0 5 1,44 1,44 0,81 0,00 4,18 0,00 1,97 159 151 131 0 497 0 235
A2AGH9 Med12 46 49 44 0 50 0 47 1,03 1,22 1,00 0,00 1,35 0,00 1,15 2354 2436 2210 0 2635 0 2409
Q99K74 Med24 22 19 19 0 19 0 20 1,11 1,11 0,98 0,00 1,11 0,00 1,08 1085 1110 1057 0 1074 0 1082
G3UW74 Med16 18 19 15 0 23 0 19 1,03 1,19 0,96 0,00 1,28 0,00 1,12 863 964 824 0 1038 0 922
E9QNV2 Med23
Mediator of RNA polymerase II transcription subunit 28
Mediator of RNA polymerase II transcription subunit 10
Mediator of RNA polymerase II transcription subunit 22
Mediator of RNA polymerase II transcription subunit 17
Mediator of RNA polymerase II transcription subunit 18
Mediator of RNA polymerase II transcription subunit 12
Mediator of RNA polymerase II transcription subunit 24
Mediator of RNA polymerase II transcription subunit 16
Mediator of RNA polymerase II transcription subunit 23 28 29 32 0 26 0 29 0,86 0,95 1,19 0,00 0,86 0,00 0,97 1483 1577 1681 0 1270 0 1503
Q3UXL9 Ccnc 5 6 8 0 8 0 7 0,75 0,96 1,19 0,00 1,61 0,00 1,13 255 240 329 0 400 0 306
Q9DB91 Med29 4 3 3 0 5 0 4 1,28 0,93 0,64 0,00 2,73 0,00 1,40 178 184 167 0 245 0 194
Q9CQI9 Med30 2 3 3 0 7 0 4 0,67 0,98 0,98 0,00 2,32 0,00 1,24 148 178 190 0 326 0 211
Q8BWD8 Cdk19 7 10 6 0 6 0 7 0,66 1,01 0,56 0,00 0,56 0,00 0,70 285 355 219 0 323 0 296
Q5SWW4 Med13 31 30 28 0 32 0 30 0,67 0,67 0,57 0,00 0,70 0,00 0,65 1498 1540 1427 0 1670 0 1534
Q925J9 Med1 20 21 15 0 28 0 21 0,61 0,68 0,48 0,00 1,23 0,00 0,75 964 966 773 0 1518 0 1055
Q8VCB2 Med25 6 5 5 0 6 0 6 0,38 0,32 0,26 0,00 0,32 0,00 0,32 316 304 300 0 300 0 305
Q7TN02 Med26 3 3 3 0 4 0 3 0,18 0,18 0,18 0,00 0,25 0,00 0,20 140 133 117 0 174 0 141
E9QLJ3 Med13l
Cyclin-C
Mediator of RNA polymerase II transcription subunit 29
Mediator of RNA polymerase II transcription subunit 30
Cyclin-dependent kinase 19
Mediator of RNA polymerase II transcription subunit 13
Mediator of RNA polymerase II transcription subunit 1
Mediator of RNA polymerase II transcription subunit 25
Mediator of RNA polymerase II transcription subunit 26
Mediator of RNA polymerase II transcription subunit 13-like 8 10 8 0 6 0 8 0,13 0,18 0,14 0,00 0,08 0,00 0,13 346 421 386 0 276 0 357
p300/CBP ###
F8VPR5 Crebbp CREB-binding protein 55 51 48 0 75 0 57 1,32 1,32 1,14 0,00 3,46 0,00 1,81 2523 2576 2311 0 4240 0 2913
B2RWS6 Ep300 Histone acetyltransferase p300 46 51 48 0 64 0 52 1,10 1,41 1,18 0,00 2,83 0,00 1,63 2122 2346 2202 0 3447 0 2529
NurD complex ###
Q9Z2D8 Mbd3 5 6 7 0 8 0 7 0,73 1,41 2,01 0,00 2,36 0,00 1,63 275 357 380 0 431 0 361
E9QAS5 Chd4 32 25 31 0 50 1 35 0,79 0,54 0,82 0,00 1,76 0,00 0,98 1334 1005 1301 0 2338 44 1495
Q9R190 Mta2 10 11 11 2 23 5 14 0,61 0,69 0,69 0,10 2,47 0,27 1,12 454 535 502 85 1194 164 671
E9QMN5 Gatad2a 6 6 4 0 14 2 8 0,38 0,38 0,24 0,00 1,35 0,11 0,59 289 279 177 0 681 95 357
Q8VHR5 Gatad2b 5 5 5 0 18 4 8 0,32 0,32 0,32 0,00 2,54 0,25 0,88 260 220 278 0 858 175 404
F8WHY8 Mta1
Methyl-CpG-binding domain protein 3
Chromodomain-helicase-DNA-binding protein 4
Metastasis-associated protein MTA2
Transcriptional repressor p66 alpha
Transcriptional repressor p66-beta
Metastasis-associated protein MTA1 5 8 5 0 19 2 9 0,25 0,37 0,25 0,00 1,48 0,09 0,59 227 314 228 0 1012 61 445
RNA pol II ###
Q80UW8 Polr2e 4 4 5 0 2 0 4 1,05 1,05 1,37 0,00 0,33 0,00 0,95 157 252 254 0 86 0 187
A0A087WR0Taf9 3 2 2 0 6 0 3 0,42 0,42 0,42 0,00 1,08 0,00 0,59 94 98 106 0 219 0 129
P08775 Polr2a 7 3 2 0 12 0 6 0,12 0,05 0,03 0,00 0,22 0,00 0,11 244 124 75 0 516 0 240
Q99J95 Cdk9
DNA-directed RNA polymerases I, II, and III subunit RPABC1
Transcription initiation factor TFIID subunit 9
DNA-directed RNA polymerase II subunit RPB1
Cyclin-dependent kinase 9 3 2 2 0 7 0 4 0,28 0,18 0,18 0,00 0,79 0,00 0,36 117 98 113 0 410 0 185
Compass complex ###
Q8BFQ4 Wdr82 5 7 5 0 9 0 7 0,66 1,03 0,83 0,00 2,72 0,00 1,31 179 300 246 0 436 0 290
Q8BX09 Rbbp5 3 2 2 0 2 0 2 0,20 0,13 0,13 0,00 0,13 0,00 0,15 109 84 92 0 52 0 84
D3YYA0 Ash2l
WD repeat-containing protein 82
Retinoblastoma-binding protein 5
Set1/Ash2 histone methyltransferase complex subunit ASH2 1 2 2 0 3 0 2 0,07 0,14 0,14 0,00 0,21 0,00 0,14 66 109 102 0 128 0 101
SWI/SNF complex ###
Q61466 5 8 0 8 0 7 0,36 0,36 0,64 0,00 0,74 0,00 0,53 190 247 275 0 388 0 275
O54941
Smarcd1 SWI/SNF-related matrix-associated actin-dependent regulator of chro 5
Smarce1 SWI/SNF-related matrix-associated actin-dependent regulator of chro 4 6 3 0 7 1 5 0,36 0,59 0,36 0,00 0,59 0,08 0,48 204 276 227 0 393 78 275
Q3UID0 Smarcc2 5. SWI/SNF complex subunit SMARCC2 8 6 8 0 8 0 8 0,23 0,23 0,30 0,00 0,30 0,00 0,27 486 371 349 0 433 0 410
Ncor complex ###
Q8BHJ5 Tbl1xr1 9 11 9 0 15 1 11 0,78 1,02 0,78 0,00 2,38 0,07 1,24 485 651 530 0 1016 62 671
Q9QXE7 Tbl1x 6 6 7 0 9 0 7 0,46 0,46 0,55 0,00 0,87 0,00 0,59 349 354 384 0 557 0 411
F8VQL9 Ncor2 16 11 8 0 44 0 20 0,24 0,14 0,11 0,00 0,82 0,00 0,33 665 495 356 0 1930 0 862
Q5RIM6 Ncor1
F-box-like/WD repeat-containing protein TBL1XR1
F-box-like/WD repeat-containing protein TBL1X
Nuclear receptor corepressor 2
Nuclear receptor co-repressor 1, isoform CRA_a 9 6 7 0 16 0 10 0,11 0,07 0,13 0,00 0,26 0,00 0,14 431 254 276 0 755 0 429
Lsd1 complex ###
Q6ZQ88 Kdm1a 9 9 7 0 15 3 10 0,36 0,41 0,31 0,00 0,84 0,12 0,48 372 507 379 0 660 97 480
Q8C796 Rcor2 3 3 3 0 6 0 4 0,21 0,28 0,21 0,00 0,45 0,00 0,29 164 179 165 0 303 0 203
Z4YJZ7 Ehmt1
Lysine-specific histone demethylase 1A
REST corepressor 2
Histone-lysine N-methyltransferase EHMT1 3 3 3 0 7 0 4 0,11 0,11 0,11 0,00 0,19 0,00 0,13 97 118 121 0 246 0 146
Coactivator ###
Histone-arginine methyltransferase CARM1 11 10 11 0 13 0 11 0,84 0,75 0,75 0,00 1,15 0,00 0,87 573 578 571 0 678 0 600
18 23 21 0 32 0 24 0,58 0,95 0,73 0,00 2,64 0,00 1,23 953 1229 1107 0 1941 0 1308
5 7 6 0 10 0 7 0,51 0,79 0,65 0,00 1,71 0,00 0,92 315 414 370 0 558 0 414
4 4 4 0 7 0 5 0,53 0,70 0,53 0,00 1,10 0,00 0,72 193 257 203 0 313 0 242
15 15 12 0 25 0 17 0,63 0,63 0,44 0,00 1,75 0,00 0,86 681 674 542 0 1337 0 809
Q9WVG6 Carm1
Q61026 Ncoa2
Q9CXY6 Ilf2
Q9R059 Fhl3
G3X8R8 Mkl2
Q9WUP7 Uchl5 4 5 4 0 4 1 4 0,46 0,61 0,46 0,00 0,61 0,10 0,54 141 252 177 0 163 44 183
P70365 Ncoa1 13 14 15 0 30 0 18 0,41 0,41 0,44 0,00 1,34 0,00 0,65 747 719 713 0 1823 0 1001
A2AJK6 Chd7 28 24 21 0 58 0 33 0,36 0,30 0,26 0,00 1,03 0,00 0,49 1270 1137 911 0 2824 0 1536
E9Q8Z6 Ctnnd1 6 9 7 0 13 0 9 0,23 0,44 0,34 0,00 0,57 0,00 0,40 279 455 360 0 569 0 416
Q45VK5 Ilf3 5 8 7 0 7 0 7 0,21 0,35 0,30 0,00 0,30 0,00 0,29 237 348 248 0 262 0 274
5 4 5 0 22 0 9 0,27 0,21 0,21 0,00 1,51 0,00 0,55 232 192 225 0 1039 0 422
5 4 6 0 11 0 7 0,18 0,18 0,22 0,00 0,54 0,00 0,28 239 148 239 0 572 0 300
D3YUG5 Mkl1
F6U238 Maml2
Q9QYH6 Maged1
Nuclear receptor coactivator 2
Interleukin enhancer-binding factor 2
Four and a half LIM domains protein 3
MCG123888
Ubiquitin carboxyl-terminal hydrolase isozyme L5
Nuclear receptor coactivator 1
Chromodomain-helicase-DNA-binding protein 7
Catenin delta-1
Interleukin enhancer-binding factor 3
MKL/myocardin-like protein 1
Protein Maml2
Melanoma-associated antigen D1 4 5 4 0 11 0 6 0,18 0,24 0,14 0,00 0,59 0,00 0,29 142 157 161 0 618 0 270
Q91ZW3 Smarca5 SWI/SNF-related matrix-associated actin-dependent regulator of chro 4 5 7 0 12 0 7 0,13 0,16 0,23 0,00 0,43 0,00 0,24 152 171 221 0 456 0 250
Cell division cycle and apoptosis regulator protein 1 2 2 5 0 2 0 3 0,06 0,06 0,15 0,00 0,06 0,00 0,08 79 76 152 0 79 0 97
5 6 3 0 24 0 10 0,07 0,08 0,04 0,00 0,38 0,00 0,14 238 288 179 0 1074 0 445
8 6 7 0 14 0 9 0,46 0,39 0,39 0,00 1,03 0,00 0,57 393 329 381 0 683 0 447
Q8CH18 Ccar1
A0A0A0MQ9Jmjd1c
Q9DBR0 Akap8
A2A655 Bptf
Probable JmjC domain-containing histone demethylation protein 2C
A-kinase anchor protein 8
Protein Bptf 6 5 2 0 36 0 12 0,07 0,06 0,02 0,00 0,51 0,00 0,17 264 200 113 0 1626 0 551
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TRRAP complex ###
E9PZA7 Trrap 24 26 16 0 41 0 27 0,23 0,25 0,14 0,00 0,43 0,00 0,26 1013 1124 694 0 1850 0 1170
Q8CHI8 Ep400
Transformation/transcription domain-associated protein
E1A-binding protein p400 6 6 4 0 26 0 11 0,06 0,07 0,23 0,00 1,80 0,00 0,54 214 243 173 0 1238 0 467
Cohesin ###
Q9CU62 Smc1a Structural maintenance of chromosomes protein 1A 7 7 5 0 14 0 8 0,19 0,19 0,13 0,00 0,43 0,00 0,24 237 297 197 0 559 0 323
Transcription Factors ###
CGG triplet repeat-binding protein 1 4 3 4 0 5 0 4 1,09 0,74 1,09 0,00 2,03 0,00 1,24 122 129 145 0 185 0 145
5 6 4 0 9 0 6 0,49 0,61 0,37 0,00 1,05 0,00 0,63 211 255 145 0 434 0 261
Q8BHG9 Cggbp1
Q00899 Yy1
B1AUC0 Nfia 6 6 5 0 11 0 7 0,49 0,49 0,40 0,00 1,09 0,00 0,62 293 304 246 0 561 0 351
Q60I23 Sox2 3 5 4 0 2 0 4 0,37 0,68 0,68 0,00 0,22 0,00 0,49 101 204 148 0 82 0 134
A2BG76 Nfib 5 5 6 0 9 0 6 0,33 0,33 0,41 0,00 0,68 0,00 0,44 287 275 310 0 458 0 333
Q62255 Sall3 10 9 9 0 24 2 13 0,40 0,36 0,26 0,00 1,23 0,05 0,56 517 451 387 0 1216 94 643
12 11 12 0 16 2 13 0,32 0,26 0,32 0,00 0,48 0,05 0,35 548 482 621 0 754 69 601
4 4 3 0 16 0 7 0,30 0,30 0,22 0,00 1,14 0,00 0,49 176 190 135 0 905 0 352
Q9CU65 Zmym2
Q61286 Tcf12
Q91VN1 Znf24 3 3 2 0 9 0 4 0,29 0,18 0,18 0,00 1,14 0,00 0,45 135 128 80 0 392 0 184
F7ARK3 Sall2
Transcriptional repressor protein YY1
Nuclear factor 1
SRY-box containing gene 2
Nuclear factor 1
Sal-like protein 3
Zinc finger MYM-type protein 2
Transcription factor 12
Zinc finger protein 24
Sal-like protein 2 6 4 5 0 7 0 6 0,25 0,17 0,17 0,00 0,29 0,00 0,22 270 239 183 0 375 0 267
Q04207 Rela 2 2 4 0 12 0 5 0,13 0,13 0,27 0,00 1,04 0,00 0,39 97 86 197 0 507 0 222
Q61624 Znf148 3 2 3 0 12 0 5 0,13 0,08 0,13 0,00 0,69 0,00 0,26 158 94 155 0 716 0 281
Q925H1 Trps1 4 5 4 0 24 0 9 0,08 0,11 0,11 0,00 0,79 0,00 0,27 158 188 145 0 1079 0 393
Q99LI5 Znf281
Transcription factor p65
Zinc finger protein 148
Zinc finger transcription factor Trps1
Zinc finger protein 281 2 2 2 0 5 0 3 0,08 0,08 0,08 0,00 0,20 0,00 0,11 114 125 87 0 178 0 126
5 6 7 0 8 0 7 0,07 0,08 0,09 0,00 0,09 0,00 0,08 165 213 256 0 256 0 223B1AWL2 Zfp462
E9Q8G4 Tcf4
Protein Zfp462
Transcription factor 4 1 1 1 0 11 0 4 0,05 0,05 0,05 0,00 0,83 0,00 0,25 53 72 76 0 487 0 172
Post-translation modification ###
Q99PQ2 Trim11 E3 ubiquitin-protein ligase TRIM11 13 16 16 0 16 0 15 2,14 2,84 2,84 0,00 3,10 0,00 2,73 955 1070 1024 0 1093 0 1036
A2AMY5 Ubap2 Ubiquitin-associated protein 2 6 4 2 0 12 0 6 0,20 0,13 0,06 0,00 0,59 0,00 0,25 236 162 74 0 614 0 272
E9Q2H1 Ubr5 E3 ubiquitin-protein ligase UBR5 10 11 8 0 26 0 14 0,12 0,15 0,09 0,00 0,40 0,00 0,19 464 456 357 0 1148 0 606
Q8CGY8 Ogt UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 4 3 3 0 12 0 6 0,13 0,10 0,10 0,00 0,49 0,00 0,21 158 116 91 0 667 0 258
Q8N7N5 Dcaf8 DDB1- and CUL4-associated factor 8 2 2 1 0 2 0 2 0,11 0,11 0,06 0,00 0,11 0,00 0,10 72 75 50 0 78 0 69
E9QME5 Trim33 4 3 2 0 3 0 3 0,12 0,09 0,06 0,00 0,09 0,00 0,09 177 178 85 0 160 0 150
O88196 Ttc3
E3 ubiquitin-protein ligase TRIM33
E3 ubiquitin-protein ligase TTC3 3 3 2 0 7 0 4 0,05 0,05 0,03 0,00 0,12 0,00 0,06 134 160 65 0 250 0 152
mRNA binding ###
Q9Z2X1 Hnrnpf 11 10 10 2 8 0 10 1,98 1,76 1,98 0,00 1,76 0,00 1,87 640 530 559 57 472 0 550
P97315 Csrp1 4 3 5 0 4 0 4 0,93 0,39 1,28 0,00 0,93 0,00 0,88 172 144 199 0 191 0 177
Q8VDP4 Ccar2 15 13 12 0 11 0 13 0,63 0,58 0,52 0,00 0,47 0,00 0,55 581 492 498 0 470 0 510
A0A0A6YWBMbnl1 3 3 3 0 4 0 3 0,29 0,29 0,29 0,00 0,41 0,00 0,32 102 98 99 0 157 0 114
Q91YT7 Ythdf2 5 4 4 0 14 0 7 0,34 0,26 0,26 0,00 1,53 0,00 0,60 211 196 185 0 720 0 328
Q9EPU0 Upf1 9 10 6 0 15 2 10 0,30 0,34 0,19 0,00 0,55 0,06 0,35 472 507 289 0 743 76 503
Q8C2Q3 Rbm14 5 5 4 0 13 0 7 0,30 0,30 0,23 0,00 1,07 0,00 0,48 251 239 173 0 730 0 348
O88532 Zfr 4 5 5 0 11 0 6 0,13 0,17 0,17 0,00 0,45 0,00 0,23 145 281 196 0 592 0 304
Q9QYS9 Qki 2 2 2 0 6 0 3 0,21 0,21 0,21 0,00 0,94 0,00 0,39 98 99 81 0 249 0 132
B7ZWL1 Cnot1 13 10 13 0 26 0 16 0,19 0,15 0,19 0,00 0,46 0,00 0,25 623 555 616 0 1282 0 769
O35218 Cpsf2 3 2 2 0 2 0 2 0,13 0,08 0,08 0,00 0,10 0,00 0,10 106 93 92 0 95 0 97
Q9EPU4 Cpsf1
Heterogeneous nuclear ribonucleoprotein F
Cysteine and glycine-rich protein 1
Cell cycle and apoptosis regulator protein 2
Muscleblind-like protein 1
YTH domain-containing family protein 2
Regulator of nonsense transcripts 1
RNA-binding protein 14
Zinc finger RNA-binding protein
Protein quaking
CCR4-NOT transcription complex subunit 1
Cleavage and polyadenylation specificity factor subunit 2
Cleavage and polyadenylation specificity factor subunit 1 5 5 3 0 9 0 6 0,12 0,12 0,05 0,00 0,20 0,00 0,12 216 194 97 0 366 0 218
Integrator complex ###
Q8K2A7 Ints10 Integrator complex subunit 10 2 2 2 0 2 0 2 0,09 0,09 0,09 0,00 0,14 0,00 0,10 86 97 77 0 106 0 92
Q6P4S8 Ints1 Integrator complex subunit 1 4 4 3 0 7 0 5 0,06 0,06 0,04 0,00 0,11 0,00 0,07 157 135 126 0 295 0 178
Corepressors ###
P23198 Cbx3 4 2 4 0 5 0 4 0,96 0,65 1,32 0,00 2,24 0,00 1,29 169 120 217 0 275 0 195
Q7TSZ8 Nacc1 5 5 7 0 13 0 8 0,37 0,37 0,55 0,00 1,74 0,00 0,76 247 287 303 0 720 0 389
Q80X50 Ubap2l 11 9 12 0 21 0 13 0,45 0,36 0,45 0,00 1,39 0,00 0,66 515 427 495 0 1129 0 642
Q9CQJ4 Rnf2 5 3 3 0 7 0 5 0,60 0,33 0,33 0,00 1,33 0,00 0,65 252 147 137 0 363 0 225
Q60520 Sin3a 11 10 12 0 6 0 10 0,32 0,32 0,42 0,00 0,16 0,00 0,31 443 386 528 0 269 0 407
A2BDX0 Adnp
Chromobox protein homolog 3
Nucleus accumbens-associated protein 1
Ubiquitin-associated protein 2-like
E3 ubiquitin-protein ligase RING2
Paired amphipathic helix protein Sin3a
Activity-dependent neuroprotector homeobox protein 4 4 3 0 3 0 4 0,12 0,12 0,09 0,00 0,09 0,00 0,11 136 180 119 0 137 0 143
other ###
A2BIE1 Qser1 Protein Qser1 19 15 15 0 33 0 21 0,45 0,34 0,34 0,00 1,28 0,00 0,60 892 784 704 0 1857 0 1059
Q3UA37 Qrich1 Glutamine-rich protein 1 6 8 6 0 11 0 8 0,28 0,40 0,34 0,00 0,87 0,00 0,47 296 315 242 0 538 0 348
Q9DCT8 Crip2 Cysteine-rich protein 2 2 2 3 0 2 0 2 0,35 0,35 0,57 0,00 0,57 0,00 0,46 75 138 178 0 127 0 130
P70168 Kpnb1 Importin subunit beta-1 6 7 8 0 8 0 7 0,25 0,29 0,34 0,00 0,34 0,00 0,31 331 362 326 0 417 0 359
Q3U1J4 Ddb1 DNA damage-binding protein 1 16 11 14 0 15 0 14 0,67 0,37 0,45 0,00 0,49 0,00 0,50 810 479 577 0 668 0 634
Q9Z191 Eya4 Eyes absent homolog 4 2 1 2 0 5 0 3 0,11 0,06 0,11 0,00 0,24 0,00 0,13 72 68 73 0 193 0 102
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Table Supplemental 2 | SEs in NSCs (genomic coordinates) 
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chr11 101502299 101519975 Arl4d 1 chr18 5805306 5823613 Zeb1/Arhgap12 151 chr4 301
chr15 85482117 85519888 Wnt7b/Mirlet7c-2 2 chr11 152 chr1 302
chr11 87275110 87285154 Rad51c 3 chr2 153 chr4
140469593 140486963 Padi2 
135991387 136001493 Chit1 
135648973 135663687 Id3 303
chr11 87256127 87262339 Rad51c 4 chr8
119566837 119577289 Rptor 
170110374 170135828 Bcas1 
129347420 129364215 Tomm20 154 chr18 5970822 5983663 Zeb1/Arhgap12 304
chr11 87235422 87240416 Rad51c 5 chr11 88387914 88408876 Msi2 155 chr1 305
chr12 88110704 88167882 Angel1 6 chr11 77963873 77970757 Traf4 156 chr9 306
chr11 98786982 98833230 Rara 7 chr8 93385734 93401737 Chd9 157 chr8 307
chr4 97268244 97333957 Nfia 8 chr9 64438337 64461582 Rab11a 158 chr1
157075334 157089623 Stx6 
116121027 116141991 Tgfbr2 
124445860 124461019 Car5a 
161591032 161618515 Tnr
308
chr1 72272346 72302938 Mreg 9 chr10 122320493 122332643 Mirlet7i 159 chr17 48562894 48577727 Apobec2 309
chr11 87931123 87976574 Cuedc1 10 chr1 39977143 40012275 Map4k4 160 chr6 29384145 29386998 Ccdc136 310
chr4 116861522 116875583 Kif2c 11 chr18 81244290 81251873 Sall3 161 chr18 81346834 81353180 Sall3 311
chr15 98798082 98824335 Tuba1a 12 chr11 16716012 16745711 Egfr 162 chr5 113560943 113582451 2900026A02Rik 312
chr5 115938824 115942514 Sirt4 13 chr5 114319446 114334043 Coro1c 163 chr4 8936157 8947227 Clvs1 313
chr11 117156345 117182248 Sept9 14 chr11 97665648 97688033 Lasp1 164 chr14 65736523 65759961 Extl3 314
chr14 26543039 26577940 Zcchc24 15 chr1 90551466 90565911 Arl4c 165 chr12 60140818 60141650 Trappc6b 315
chr18 5130392 5165290 Zfp438 16 chr14 100338322 100345888 Klf12 166 chr9 35137770 35150197 4933422A05Rik 316
chr7 80729113 80766141 1810026B05Rik 17 chr11 49574375 49580983 Gfpt2 167 chr4 134852801 134859097 Clic4 317
chr11 120112669 120126041 Bahcc1 18 chr2 30284316 30304337 Ppp2r4 168 chr12 81062489 81073185 9430078K24Rik 318
chr15 77611812 77655136 Myh9 19 chr17 87320926 87338653 Rhoq 169 chr7 53762869 53772311 Kcnc1 319
chr18 37982390 38012569 Pcdhgc family 20 chr5 24101501 24118490 Smarcd3 170 chr11 62779165 62781844 Cdrt4 320
chr15 85429940 85446290 Wnt7b/Mirlet7c-2 21 chr11 103001805 103006975 Hexim2 171 chr11 77598914 77607555 Myo18a 321
chr16 30171292 30201194 Hes1 22 chr12 16625392 16671585 Lpin1 172 chr9 107512784 107518245 Sema3b 322
chr16 91300931 91316898 Olig1 23 chr2 26386212 26407938 Notch1 173 chr18 35832971 35839090 Spata24 323
chr8 10943368 10992655 Irs2 24 chr7 143236009 143243275 Mki67 174 chr14 27978449 27991717 Arhgef3 324
25 chr6 53984690 54024937 Chn2 175 chr12 83376347 83390351 Sipa1l1 325chr7 
chr5
152278676 152309068 Ccnd1 
125614247 125647398 Ncor2 26 chr5 176 chr14 101146771 101153365 Prr30 326
chr4 8835933 8882787 Chd7 27 chr4 177 chr11 6005975 6023534 Camk2b 327
chr11 35731471 35749952 Wwc1 28 chr6
121012463 121019436 Tpcn1 
106508605 106523148 Ssbp3 
114214004 114248479 Slc6a1 178 chr15 73262364 73292509 Ptk2 328
chr15 61908412 61941902 Myc 29 chr13 64001745 64022125 Ercc6l2 179 chr8 26573553 26578214 Fgfr1 329
chr10 59352662 59379935 Dnajb12 30 chr8 13613545 13626651 Rasa3 180 chr12 70597916 70604630 5830428M24Rik 330
chr2 116797035 116807250 D330050G23Rik 31 chr13 112074423 112085101 Gpbp1 181 chr8 37205364 37223732 D8Ertd82e 331
chr6 39465192 39499349 Dennd2a 32 chr15 77188962 77199095 Rbfox2 182 chr11 101337567 101341639 Rnd2 332
chr13 60011111 60050908 Zcchc6 33 chr1 34719932 34737116 AA619741 183 chr12 80779237 80798075 9430078K24Rik 333
chr1 88386927 88408896 Ptma 34 chr11 76458691 76462174 Gosr1 184 chr13 102568876 102584348 Pik3r1 334
chr18 69719430 69759581 Tcf4 35 chr7 86501160 86513711 Rlbp1 185 chr14 52623496 52632429 Zfp219 335
chr18 5927357 5950006 Zeb1/Arhgap12 36 chr11 45875589 45883899 Adam19 186 chr16 37682996 37686232 Ndufb4 336
chr10 39364940 39397688 Rev3l 37 chr15 76290520 76297397 Bop1 187 chr5 135933897 135944363 Pom121 337
chr10 21918559 21946849 Raet1c 38 chr9 49784575 49814700 Ncam1 188 chr15 30368065 30388874 Ctnnd2 338
chr4 81370973 81411114 Mpdz 39 chr17 25791100 25818928 Sox8 189 chr6 36786558 36811119 Ptn 339
chr15 78454098 78469246 Tst 40 chr2 28376738 28396020 Ralgds 190 chr9 72475905 72489493 Nedd4 340
chr3 87784757 87795603 Nes 41 chr8 122845943 122864224 Gse1 191 chr1 9543368 9561036 Adhfe1 341
chr6 52007076 52047390 Skap2 42 chr18 38900865 38928521 Spry4 192 chr4 106450160 106460814 Acot11 342
chr5 135728452 135752267 Fzd9 43 chr14 193 chr2 38678183 38681875 Mir181a-2 343
chr9 65043416 65044793 Parp16 44 chr11
106019938 106032695 Spry2 
107186922 107221669 Pitpnc1 194 chr11 102068207 102081095 Mir8101 344
chr17 10069869 10104111 Qk 45 chr5 65091139 65103112 Klf3 195 chr12 55076846 55087701 Npas3 345
chr4 124269570 124304820 Pou3f1 46 chr11 100247060 100255613 Jup 196 chr18 65721577 65727797 Zfp532 346
chr4 62242178 62291719 Rgs3 47 chr19 21797403 21818695 Tmem2 197 chr10 59656782 59673902 Chst3 347
chr5 125681568 125710489 Ncor2 48 chr6 143990591 144008324 Sox5 198 chr12 348
chr14 26189541 26199113 Zmiz1 49 chr17 29847980 29875911 Ccdc167 199 chr4
107197439 107214545 Vrk1 
151444093 151454584 Plekhg5 349
chr17 87758354 87796822 Calm2 50 chr16 35587713 35625492 Sema5b 200 chr8 87251095 87268911 Lyl1 350
chr1 87926058 87953470 2810459M11Rik 51 chr2 166495405 166519996 Mir6364 201 chr12 73531504 73541049 Lrrc9 351
chr4 132493828 132520993 Ahdc1 52 chr12 87982084 88002414 Vash1 202 chr7 71095640 71116327 Klf13 352
chr15 8605991 8618845 Slc1a3 53 chr6 72460631 72471111 Mat2a 203 chr11 5898824 5904126 Ykt6 353
chr18 36007350 36036753 Cxxc5 54 chr5 204 chr17 29477951 29494001 Mtch1 354
chr10 120933693 120946080 Rassf3 55 chr4
141011853 141033240 Chst12 
104840775 104857349 Plpp3 205 chr6 114661667 114672322 Atg7 355
chr18 39047596 39090160 Fgf1 56 chr14 79581611 79609988 Zfp957 206 chr11 20376341 20378512 Sertad2 356
chr11 60021829 60025403 Mir6922 57 chr6 207 chr3 109101057 109113595 Vav3 357
chr1 135955951 135964641 Btg2 58 chr1
136479697 136505087 Atf7ip 
171388527 171417062 Nuf2 208 chr17 35886598 35892597 Ier3 358
chr9 13471785 13509560 Mtmr2 59 chr15 38397915 38404625 Mir6951 209 chr1 64331347 64353823 Klf7 359
chr4 132611406 132651895 Ahdc1 60 chr13 112716978 112735932 Gm15326 210 chr11 54829010 54838136 Anxa6 360
chr11 20813571 20824144 Lgalsl 61 chr13 34238485 34247378 Tubb2b 211 chr7 87294161 87317692 Sema4b 361
chr15 103128946 103138067 Copz1 62 chr11 117488035 117490540 2900041M22Rik 212 chr12 83152113 83159247 Sipa1l1 362
chr7 87333320 87344538 Sema4b 63 chr12 74509264 74518368 D830013O20Rik 213 chr17 35913022 35921493 Ier3 363
59002559 59031582 Mtss1 64 chr16 91172132 91196351 Olig2 214 chr4 124122620 124130349 Pou3f1 364
37655131 37671882 Gm5148 65 chr15 58871421 58886972 Mtss1 215 chr15 85384277 85400995 Wnt7b 365
8342981 8369889 Tns3 66 chr13 26659373 26672488 Hdgfl1 216 chr11 117268050 117271978 Sept9 366
133357056 133391143 Srgap2 67 chr16 22541970 22549876 Etv5 217 chr4 82327709 82351755 Nfib/Zdhhc21 367
25681462 25705837 Myo10 68 chr11 68849115 68855239 Aurkb 218 chr15 78231658 78247788 Mpst 368
21695113 21736102 Tbl1xr1 69 chr8 97870915 97902135 Mmp15 219 chr2 165238990 165247308 Ocstamp 369
78498507 78523432 Cdc42ep1 70 chr3 220 chr10 58061925 58068273 Edar 370
5809441 5828444 Malat1 71 chr7 221 chr10 98659891 98668241 Dusp6 371
72 chr11
122163561 122187231 Bcar3 
130172936 130191822 Rbbp6 
117383807 117396713 Tnrc6c 222 chr1 372105323427 105351914 Kcnd3 
125415483 125442499 Cd9 73 chr15 27706763 27728254 Fam105a 223 chr1
133312343 133335917 Srgap2 
133274183 133283339 Srgap2 373
chr15 
chr3 
chr11 
chr1 
chr15 
chr3 
chr15 
chr19 
chr3 
chr6 
chr11
88336246 88372755 Msi2 74 chr1 74433011 74444840 Ctdsp1 224 chr11 69839610 69843883 Dlg4 374
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Table Supplemental 2 | continuation
39252947chr10 39275332 Fyn 75 chr8 122892469 122907958 Gse1 225 chr11 86405505 86410125 Vmp1 375
chr9 110186503 110201403 Elp6 76 chr1 36645343 36665085 Sema4c 226 chr11 75021681 75028384 Rtn4rl1 376
chr6 36702984 36750809 Ptn 77 chrX 162743290 162768051 Gpm6b 227 chr3 88558867 88567366 Syt11 377
chr13 48640358 78 chr11 98607594 98613816 Thra 228 chr11 107589197 107605134 Cacng1 378
chr2 30501723 79 chr3 229 chr6 28791218 28796815 Lrrc4 379
chr11 31727738
48663417 Mirlet7a-1 
30516698 Ier5l 
31748918 Cpeb4
80 chr14 230 chr9 80002525 80027585 Myo6 380
chr12 101526618 101566851 Calm1 81 chr11 231 chr2 156388332 156411882 Aar2 381
chr15 82 chr15
121388273 121411290 4930432M17Rik 
100854257 100863838 Klf12 
107735817 107738929 Cacng5 
102485657 102490508 Atp5g2
232 chr13 55428521 55440531 Mxd3 382
chr1
78661793 78667613 Cdc42ep1
137050543 137092644 Gpr37l1 83 chr13 43624890 43636456 Mcur1 233 chr4 135688796 135693829 Id3 383
chr13 99866942 99873487 Tnpo1 84 chr17 45717443 45723481 Slc29a1 234 chr11 51898872 51901371 Ppp2ca 384
chr3 154353144 154365670 Tyw3 85 chr4 45479393 45503906 Shb 235 chr8 114239316 114250867 Bcar1 385
chr13 98516438 98548119 Enc1 86 chr17 73599158 73608387 Lclat1 236 chr16 43571139 43579759 Mir568 386
chr15 79153194 79166581 Pla2g6 87 chr11 88464669 88470954 0610039H22Rik 237 chr7 387
chr16 22514952 22528945 Etv5 88 chr15 85287905 85306749 7530416G11Rik 238 chrX
123410058 123427461 Plekha7 
100745666 100760134 Gm9159 388
chr2 30591868 30616196 Ntmt1 89 chr9 77757413 77760135 Elovl5 239 chr11 20756904 20760894 Lgalsl 389
chr11 69221609 69233544 Kdm6b 90 chr3 126716030 126725976 Ank2 240 chr2 165987701 166007365 Sulf2 390
chr14 32472471 32484205 Btd 91 chr2 72832158 72844442 Sp3 241 chr13 60151109 60181610 A530065N20Rik 391
chr1 184011739 184049049 Srp9 92 chr12 80832265 80855286 Zfp36l1 242 chr17 31692614 31718635 Pknox1 392
chr6 94579953 94606822 Lrig1 93 chr6 86518508 86536863 1600020E01Rik 243 chr2 30547262 30551415 Ntmt1 393
chr2 13305156 13337097 Vim 94 chr4 41562329 41579764 Enho 244 chr12 55839189 55840100 Eapp 394
chr1 39789060 39821375 Map4k4 95 chr8 14989534 15006822 Kbtbd11 245 chr11 395
chr10 82579250 82609544 Chst11 96 chr1 74149984 74166326 Tns1 246 chr9
116189998 116194923 Foxj1 
106278968 106309549 Dusp7 396
chr15 58806194 58810009 Ndufb9 97 chr6 85244303 85271543 Sfxn5 247 chr17 10525646 10531094 1700110C19Rik 397
chr2 91793586 91827535 Dgkz 98 chr13 112949010 112960151 Ankrd55 248 chr12 83121484 83128456 Sipa1l1 398
chr6 90477513 90492911 Klf15 99 chr11 88267894 88289697 Msi2 249 chr15 95735967 95763426 Ano6 399
chr1 139794284 139805162 Mir181a-1 100 chr2 93720525 93752955 Accsl 250 chr11 53305197 53322737 Sept8 400
chr7 86664292 86680964 Polg/Mir9-3 101 chr19 36770308 36781653 1500017E21Rik 251 chr8 94650727 94659962 Crnde 401
chr14 55668547 55676284 Ngdn 102 chr8 74804986 74835449 Klf2 252 chr2 30961546 30976237 Fnbp1 402
chr17 15125416 15130870 9030025P20Rik 103 chr6 136414498 136420436 Mir125b-1/311003 253 chr12 81927296 81965098 Susd6 403
chr19 44355124 44360183 Scd2 104 chr9 41683624 41699969 Pkm2 254 chr2 131271425 131289448 Smox 404
chr9 34791299 34805746 St3gal4 105 chr9 59538799 59543968 Gramd2 255 chr15 99267484 99280734 Nckap5l 405
106 chr11 118058189 118064612 Cyth1 256 chr4 62319913 62332185 Rgs3 406chr3 
chr9
105365912 105396277 Kcnd3 
121266324 121282187 Trak1 107 chr15 84861897 84873879 Fam118a 257 chr5 43745039 43752089 Cpeb2 407
chr9 56714927 56731970 Snx33 108 chr17 84480290 84512248 4933433H22Rik 258 chr3 101504274 101517745 Atp1a1 408
chr3 34338789 34366158 Sox2 109 chr1 259 chr14 51707262 51714893 Ang 409
chr9 44286307 44304119 Bcl9l 110 chr11 260 chr11 54565119 54570306 Cdc42se2 410
chr17 15155439 15162263 Gm3435 111 chr5
182307087 182340046 Gm5069 
102194399 102201283 Ubtf 
135960939 135970246 Hip1
261 chr17 26639262 26642523 Dusp1 411
chr9 62356315 62381012 Coro2b 112 chr9 56344605 56365585 Hmg20a 262 chr4 8299838 8310262 Car8 412
chr13 25817776 25847367 Gm11351 113 chr4 155149195 155159718 Mrpl2 263 chr6 91123339 91153252 Fbln2 413
chr19 44385015 44390289 Scd2 114 chr19 6443147 6466666 Nrxn2 264 chr8 13449303 13468670 Tmem255b 414
chr2 167569381 167603828 Cebpb 115 chr6 265 chr1 415
chr18 38944592 38972979 Fgf1 116 chr9 266 chr1
128576891 128584916 Nckap5 
139822383 139828925 Mir181a-1 416
chr7 104572058 104597317 Ndufc2 117 chr2 267 chr3 85103159 85115027 1700036G14Rik 417
chr11 31611849 31635912 Bod1 118 chr2 268 chr1 196565187 196575574 Plxna2 418
chr13 56682238 56703022 Smad5 119 chr5
112807023 112841300 Srgap3 
107603884 107627578 Sema3f 
166167580 166186470 Gm11468 
152161301 152177011 Trib3 
124443078 124470006 Vps37b
269 chr15 80502731 80512260 Tnrc6b 419
chr9 57266721 57282574 Ppcdc 120 chr1 64234470 64249750 Klf7 270 chr9 43878618 43887871 Usp2 420
chr17 29186499 29200742 Srsf3/Cdkn1a 121 chr10 92737558 92739987 Elk3 271 chr17 31671150 31679500 Ndufv3 421
122 chr19 46592847 46607119 Trim8 272 chr6 113280566 113288654 Ogg1 422chr1 
chr1
137540473 137585381 Nav1
186264104 186280978 Hlx 123 chr18 38538643 38546213 Ndfip1 273 chr12 55132907 55138973 Npas3 423
chr14 106127780 106142495 Spry2 124 chr17 84652297 84675091 Zfp36l2 274 chr5 34031087 34049607 Fgfr3 424
chr15 59445607 59469858 Trib1 125 chr9 31072452 31091003 Gm7244 275 chr5 91530384 91546502 Areg 425
chr18 65674684 65691615 Zfp532 126 chr2 26340749 26345305 Notch1 276 chr8 91560010 91567809 Sall1 426
chr1 88329973 88340197 Ncl 127 chr6 53397179 53422217 Creb5 277 chr14 25756779 25761407 4930572O13Rik 427
chr14 26125981 26141394 Zmiz1 128 chr12 73032419 73055731 Daam1 278 chr10 6224636 6242419 Mthfd1l 428
chr8 13528802 13551745 Rasa3 129 chr2 136503440 136513657 Snap25 279 chr17 45885742 45907544 1600014C23Rik 429
130 chr19 7024721 7028144 Bad 280 chr2 72919925 72927796 Sp3 430chr11 119376092 119385608 Endov 
chr11 107271012 107281765 Pitpnc1 131 chr8 113185121 113213595 Mtss1l 281 chr16 43502316 43511338 Gm15713 431
132 chr7 54240533 54257788 Spty2d1 282 chr1 432chr7 
chr8
119960982 119986425 Tead1
129189159 129193320 Irf2bp2 133 chr8 122939645 122951964 Gse1 283 chr11
173032153 173042525 Mpz 
113043188 113054240 2610035D17Rik 433
chr17 9212696 9229211 6530411M01Rik 134 chr12 55810864 55812120 Eapp 284 chr5 25114042 25123783 1700096K18Rik 434
99162347 99175420 Fmnl3 135 chr14 26044478 26049525 4930572O13Rik 285 chr6 435
79021229 79033974 Pick1 136 chr15 12290142 12301766 Golph3 286 chr4
142815022 142828647 Gm7457 
124385034 124388644 Sf3a3 436
22978017 23016587 Klf9 137 chr1 72783015 72800660 Rpl37a 287 chr11 4090272 4104237 Tbc1d10a 437
44320244 44324739 Scd2 138 chr11 94019856 94023396 Tob1 288 chr12 16521050 16540843 Lpin1 438
98642944 98651171 Msl1 139 chr1 42584731 42599926 Pou3f3 289 chr5 54486695 54495960 Stim2 439
93994779 94007015 Tob1 140 chr8 26154016 26182438 Adam9 290 chr5 125743298 125751794 Scarb1 440
77738396 77753515 Sez6 141 chr11 83084573 83085029 Pex12 291 chr15 99250086 99252820 Tmbim6 441
78335960 78354451 Eef1a1 142 chr3 35038826 35053871 Mir6378 292 chr7 442
90642678 90651315 Tmpo 143 chr15 95656244 95661884 Ano6 293 chr5
141436315 141455911 Adam12 
138197068 138202120 Tsc22d4 443
124595576 124619488 Xylt1 144 chr11 32134474 32145299 Mpg 294 chr16 11011201 11022405 Gm4262 444
93099876 93110430 Ramp1 145 chr3 101569935 101610913 Mab21l3 295 chr5 22669061 22674497 5031425E22Rik 445
53853925 53863806 Sergef 146 chr17 9913544 9922915 Qk 296
114823567 114844354 Vgll4 147 chr3 35231237 297
30200074 30218354 Ctnnd2 148 chr3 88007793 298
149 chr9 89663983 299
chr15 
chr15 
chr19 
chr19 
chr11 
chr11 
chr11 
chr9 
chr10 
chr7 
chr1 
chr7 
chr6 
chr15 
chr5 
chr4
135005963 135032236 Clip2 
130352907 130372208 Sdc3 150 chr6 22740908
35242401 Gm6639 
88012001 Mir3093 
89686399 Tmed3 
22748985 Ptprz1
300
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Table Supplemental 3 | GO terms of SE, Broad and SE+Broad genes 
SE SE+Broad
Benjamini Enrichment GO terms Benjamini Enrichment GO terms Benjamini Enrichment
8,00E-47 41.4 Transcriptional regulation 5.5E-8 7.1 Transcriptional regulation 4.4E-10 9.0
Broad H3K4me3 promoter
GO terms
Transcriptional regulation
mRNA splicing 1.7E-5 5.0 Semaphorin 0.2;  not significant 2.1
Benjamini Enrichment
Benjamini Enrichment Benjamini Enrichment
TFs SE+Broad
GO terms
Regulation of neurogenesis 0.002 3.1
8.2E-6 3.7
TFs SE
GO terms
Regulation of neurogenesis 0.01 2.6
4.3E-5 3.3
TFs Broad
GO terms
Ventricular septum morphogenesis
Regulation of neurogenesis
Oligodendrocyte differentiation 7.2E-5 3.9
Broad-SE SE-Broad
GO terms Benjamini Enrichment GO terms Benjamini Enrichment
Transcriptional regulation 9,00E-36 32 Semaphorin 0.35; not significant 2.1
mRNA splicing 1.2E-5 5.1
TFs Broad-SE
GO terms Benjamini Enrichment
Fat cell differentiation 0.11; not significant 1.8
Table Supplemental 4 | Genes with 
SE(s) and broad H3K4me3 promoters in 
NSCs 
Table Supplemental 5 | Datasets used in the study 
1810026B05Rik Kdm6b Rasa3
Klf12 Rassf3
Klf13 Rbbp6
Klf3 Rev3l
Klf7 Rhoq
Klf9 Sall1
Lrig1 Sall3
Malat1 Scd2
Map4k4 Slc1a3
Mir125b-1 Snx33
Mir181a-1 Sox2
Mir3093 Sox8
Mir9-3 Spry2
Mirlet7c Spry4
Mki67 Srgap2
Mmp15 Srsf3
Msi2 Stim2
Msl1 Sulf2
Mtss1 Tbl1xr1
Mtss1l Tcf4
Myc Thra
Myh9 Tnpo1
Myo18a Tob1
Nav1 Traf4
Ncor2 Trib1
Nedd4 Trim8
Nes Tuba1a
Nfia Tubb2b
Nfib Ubtf
Notch1 Vash1
Npas3 Vav3
Olig1 Vgll4
Olig2 Vim
Pcdhgc4 Vps37b
Pik3r1 Wwc1
Plxna2 Xylt1
Polg Zcchc24
Pom121 Zeb1
Pou3f1 Zfp36l1
Pou3f3 Zfp36l2
Ptk2 Zfp532
Ptma Zmiz1
Ptn Qk
5031425E22Rik
Adam12
Adhfe1
Ahdc1
Ank2
Arl4c
Aurkb
Bahcc1
Bcl9l
Calm2
Camk2b
Ccnd1
Cdkn1a
Chd7
Chst11
Cpeb4
Ctnnd2
Cxxc5
D8Ertd82e
Ddr1
Dennd2a
Dlg4
Dusp1
Dusp6
Dusp7
Eef1a1
Egfr
Enc1
Etv5
Fam105a
Fgf1
Fgfr3
Fyn
Gm5069
Golph3
Gpm6b
Hes1
Hip1
Hlx
Ier5l
Irf2bp2
Irs2
Kcnc1 Ptprz1
GSM2928425
GSM2928426
GSM2928427
GSM2928428
GSM1187180
GSM1820990
ChIP-seq
Med1
Jmjd1c
Carm1
IgG
mNSCs Input
Tcf4
Sox2
NFI
Olig2
Ints11
RNA pol II
Ep300
H3K27ac
H3K4me3
Cbx8
Ctcf
ERR414096
ERR414099
GSM1820994
ERR1173522
ERR1173526
ERR216112
ERR216108
SRR006888_SRR006889
GSM2393587
GSM883647
RNA-seq
wild-type NSCs GSM1861892, GSM1861893, GSM1861894
scrambled shRNA NSCs GSM1861886, GSM1861887, GSM1861888
Tcf4 knock down NSCs GSM1861889, GSM1861890, GSM1861891
93
Chapter 3 
Cgg-binding protein 1 regulates neural 
induction and neural stem cell homeostasis 
RA receptor
Cggbp1
Sox21
Cbx8
Cbx7
 Zfp42
Pou5f1
Gsc
Cggbp1
Mesodermal 
Pluripotency
Sox1,3
Neural lineage
Cggbp1
repression?
Direct Polycomb
interaction?
Cbx8
PRC
- Work in progress - 
Cgg-binding protein 1 regulates neural induction and neural stem cell homeostasis 
Marti Quevedo1*, Lleches-Padilla A1, Gordaliza I1, Mike R. Dekker1, Dick H.W. Dekkers2, Zeliha 
Ozgür3, Wilfred F.J. van IJcken3, Jeroen Demmers2, Raymond A. Poot1 
1Department of Cell Biology, Erasmus MC, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands 
2Center for Proteomics, Erasmus MC, The Netherlands 
3Center for Biomics, Erasmus MC, The Netherlands 
*Corresponding author
ABSTRACT 
Neural induction represents the earliest step in the determination of ectodermal cell fates. During 
early embryogenesis a complex transcriptional network regulates the balance between embryonic 
stem cells pluripotency versus differentiation towards neural precursors. Among them, Polycomb 
group proteins regulate the state of many developmental genes by keeping them in a poised state.  
In our study we have identified Cggbp1, a small zing finger protein, as a regulator of neural induction 
and neural progenitor homeostasis. Cggbp1 binds to early neural fate gene promoters together with 
the Mediator complex and chromatin remodelers to activate transcription. In addition, we find an 
association between Cggbp1 and neural poised genes in embryonic stem cells and we explore its 
relation to Polycomb mediated derepression. 
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INTRODUCTION 
The central nervous system originates from the dorsal part of the ectoderm layer. Around embryonic 
day 7.5 in the mouse a part of the ectoderm thickens and flattens forming the neural plate, which will 
wrap in on itself to give rise to the neural tube. This developing neuroepithelium will in time generate 
most of neurons and glia in the body1. 
The combination of morphogenetic signals expressed within the neural ectoderm and among 
surrounding tissues integrate through several signaling cascades to activate cell-intrinsic factors that 
cooperate to stabilize neural fate2. During this process the balance between pluripotency and 
differentiation is tightly regulated at the transcriptional level by factors such as the Polycomb group 
(PcG) proteins. PcG proteins are powerful regulators of cell fate decisions as they dictate the state of 
many developmental genes by keeping them in a poised state. The selective derepression of poised 
genes depends on the combination of cell extrinsic morphogens and cell intrinsic factors to which 
cells are exposed. Recent studies suggest that Polycomb repressive complexes are recruited through a 
range of different mechanisms, from non-coding RNA, to CpG islands and transcription factors3. 
Cggbp1 is a 167 amino acid long 20 kDa zinc finger protein originally identified in a screen for factors 
associated with CGG tandem repeats4. However, the reported function of Cggbp1 in transcription is 
ambiguous. Initially, its association with CGG repeats attracted some attention as a regulator of the 
fragile X mental retardation 1 gene (FMR1) due to its pathology being caused by an expansion of the 
CGG tripleat4. On top of that, several studies have pointed Cggbp1 as a transcription repressor. 
However, one study postulates a direct transcription effect at specific heat-shock promoters5, while 
another study points at a genome-wide effects on Alu/SINE repeats6.  
Here we identify Cggbp1 as an activating transcription factor that regulates the expression of neural 
specific genes. Cggbp1 binds to GCC repeats in gene promoters of neural stem cells (NSCs) together 
with the Mediator complex and chromatin remodelers and activates their transcription. Cggbp1 levels 
are essential not only for the correct expression of key NSCs genes but also for NSCs survival. 
Furthermore, we identified a Cggbp1 role at early stages of embryonic stem cells (ESCs) neural 
induction where it regulates transient neural inducers such as Sox21 in response to retinoic acid (RA). 
Finally, we associated Cggbp1 early neural fate function to Polycomb poised gene regulation and we 
preliminarily explore their cooperation. 
RESULTS 
Cggbp1 is expressed in NSCs and interacts with the Mediator complex 
We have identified Cggbp1 as a DNA-independent protein-protein interactor of the Mediator 
complex in Mediator subunit 15 (Med15)-FLAG purifications from NSCs. Cggbp1 was consistently 
present in all 4 Mediator purifications, irrespective of the addition of Benzonase or Ethidium Bromide 
(Figure 1A, Chapter 2 of this thesis). Subsequent Cggbp1-Flag purifications confirmed its interaction 
with Mediator in NSCs (Figure 1B). In addition, immunohistochemistry staining of Cggbp1 in NSCs 
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showed endogenous nuclear localization (Figure 1C). Cggbp1 interaction with Mediator, a central 
core piece of transcription activation7, and the published interaction with NFIX4, a transcription factor 
recently identified as a crucial NSCs regulator8, lead us hypothesize a wider role in NSC transcription 
for Cggbp1. 
Figure 1 | Cggbp1 is expressed in NSCs and interacts with the Mediator complex 
(A) Mass spectrometry counts for Cggbp1 in Med15-Flag purifications in NSCs. (B) Flag-Cggbp1 or control 
purifications in NSCs analyzed by western blot. (C) Protein structure of Cggbp1 and reportedphosphorylations. 
(D) Immunocytochemistry with Cggbp1 and Nestin antibodies on NSCs showing nuclear localization of 
endogenously expressed Cggbp1.  
Cggbp1 positively regulates essential neural genes 
In order to explore Cggbp1 function in transcriptional regulation, we determined Cggbp1 genomic 
occupancy by chromatin immunoprecipitation followed by high-throughput sequencing of the bound 
DNA (ChIP-seq) in NSCs. We identified 1855 specific Cggbp1 binding sites after filtering with a 
published NSC input background signal. Cggbp1 has a strong preference for promoter sequences 
(Figures 2A-C) including CpG islands (Figure 2A,D). Analysis of Cggbp1 DNA binding sites retrieved 
sequences with a highly significant accumulation of 3 times the GCC triplet (Figure 2E).  
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Cggbp1 bound genes identified by gene annotation of Cggbp1 promoter peaks showed slightly 
increased expression compared to all NSC expressed genes suggesting a role of Cggbp1 beyond 
transcriptional repression (Figure Supl. 1A). The amount of Cggbp1 signal in each promoter peak did 
not correlate with the expression of the assigned gene (Figure Supl. 1B). 
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Figure 2 (at previous page)| Cggbp1 activates promoters of neural induction genes 
(A) Chip-seq tracks of Cggbp1 and histone modifications H3K4me3 and H3K4me1 at different neural genes loci. 
Purple bars indicate CpG islands. Range of reads per million per base pair is indicated on the y-axis. Scale bar is 
indicated.  (B) Distribution of Cggbp1 genomic binding sites. (C) ChIP-seq meta-profile plots around promoters. 
Mean Cggbp1 ChIP-seq density (y-axis) and distance to TSS (x-axis) are shown. (D) Quantification of the 
genomic overlap of Cggbp1 peaks to CpG islands. (E)Significant enriched motifs in Cggbp1 peaks. Significant 
values as reported by HOMER are listed. (F) DAVID cluster analysis on genes bound by Cggbp1. GO terms 
related to transcription are highlighted. (G) GO analysis on genes from the transcription category in F. Neural 
GO terms are highlighted. (H) Normalized Med1 ChIP signal values at different loci in NSCs after 40h 
transfection with scramble or shCggbp1. (I) Chip-seq tracks of Cggbp1, Med1 and histone modifications 
H3K4me3 and H3K4me1 at different neural genes loci. Purple bars indicate CpG islands. Range of reads per 
million per base pair is indicated on the y-axis. Scale bar is indicated. 
Despite being associated to the Mediator complex, which in a previous study we mapped to almost 
all active genes in NSCs (see Chapter 2 of this thesis), we found Cggbp1 to bind to a very small subset 
of active genes. In fact, GO term analysis of Cggbp1 bound genes revealed a strong enrichment for 
genes involved in transcription followed by genes involved in phosphorylation, gene silencing by 
RNA and cell cycle (Figure 2F). Interestingly, Cggbp1 knock down effects have been reported to have 
substantial effects on transcription regulators in cancer cells9. In the same study, effects in cell cycle 
were also observed, although they were not associated with direct Cggbp1 transcriptional regulation 
of cell cycle genes, as our results would suggest.  
A closer examination on the transcription gene cluster revealed many transcription factors and 
chromatin remodelers involved in early neural development such as boundary establishment and 
neural tube patterning (Figure 2G). Moreover, important genes for NSC regulation were also found to 
be bound by Cggbp1 (Figure 2A and 2G). Next, we investigated the capacity of Cggbp1 to regulate 
some of its target genes. Depletion of Cggbp1 by shRNA knock down lead to a downregulation of 
most of the targets tested (Figure 3A and Figure Supl. 2A-B). Importantly, Fmr1 expression, which 
recently was stated not to be affected by Cggbp1 reduced levels10, was found to be also affected in 
NSCs.  
In addition, we examined the capacity of Cggbp1 to recruit activation machinery to one of its targets. 
After Cggbp1 depletion, we observed a Mediator complex recruitment defect at Jag1 promoter, a gene 
target of Cggbp1, but no defects on Jag1 enhancer neither to ActB promoter, a non Cggbp1-bound 
gene (Figure 2H,F). 
As hinted by our genome wide GO analysis, depletion of Cggbp1 affected the homeostasis of NSC 
and by 72 hours most of Cggbp1 depleted NSCs had died (Figure 3A-C). Changes in proliferation and 
viability could be explained described function of Cggbp1 in cell cycle regulation9. However, FACS 
cell cycle analysis of misregulated Cggbp1 NSCs showed no significant changes compared to their 
transfected controls (Figure Supl. 2D). Overexpression of Cggbp1 showed no major effects on its 
targets except the downregulation of Sox11 and Pou3f3 (also known as Brn1) neither significantly 
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affecting NSC viability (Figure 3C-D, Figure Supl 2C). Taken together, these results suggest that 
Cggbp1 mainly acts as a transcriptional activator that regulates genes essential for NSCs survival.  
Figure 3 | Cggbp1 regulates genes essential for NSCs survival 
(A) Immunocytochemistry with Nestin antibodies on NSCs transfected with shCggbp1, F2V5Cggbp1. Control is 
representative of scramble and F2V5empty. (B) Plate wells incubated with alamarBlue showing the effects of 
Cggbp1 misregulation in NSCs . (C) Fluorescence quantifications by alamarBlue incubation (cell viability) of 
transfected NSCs at different time points. Error bars represent SEM, *p < 0.05, unpaired Student’s t test, n=2.  (D) 
qPCR analysis on NSCs transfected with scramble or Cggbp1-targeting shRNA. Error bars represent SEM, *p < 
0.05, **p < 0.01, ***p<0.001, unpaired Student’s t test, n=3.  
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Cggbp1 regulates early lineage specification and induces loss of pluripotency 
Due to its association with genes involved in early neural specification events, its putative regulation 
of histone (de)methylases (Figure 2G) together with its increased expression during brain and testis 
development11, we hypothesized that Cggbp1 may play a function in early neural development.  
Cggbp1-bound promoters in NSCs partially overlap with histone H3 lysine K27 trimethylation 
(H3K27me3)-marked promoters in ESCs (Figure 4A and 4B). Indeed, genes from the resulting overlap 
are enriched for neurodevelopment and cell differentiation (Figure 4C). 
Figure 4 | Cggbp1 binds promoters of neural induction genes poised in ESCs 
(A) Chip-seq tracks of Cggbp1, histone modifications H3K4me3, H3K4me1 from NSCs and H3K27me3 from 
ESCs at different genes loci. Purple bars indicate CpG islands. Range of reads per million per base pair is 
indicated on the y-axis. Scale bar is indicated. (B) Venn diagram representing the overlap between ESCs 
H3K27me3 promoter peaks and NSCs Cggbp1 promoter peaks. (C) GO analysis on overlap genes from B. (D) 
Genome-wide quantification of GCC(3) repeats at gene subsets promoters (+/- 1,5Kb from TSS). Significance 
assessed by Chi square test (Yates correction, *** p<0.001). (E) Genome-wide quantification of GCC(3) repeats at 
gene subsets promoters (+/- 1,5Kb from TSS). Gene subsets extracted by GO term clusters. Significance assessed 
by Fisher exact test (*** p<0.001). 
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Interestingly, when we analyzed cell specific genes from different lineages, we found a significant 
enrichment for the Cggbp1 DNA binding motif at ESCs poised promoters at the same levels as in 
NSCs promoters but not in the whole ESCs population neither at mouse embryonic fibroblasts (MEFs) 
promoters (Figure 4D). We found that forebrain developmental genes have significantly more GCC(3) 
motifs than genes from an endodermal lineage subset such as liver development. Moreover, among 
the neural lineage, neuronal genes were noticeably more enriched with the Cggbp1 motif than 
astrocyte genes (Figure 4E). 
In summary, Cggbp1 motif is overrepresented in neural lineage genes, of which many of them are 
poised in ESCs.  
To characterize the physiological role of Cggbp1 during early ESC differentiation, we evaluated its 
transcriptional regulation effects on mouse ESCs. After 48hours, ESCs transfected with either 
shCggbp1 or F2V5Cggbp1 presented a clear misregulation of genes involved in pluripotency and 
early lineage specification (Figure 5A, upper graphic). While Cggbp1 knock down had no effect on 
pluripotency genes, its overexpression caused a significant reduction of Nanog and Zfp42 (also known 
as Rex1) together with Sox2, all known to be reduced during ESC differentiation. Surprisingly, 
Cggbp1 overexpression did not trigger the upregulation of neural induction genes found to be bound 
in NSCs such as Sox1 and Sox3 but only Sox21. A direct activation effect of Cggbp1 on the Sox21 
promoter could also be observed at the epigenetic level as early as 24hours after F2V5Cggbp1 
transfection (Figure 5B). Interestingly, the alteration of the normal levels of Cggbp1 caused a robust 
regulation of mesodermal markers. Furthermore, Sox17, an endoderm marker but found to be bound 
by Cggbp1 in NSCs, responded positively to Cggbp1 overexpression. Finally, Irx3 both expressed 
during mesodermal and neural specification was upregulated in both conditions (Figure 5A, lower 
graphic).  
Considering the drastic effects on pluripotency and lineage markers found in transient transfected 
ESCs, we proceeded to evaluate their renewal capacity after loss or overexpression of Cggbp1. We 
observed that the upregulation but not absence of Cggbp1 produced a defect in ESC colony formation 
(Figure 5C and 5D). On the basis of our findings we propose a role for Cggbp1 in neural lineage 
specification and pluripotency exit.  
Figure 5 (at next page)| Cggbp1 induces loss of pluripotency and neural lineage specification 
(A) qPCR analysis on ESCs after 48h transfection with scramble or Cggbp1-targeting shRNA and F2V5empty or 
F2V5Cggbp1 constructs. Values normalized to their respective controls. Error bars represent SEM, *p < 0.05, 
unpaired Student’s t test, n=2. (B) Normalized histone modifications ChIP signal values at different loci in ESCs 
after 24h transfection with F2V5empty or F2V5Cggbp1. (C) Plate wells stained with coomassie blue to visualize 
ESCs 9 days colony formation after transfection with scramble or Cggbp1-targeting shRNA and F2V5empty or 
F2V5Cggbp1 constructs. (D) Quantification of number of cells after 48h transfection with scramble or Cggbp1-
targeting shRNA and F2V5empty or F2V5Cggbp1 constructs or number of colonies after seeding 500 cells from 
each condition. Values normalized to their respective controls. Error bars represent SEM, *p < 0.05, unpaired 
Student’s t test, n=2. 
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Cggbp1 regulates Sox21 during early ESCs neural induction mediated by retinoic acid 
Subsequently, we studied 1 the effect of Cggbp1 in a dynamic system of ESC differentiation. We used 
the embryonic body (EB) model of ESC differentiation where neural fate is acquired by the removal of 
leukemia inhibitory factor (LIF) and the addition of retinoic acid (RA)12. First, we analyzed the 
behavior of known markers to evaluate the profile of differentiation of our system. We could observe 
that pluripotency markers such Zfp42 and Oct4 (also named Pou5f1) were reduced rapidly while 
neural markers such as Nestin started to be upregulated after RA stimulation (Figure 6A). 
Intriguingly, Cggbp1 showed a powerful induction within the first days of RA treatment followed by a 
downregulation; in contrast with the steady increase of Nestin expression. 
Focusing on the Cggbp1 locus revealed not only an upstream H3K27me3 poised enhancer in ESCs but 
also a clear binding by the Retinoic acid receptor alpha (RARa) both at the enhancer and the promoter 
of the Cggbp1 gene implying a direct activation by RA (Figure 6B). Indeed, Cggbp1 levels were 
increased in ESCs cultured in pluripotency conditions 24 hours after stimulation with RA and then 
returned to initial levels after another day (Figure 6C). These experiments also allowed us to observe 
the early RA ESC response. First, a primary quick response takes place within the first 6h where Sox1 
is already activated and the first decrease in pluripotency is observed by a decrease in Zfp42 levels. 
However, the expression of certain pluripotency markers is partially retained until a secondary 
response around 12-24 hours where a peak on Cggbp1 and Sox21 is observed, suggesting these neural 
inducers could have a transient upregulation during neural specification that mediates the definitive 
exit from pluripotency.  
As we unraveled the short burst of Cggbp1 levels after RA treatment, we designed a short dynamic 
differentiation experiment in order to bypass several days of EB formation where the transfection 
effects would be lost (see methods). Only 24h without LIF was enough to prepare the cells for RA 
induction, although the effects were not as pronounced as in the EB protocol (Figure 6A). However, 
this approach supports the study of ESC differentiation towards either the neural or the mesodermal 
lineages in parallel, using the same induction timing. Indeed, this allowed us to observe that neural 
induction stimulated Cggbp1 and Sox21 expression while mesodermal induction produced opposite 
effects (Figure 6D). Moreover, the knock down effects were preserved until day 5 (d5) making it 
possible to observed a Cggbp1 dependency on the RA mediated Sox21 induction (Figure 6E). 
Therefore, we conclude that Cggbp1 acts in early neural induction by inducing transient genes such 
Sox21 in response to retinoic acid.  
Cggbp1 associates with Polycomb 
Cggbp1 association with poised promoters in ESCs suggests a role in the activation of poised genes 
with a preference for the neural lineage. To better understand how Cggbp1 regulated these genes, we 
have identified its protein-protein interaction partners in ESCs by FLAG affinity purification coupled 
to mass spectrometry. We found several Polycomb components interacting specifically with Cggbp1 
3 
Chapter 3 | Cggbp1 regulates neural induction and NSCs homeostasis
104
(Figure 7A). On the other hand, we also observed many components of NuRD and SWI/SNF, 
remodeling complexes more related to activation rather than silencing. 
Figure 6 | Cggbp1 regulates Sox21 during early ESCs neural induction mediated by RA  
(A) RNA expression profiles of several genes during early ESCs EB differentiation with RA, n=1. (B) Chip-seq 
tracks of Cggbp1, histone modifications H3K4me3, H3K4me1 from NSCs and H3K27me3 and RARa from ESCs 
at Cggbp1 locus. Purple bars indicate CpG islands. Range of reads per million per base pair is indicated on the 
y-axis. Scale bar is indicated. (C) RNA expression profiles of several genes during ESCs stimulated with retinoic 
acid, n=1. (D) RNA expression profiles of several genes during short neural or mesodermal induction of EBs. (E) 
RT-qPCR analysis of ESCs genes after transfection with scramble or Cggbp1-targeting shRNA constructs and 
treated with CA media (no LIF) or with neural or mesodermal inducer media for 4 days. Values normalized to 
their respective controls, n=1. EB, embryonic body; RA, retinoic acid; RARa, retinoic acid receptor alpha.  
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Although Cggbp1 levels are lower in ESCs than NSCs, we were able to ChIP Cggbp1 at poised 
promoters suggesting that Cggbp1 is already present on some of its targets before its activation by RA 
(Figure 7B).  
Figure 7. Cggbp1 associates with Polycomb in ESCs. 
(A) Mass spectrometry emPAI scores for proteins found in Cggbp1-Flag and control purifications in ESCs after 
24h transfection with F2V5Cggbp1 construct. (B) Normalized Cggbp1 and GFP control ChIP signal values at 
different loci in ESCs. n=1. 
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The ability to bind both silencing Polycomb proteins but also activating remodelers makes us 
postulate that Cggbp1 may act as a switch for poised promoters during the transition to the neural 
lineage.  
DISCUSSION 
Although Cggbp1 has been poorly studied, several reports from Westermark’s lab have indicatednew 
functions for this protein, ranging from transcription both at heat shock genes and Alu repeats, 
genomic integrity, cell cycle and DNA methylation13. However, despite that its ubiquitous expression 
is only altered at early development, where it is enriched in the brain and testis, Cggbp1 role in 
embryogenesis has not been explored. 
Here, we have identified Cggbp1 as a transcription factor acting both in NSCs and in early neural 
induction. Our data indicate that Cggbp1 can act as an activator, in contrast with the repressing roles 
previously reported5,9. We support this claim not only by the downregulation of Cggbp1 targets upon 
Cggbp1 knock down in NSCs but both the epigenetic activation of the Sox21 after 24h Cggbp1 
overexpression in ESC and the dependence on Cggbp1 for the recruitment of the Mediator complex at 
one of its targets in NSCs. In relation with a previous report denying a role in Fmr1 gene regulation10, 
we hypothesize that the cell type model may be important in order to evaluate Cggbp1 effects. We 
suggest that our NSCs may be more representative than lymphoblasts or fibroblasts used in that 
study, in part because Cggbp1 and FMR1 have neural functions and Cggbp1 regulation is highly 
dependent on post-translation modifications triggered by growth factors.  
Although we found a small fraction of Cggbp1 associated with Alu/SINE repeats (data not shown) 
almost 80% of Cggbp1 occupancy consisted in gene promoters with the GCC(3)motif, highly correlated 
with CpG islands. Interestingly, CpG island promoters are largely found in early developmental 
genes marked by DNA methylation valleys (DMVs), which are devoid of DNA methylation and use a 
H3K27me3-Polycomb-based mechanism for silencing14.  
Recently, a wide characterization of cis and trans components associated to Polycomb repressive 
complex 2 (PRC2) in Arabidopsis has given exciting hints on the Cggbp1 mechanism of early neural 
induction15. Xiao and colleagues identified several cis motifs in Polycomb reponse elements (PRE) 
with CCG/GCC as the second most significant one. Polycomb regulation is widely conserved in 
metazoans suggesting that Cggbp1 could be one of the paralogue zing finger proteins binding GCC in 
mammalian PREs. 
In addition recent discoveries suggest that enhancer-promoter loops are already established in poised 
genes16. Our finding that low levels of Cggbp1 are already binding ESCs poised genes together with 
the fact that Cggbp1 defects in ESCs mimics a loss of PRC2 in differentiating ESCs supports a putative 
role for Cggbp1 in Polycomb response, possibly as a recruiting factor at poised promoters. 
Remarkably, Cggbp1 association with Polycombappears not to end at the protein level as we 
identified PRC1 components Cbx4 and Cbx8 as targets of Cggbp1 (Figure Supl. A). In an exciting 
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recent study, it has been shown that Polycombmediated regulation of poised genes requires a switch 
in PRC1 component Cbx7 to be replaced by Cbx2, Cbx4 and/or Cbx8 in order to resolve poised genes to 
the activation phase17–20. Indeed, we observed a change in expression for several 
Polycombcomponents depending on the cell type (Figure Suppl. 3B). When tested in our dynamic 
ESCs induction protocol, we observed that Cbx4 and Cbx8 were induced during neural but not 
mesodermal stimulation and that Cggbp1 depletion greatly affected that induction (Figure Suppl. 3C). 
On the verge of more conclusive data, we hypothesize that Cggbp1 acts during the transition from 
pluripotency to the neural lineage by direct induction of neural gene targets but also by modulating 
the Polycomb response.  
MATERIAL AND METHODS 
Neural stem cell culture and transfection 
NS-5 neural stem cells (NSCs) derived from 46C embryonic stem cells were cultured as described21 
and regularly tested for mycoplasma contamination and for authenticity by expressed NSC markers 
Pax6, Sox2 and Nestin22.  
NSCs were electroporated as previously described23 with pCAG promoter-driven plasmids 
containing the FLAG-V5 tags and Cggbp1 cDNA in parallel to an empty pCAG FLAG-V5 in 
overexpression experiments. pSuper-puro constructs encoding Cggbp1 short hairpin RNA (shRNA 
sequence: 5′- GGTGAGCTTCATGAGGATG-3′), or a control scrambled sequence were used in knock 
down experiments. Puromycin (2 μg per ml) was added after 24 hours and NSCs were collected for 
the several analyses at 40 h after electroporation.  
Neural stem cell viability quantification 
After electroporation, NSCs from each condition were counted and re-seeded in triplicates in p96 
plates 1000 cells per well. The next day (48h) or the day after (72h) cells were incubated with 
alamarBlue (DAL1025, Invitrogen) and viability was quantified by fluorescence-based 
instrumentation.  
Embryonic stem cell culture and transfection 
Mouse ESC (46C line)24 were grown on gelatin-coated dishes without feeders in Glasgow minimal 
essential medium (GMEM) supplemented with leukemia inhibitory factor (LIF), 15% fetal bovine 
serum, 0.25% sodium bicarbonate, 1 mM glutamine, 1 mM sodium pyruvate, nonessential amino 
acids, 50 μM beta-mercaptoethanol, and penicillin-streptomycin, as described previously25. Plasmid 
transfections were performed with Lipofectamine 2000 (Invitrogen) and puromycin (2ug or 1ug per 
ml for 24 or 48 hour experiments, respectively) was used to select expressing cells. 
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Embryonic stem cell colony formation 
3*10E6 ESCs were transfected and selected with 1ug/ml puromycin for 48 hours. Cells were collected 
and counted (Figure C, upper graph) and 500 cells were re-seeded in triplicates into p6 plate wells in 
normal ESCs media. 7 days after re-seeding colonies were stained using Coomassie Brilliant Blueand 
counted using GelCountTM (Oxford Optronix, version 1.1.2.0). 
Embryonic stem cell differentiation protocols 
We used a standard embryonic body differentiation protocol described in26 for Figure 6A. In addition 
we adapted the same principle plus a mesoderm (heart) differentiation protocol27 to design a short 
term neural/mesoderm parallel differentiation protocol compatible with short term transfection (for 
Figure 6D).  
The basis of this protocol is the short preparation phase without LIF to adherent ESCs cultures before 
the application induction media. After normal lipofectamine transfection the media is replaced the 
same day into ESCs media without LIF (CA media). After 24 hours, induction media (either neural 
with RA, or mesodermal with ascorbic acid and activin) are added together with the selection agent 
(by 1ug/ml puromycin). The same media is used to refresh the culture 48 hours later. For Figure 6E 
we extended a control condition without induction media (just CA media) for 4 extra days to 
compensate for the possible effects that a removal of LIF alone could explain. 
Immunocytochemistry 
Cells were grown on poly-D-lysine–coated cover slips and fixed in 4% formaldehyde, 15min at room 
temperature. After fixation, they were permeabilized with Triton X-100 in PBS and blocked with 
blocking buffer (10% FCS, 0.2 M glycine, 0.1% Triton X-100 and 0.05% Deoxycholatein PBS-2% 
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gelatin) for 1 h at room temperature. To label the cells, the following antibodies or dyes were used: 
anti-Nestin (mAb1259, R&D systems) and anti-Cggbp1 in blocking buffer for 2 h and with the 
corresponding secondary antibodies labeled with fluorochromes (Alexafluor 546 or 488, Invitrogen). 
Samples were mounted in MOWIOL (#324590 Sigma-Aldrich) and nuclei were stained with DAPI 
(Vector laboratories). 
Images were capture by confocal microscopy using a Leica SP5 microscope. Image processing was 
performed using FIJI (ImageJ)28. 
Affinity protein purification of Cggbp1 
Embryonic stem cells were transfected with pCAG promoter-driven plasmids containing C-terminally 
FLAG-tagged Cggbp1. After 24h cells were harvested and nuclear extract was prepared from ESCs 
expressing FLAG-Cggbp1 and from control ESCs29. Nuclear extracts, equivalent to 2*108 ESCs were 
incubated with Benzonase (150U per ml nuclear extract) and used in FLAG-affinity purifications 
together with nuclear extracts from control ESCs, as described 22,25. Identification of proteins by mass 
spectrometry was as described25.  
Similarly, 1 ml of nuclear extracts from NSCs containing FLAG-Cggbp1 or parental lines were used to 
perform large-scale immunoprecipitations. The resulting western blots were probed with antibodies 
against Med12 antibody (Bethyl Laboratories #A300-774A) and Cggbp1 antibody (Bethyl Laboratories 
#A304-037A).  
Chromatin immunoprecipitation combined with high-throughput sequencing (ChIP-seq) 
For Cggbp1, we adapted protocols previously described in Chapter 2 of this thesis with some 
modifications. We single crosslinked the cells with 1% formaldehyde solution for 30 min at room 
temperature. We apply the same incubation and washing buffer replacing Tris-HCl for HEPES 
solutions. Primers used for small scale ChIP-QPCR can be found in 22 in addition to: 
Sox21_P_F CTGATCTCCGAGTTGTGCAT Pou5f1_P_F GATCCTCGAACCTGGCTAAG 
Sox21_P_R CAGCATGTCCAAGCCTGT Pou5f1_P_R CCAACCTGAGGTCCACAGTA 
ChIP-seq data analysis 
Together with our own Cggbp1 ChIP-seq data we used the following set of published data to 
complement our study: 
NSCs_Med1 GSM2928425 
NSCs_mNSCs_Input GSM1187180 
NSCs_H3K4me3 SRR006888_SRR006889 
NSCs_H3K4me1 SRR002250_SRR002251_SRR002252 
ESCs_H3K27me3 GSM307619 
ESCs_RARa SRR627785_SRR627786 
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In addition we download CpG Island coordinates in mm9 mouse reference genome from UCSC 
genome browser. Finally, RNA-seq data from wild-type mNSCs was extracted from23. 
Most of the ChIP-seq analysis, after the first processing steps similar as in Chapter 2 of this thesis, 
were performed using HOMER30 and BEDTOOLS31. In order to characterize the enrichment of GCC 
repeats across the genome in Figure 4D we curated lists of specific genes from ESCs, NSCs and MEFs 
using the published expression analysis32 by selecting genes that were expressed 5 times higher to the 
other two conditions for each subset. Next, we extracted their DNA promoter sequences (1,5 Kb 
around the TSS) and proceed to quantify GCC(3) occurrence on each subset. We added gene promoters 
marked with H3K27me3 in ESCs (own analysis) and the whole list of mouse promoters to our 
analysis. We followed a similar approach for Figure 4E but we subtracted gene lists according to the 
terms depicted in the figure from the Gene Ontology consortium database33 and applied the same 
analysis.   
Expression analysis 
Quantitative real-time PCR analyses on complementary DNA transcribed from total RNA with 
Superscript IV Reverse Transcriptase (#18090010 Invitrogen) was performed on a DNA Engine 
Opticon2/CFX96 (Biorad) and normalized for B-Actin expression. Primer sequences used can be 
found in 22,23 in addition to: 
Cbx4_Forw TGCTGATCGCCTTCCAGAA Sox1_forw GTTTTTTGTAGTTGTTACCGC 
Cbx4_Rev GGGCCCTCTCTTGCGATATC Sox1_Rev GCATTTACAAGAAATAATAC 
Cbx8_Forw GAGGACCCAAGCCTAAAACC Zfp42_forw TTGGGGCGAGCTCATTACTT 
Cbx8_Rev CCTGGAAGTAGACGCCAAATC Zfp42_rev TTGCCACACTCTGCACACAC 
B-Actin_forw TCTCCTTCTGCATCCTGTCAGCAA Nanog_forw ATGAAGTGCAAGCGGTGGCAGAAA 
B-Actin_rev TCTTGGGTATGGAATCCTGTGGCA Nanog_rev CCTGGTGGAGTCACAGAGTAGTTC 
Sox17 _forw ACTTGCTCCCCACAATCACT Sox21_f CCTAAGATGCACAACTCGGA 
Sox17 _rev ACCCCGCTGTTTGTGTTTAG Sox21_r CTTGTAGTCGGGATGCTCC 
FoxA2 _forw TGGTCACTGGGGACAAGGGAA Pou3f3_F CTCACCTCCCGTCCATGG 
FoxA2 _rev CTGCAACAACAGCAATAGAGAACAA Pou3f3_R GATGGTGGTGATGATGCTCC 
T_forw AAGGAACCACCGGTCATC Fmr1_F agatcaagctggaggtgcca 
T_rev GTGTGCGTCAGTGGTGTGTAATG Fmr1_R cagagaaggcaccaactgcc 
Mixl1_forw GCACGTCGTTCAGCTCGGAG Nfib_Forw GGACAGCTTTGTAAAATCCGGA 
mixl1_rev GTCATGCTGGGATCCGGAACGTG Nfib_Rev GTGGAGAAGACAGCGACCT 
Eomes_forw GGTACGGCGTTCAAAACTTC Cggbp1_FW TGCCATTAGTGACCACCTCA 
Eomes_rev ATGGGAGCAAGGTACTGGAA Cggbp1_RV GGACCCTCCGTTCTTCACAT 
Gsc_forw TCCAGGAGACGAAGTACCCAGACGT 
Gsc_rev CTCGGCGGTTCTTAAACCAGACCT 
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SUPPLEMENTAL INFORMATION 
Figure Supplemental 1 | Genome wide RNA correlations 
(A) Box plot representation of RNA expression levels of Cggbp1 targets compared to all NSCs expressed genes. 
Whiskers represent maximum and minimum values. **p < 0.05 unpaired Student’s t test. (B) Scatter plot 
displaying peak score of Cggbp1 Chip-seq data on X axis vs the corresponding RNA expression (RPKM) of the 
annotated gene on Y axis. Pearson correlation coefficient = 0,01.  
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Figure Supplemental 2 (at previous page) | Cggbp1 levels modulation in NSCs. 
(A) QPCR analysis on NSCs after 40h transfection with scramble or Cggbp1-targeting shRNA and F2V5empty 
or F2V5Cggbp1 constructs. Values normalized to their respective controls. Error bars represent STD, **p < 0.01, 
unpaired Student’s t test, n=2. (B) Cggbp1 protein levels analyzed by western blot from NSCs after 40h 
transfection with scramble or Cggbp1-targeting shRNA and F2V5empty or F2V5Cggbp1 constructs. (C) qPCR 
analysis on NSCs after 40h transfection F2V5empty or F2V5Cggbp1 constructs. Values normalized to their 
respective controls. Error bars represent STD, *p < 0.05, unpaired Student’s t test, n=2. (D) FACS cell cycle 
quantification of NSCs stained with propidium iodide after after 40h transfection with scramble or Cggbp1-
targeting shRNA and F2V5empty or F2V5Cggbp1 constructs. n=1.  
Figure Supplemental 3 |Cggbp1 as a Polycomb protein 
(A) Chip-seq tracks of Cggbp1, histone modifications H3K4me3, H3K4me1 from NSCs and H3K27me3 and 
RARa from ESCs at Polycomb gene loci. Purple bars indicate CpG islands. Range of reads per million per base 
pair is indicated on the y-axis. Scale bar is indicated. (B) Normalized RNA expression levels of Cggbp1 and 
Polycombgenes in different cell types, normalized to ESCs relative expression. Data from34. (C) qPCR analysis of 
ESCs Polycomb genes after 48h transfection with scramble or Cggbp1-targeting shRNA constructs and treated 
with neural or mesodermal inducers. Values normalized to their respective controls, n=1.  
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ABSTRACT 
Neuronal cells endure a long process of maturation before they integrate to functional signaling 
networks. The correct regulation of the maturation process is essential for the assembly of adult 
neuronal networks leading to neurodevelopmental disorders when not successfully accomplished. 
Recent studies have revealed a gene expression switch occurring early in neuron maturation. 
However, the effectors of these changes remain to be discovered. In the present study we have used 
chromatin immunoprecipitation coupled to next generation sequencing (ChIP-seq) of the active 
chromatin mark histone H3 lysine K27 acetylation (H3K27ac) applied to a model of in vitro 
maturation of mouse hippocampal neurons in order to characterize the epigenetic dynamics of 
neuronal maturation. We have identified several transcription factors specific to different maturation 
stages and several candidates are suggested based on their in vivo expression. 
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INTRODUCTION 
The integration of classic neurophysiology approaches with the next generation of “-omics” 
disciplines have the potential to surpass the current limitations in nervous system research.  
While next-generation techniques have been rapidly implemented in other biological systems, the 
extreme cellular heterogeneity and complexity of the neural tissue have delayed in great measure 
their use. Nevertheless, the development of better isolation sorting techniques1, in vitro primary pure 
neuronal cultures2, in vitro differentiation protocols3 and single-cell sequencing4,5 have provided a 
breach an increasing number of neuroscientists are starting to exploit.  
Indeed, the transcriptional networks governing differentiation and functionality of matured neurons 
have been molecularly explored in depth in the last decade6–8. However, the maturation steps from 
the early post-mitotic phase to a fully synaptic active neuron remains still poorly understood. This 
transition period has been proven to be essential for the correct assembly of neuronal networks as not 
only the proper number of cells is important but their development and integration to the system are 
key variables. Perhaps the best example representing the importance of maturation is Rett syndrome 
patients, who suffer from several neurodevelopmental defects and present intellectual disability. The 
major cause for Rett syndrome is the mutation in the chromatin regulator MeCP29. MeCP2 levels are 
tightly controlled during neurogenesis and increase dramatically during neuronal maturation10. 
Recent studies have shown that in matured neurons, MeCP2 can largely substitutes for histone H1 in 
vitro and is distributed throughout the genome affecting nucleosome spacing. In addition, its 
increased levels allow MeCP2 binding to the epigenetic mark 5hmC in active genes, regulating 
important synaptic processes11.  
The genome-wide epigenetic changes response during neuronal maturation remain to be defined. 
Several groups have analyzed the transcriptome changes through well-defined neuronal maturation 
time points, uncovering a massive switch in the expression profiles of maturing neurons12–14. 
However, the effectors of these changes remain to be discovered.  
In this study, we analyze the dynamic changes in the active chromatin regions during hippocampal 
neuron in vitro maturation. Using chromatin immunoprecipitation coupled to next generation 
sequencing (ChIP-seq) of the active promoter and enhancer mark histone H3 lysine K27 acetylation 
(H3K27ac) we imply the transcription factor response at several stages of neuronal maturation and 
propose several transcription factor candidates based to play a role on their in vivo expression.     
RESULTS 
Hippocampal neuronal maturation timing in vitro 
To establish a comprehensive epigenetic profile during the development of primary mouse 
hippocampal neurons in culture, we took time points corresponding to the peak periods for which 
major cellular and physiological events occur during neuronal development in culture as defined by 
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Dotti et al.15(Figure 1A). Interestingly, when compared to expression profiles of neurons isolated from 
developing mousebrains, it was demonstrated that in vitro neurons reach maturation sooner13. In 
addition to the described expression profile switch that takes place around 4 days in vitro (D IV), in 
vivo brain levels of MeCP2 have been quantified10 suggesting that its upregulation starts around this 
switch period. MeCP2 levels inversely correlate to the differential nucleosome repeat length (NRL), or 
nucleosome spacing, seen in neurons and its shortening represents a macro-signature of the 
epigenetic changes that these cells undergo16,17 (Figure 1B). 
Figure 1 | Hippocampus in vitro culture as a model of neural maturation  
(A) Morphologically stages of neural maturation adapted from Dotti et al. 1988 (B) Time line representation of 
hippocampal maturation. Nucleosome spacing and MeCP2 protein levels are depicted in cyan and purple lines.  
Thus, we chose to sample six points between 7 hours and 12 days in culture in order to capture the 
full process of neuronal maturation. Indeed we observed that briefly after plating, cells have a 
symmetric appearance extending lamellipodia all around the soma (stage 1, Figure 2A 7h). After 7 
hours in vitro (h IV) minor neurites are observed (stage 2, Figure 2A 18h). Then, one of the neurites 
grows without retracting and acquires axonal properties. This axon can be identified in most neurons 
at 40h IV (stage 3, Figure 2A 40h). The axon continues to grow promptly, whereas the remaining 
neurites elongate more slowly and become dendrites. At the end of stage 3 (around 72h IV, Figure 2A 
72h IV) many axons contact neighboring neurons and the remaining minor neurites acquire 
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characteristics of dendrites. From 72h to 8D IV (stage 4, Figure 2A 8D IV), a greater number of 
outgrowing and branching dendrites are observed and the first synapses are formed. Within the next 
days, an extensive network of synaptic connections will be formed and around 12D IV (stage 5, Figure 
2A 12D IV), all cells are fully developed and display a mature neuronal morphology with axons 
forming a dense mesh on the culture dish14. Hence we are able to establish a reliable primary 
hippocampal neuron culture where all stages of maturation are represented.  
Figure 2 | Confirmation of the epigenetic switch in the hippocampal culture 
(A) Immunocytochemistry with Tuj1 (neuron-specific class III beta-tubulin) antibody and dapi staining at 
different hippocampal neuron cultures time points. (B) Micrococcal nuclease digestion of neuron chromatin 
isolated from in vitro cultured hippocampal neurons at different times of maturation. (C) Principal component 
analysis plot of the ChIP-seq data that characterizes the trends exhibited by the different time points. PC1 
represents biological variance while PC2 represents experimental variance. Data points are grouped 
accordingly.  
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Next we tested if we could observe the switch in NRL, characteristic in healthy adult neurons. By 
using micrococcal nuclease digestion followed by gel electrophoresis we ascertained that in our 
hippocampal in vitro culture the NLR of neurons started shortening from 72h IV and reached its 
minimum already at 8D IV (Figure 2B). Thus, our culture system recreates the major chromatin 
remodelling event during neuronal maturation. 
Dynamics of epigenetic active sites during neuronal maturation 
We used active chromatin profiling for H3K27ac, a mark of active enhancers and promoters, across 
the six time points. Principal component analysis of our ChIP-seq data showed a clear distinction of 
the samples depending on their maturation stage. We decided to merge samples 7h and 18h IV and 
samples 8D IV and 12D IV into early stage and late stage groups, respectively. Samples 40h and 72h 
IV represent the maturation transition points and were grouped into a switch category (Figure 2C).  
We focused our analysis on regions with a clear dynamic behavior. Hence, we applied several 
filtering criteria to select regions that at early maturation phase were active and become inactivated at 
late stages and vice versa, terming those decrease and increase regions, respectively. Additionally, we 
identified regions which present their maximum in the switch period and we termed those switch 
regions (Figure 3A). We observed that dynamic regions presented a gradual activation or inactivation 
with intermediate levels during the switch period. Nonetheless, in addition to the 330 decreased 
regions and the 1330 increased regions, we could identify 170 regions that were significantly higher 
during the switch (examples in Figure 3C-E). 
As seen from published transcriptomic studies12–14, genes annotated to decreased regions were 
associated to cell morphogenesis involved in differentiation. Additionally, we found a significant 
enrichment of genes associated with alternative splicing and EGF signaling (Figure 3B). Also expected 
was the association of late increased regions to genes involved in synapse activity and calcium 
response. However, little information is described on the genetic processes in the transition between 
these two phases. We observed that regions activated during the switch were enriched in genes 
involved both in cell morphogenesis, locomotion and adhesion but also synaptic activity. This finding 
concurs with the hypothesis that synaptic gene expression precedes protein expression of synapse 
markers and the onset of spiking activity18. Taken together, our data represent a map of biological 
relevant dynamic active regions during neuronal maturation. 
Analysis of transcription factor signatures in dynamics regions 
We next analyzed the sequences of the different dynamic regions searching for DNA motifs. For each 
dynamic group several significantly enriched motifs were found (Figure 4A). Among the decreased 
regions, many of the motifs found belong to transcription factor (TF) families like NFI, Sox and 
NeuroD, many members of which areinvolved both in neural progenitor regulation and initiation of 
neurogenesis19–21. On the other hand, at late increased regions, we found TFs known to regulate 
synapse activity such as the MEF and STAT families22,23. The Rfx motif has been previously described 
to  be  enriched  at  forebrain   tissue   although   without    presenting     changes    through .   neuronal 
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Figure 3 | Genome wide identification of dynamic epigenetic regions
(A)  Meta-enhancer profiles of H3K27ac Chip-seq data at the different dynamic subsets. (B) GO analysis on 
genes annotated to each dynamic subset together with their associated p-value (Benjamini corrected). (C-D) 
Chip-seq tracks of histone modification H3K27ac across the 6 time points at loci with decreased (A), switch (B) 
or increased (C) dynamics. Examples of dynamic regions are highlighted.  
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maturation24.  Intriguingly, the most significant motifs for the switch regions were for factors not 
documented to work on neuronal transcription such as Spi-B and the hepatic nuclear factor (HNF) 
family. In addition, we also found the motif of Pou2f family of transcription factors and for HMG-box 
transcription factor 1 (Hbp1), which have been associated to neuronal function25,26.  
In order to validate the biological relevance of our findings, we proceeded to evaluate the expression 
of candidate transcription factors to bind these motifs during in vivo brain mouse development 
(Figure 4B). We retrieved the genome expression data from the Allen developing mouse brain atlas27 
focusing on telencephalic vesicle development and time-points comparable to the in vitro 
development steps in our cultures (Figure 1B). We selected factors binding to the identified DNA 
motifs that presented clear dynamic expression and grouped them by the dynamic region they were 
found in. 
Regarding decreased region TF candidates, we could confirm the downregulation of NeuroD1,6 and 
Sox4,5,11 all known to play around in the first steps of neurogenesis. Interestingly, NFI factors, which 
play a crucial role during the progenitor phase, remain active throughout the whole process of 
maturation. Strikingly, factors binding the forkhead FOXO motif behave reversely from expected as 
they have a clear activation towards the end of neuronal maturation. On the other hand, the 
expression of TF identified in late increased regions followed overall an upregulation at late stages. 
Not only known synaptic regulators such as MEF and STAT families correlated with the time of 
expression but also new identified factors such as the Mybl and Tcfap families and Mafk. Finally, we 
found that most of the switch TF candidates had a transient expression or were peaking halfway 
through maturation, suggesting a real function for factors with unknown relation to neurons. Hence, 
we conclude that our list of TF candidates have a potential biological role at different steps of 
neuronal maturation.  
DISCUSSION 
Next-generation sequencing approaches provide an exceptional opportunity for understanding brain 
function and development but also raise unique limitations because of the complexity of the nervous 
system. One significantly neglected field in neurodevelopment has been the neuronal maturation 
phase during neurogenesis. Nevertheless, some groups have provided gene expression profiles 
during the neuronal development either in vivo or in in vitro culture systems revealing a major switch 
in neuron behavior since they are born until they integrate to signaling networks28.  
Here, we have complemented those studies trying to decipher which transcription factors govern the 
epigenetic phases of neuronal maturation. We have chosen an in vitro culture of primary hippocampal 
neurons as it has proven to provide homogenous amounts of pyramidal neurons that re-synchronize 
upon isolation15,29. These two characteristics are fundamental for the study of distinctive cell state 
events.  
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Figure 4 | Identification of candidate transcription factors involved in neural maturation 
(A) Significant enriched motifs found at each dynamic subset, associated p-value and transcription factor 
associated to them. (B) Normalized RNA expression levels of candidate transcription factors though different 
time points of telencephalon in vivo maturation (Extracted from Allen Developing Mouse Brain Atlas 2013). 
Missing data is represented by black boxes. 
By using ChIP-seq of H3K27ac, our approach provides a catalog of dynamic active regions that 
change during the course of neuronal maturation. To our knowledge this is the first study identifying 
open sites throughout the development of neurons. Our data offers specific single-base resolution 
footprints for TFs candidates to have pivotal roles at different times of neuronal maturation. 
Combined with in vivo expression we found an auspicious subset of transcription factors regulating 
each time period.  
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Nevertheless, several limitations in our approach should not be obviated. First, DNA motif 
identification provides a prediction of described or predicted DNA sequences associated to known 
factors. Hence, it is possible that unidentified factors could have been missed in our screen. Also, 
there is the possibility that several factors bind similar motifs but only one is represented. In order to 
validate our findings we have recurred to in vivo expression data with the assumption that the 
expression levels of candidate TFs would correlate with the time where their motifs are found. 
However, TF activity can be regulated not only at the transcriptional level but by other processes such 
as repressor competition or post-translational modification. 
Despite these limitations, we have been able to identify TFs following both expression and binding 
patterns. Further research is needed to confirm the relevance of our findings and to characterize the 
exact biological role of these candidates.  High-throughput screens would provide an excellent tool 
not only to corroborate our candidate list but also to find other factors involved in maturation with 
other functions rather than DNA binding. For example, Sharma et al. introduced in 2013 a platform to 
screen for synaptogenic genes in hippocampus in vitro culture evaluating 800 different proteins by 
shRNA30. We propose that the combination of similar screening techniques with genome-wide studies 
would represent a big step towards an integrated systems biology view of neurodevelopment and 
would take us closer to understand the vast complexity of the brain. 
MATERIAL AND METHODS 
Mouse hippocampal primary neuron culture 
The morning of identification of vaginal plug was assigned as the first day of gestation, embryonic 
day E0.5. Fetal E16.5 mouse brains (FVB strain) were dissected in PBS containing 2% glucose and the 
hippocampi isolated. After trypsin (Invitrogen) and DNAse treatment (Roche Diagnostics), tissue 
pieces were dissociated, and cells were seeded onto 0.5 mg ml−1 poly-D-lysine (Sigma-Aldrich)-
coated coverslips (for immunocytochemistry) in a density of 0.5x106 cells/cm2 or 100-mm plates (for 
MNase and ChIP) in a density of 1.5x106 cells/cm2 in neurobasal medium (Gibco) containing 2 
mMglutamax, 120 μg/ml Penicillin, 200 μg/ml Streptomycin and B27 supplement (Invitrogen), and 
were maintained at 37°C in the presence of 5% CO2. 
Immunocytochemistry 
Cells were grown on poly-D-lysine–coated cover slips and fixed in 4% formaldehyde for 15min at 
room temperature. After fixation, they were permeabilized with Triton X-100 in PBS and blocked with 
blocking buffer (10% FCS, 0.2 M glycine, 0.1% Triton X-100 and 0.05% Deoxycholate in PBS-2% 
gelatin) for 1 h at room temperature. To label the cells, the following antibodies or dyes were used: 
anti-βIII Tubulin (Tuj1, Sigma) in blocking buffer for 2 h and with the corresponding secondary 
antibodies labeled with fluorochromes (Alexafluor 488, Invitrogen). Samples were mounted in 
MOWIOL (#324590 Sigma-Aldrich) and nuclei were stained with DAPI (Vector laboratories). 
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Images were captured by confocal microscopy using a Leica SP5 microscope. Image processing was 
performed using FIJI (ImageJ)31. 
Measurements of chromatin repeat length 
We followed Woodcock’s protocol as in32. Briefly, neural nuclei were digested with a dilution series of 
micrococcal nuclease (Worthington) at 37°C. Electrophoretic resolution was optimal with digestion 
times of 120s. Chromatin digests were extracted and the DNA fragments were run in electrophoresis 
4%Tris-Glycine agarose gels at pH 7.8 (40 mMTris acetate, 20 mM sodium acetate, 2 mM EDTA) for 
2.5 h at a constant current of 100 mA. Visualization of the bands was performed by ethidium bromide 
and images captured after exposure with Typhoon FLA 9500 scanner (GE Healthcare Life Sciences). 
Calculation of NRL was performed in Adobe photoshop. 
Chromatin immunoprecipitation combined with high-throughput sequencing (ChIP-seq) 
For H3K27ac histone modification, we adapted the standard “UPSTATE” protocol. Briefly, around 5-
8x106 cells were used per condition. Crosslinking was performed “in plate” adding 1% final 
concentration of formaldehyde. Cells were harvested and 4 times nuclei lysis buffer (1% SDS + 50 mM 
Tris-HCL(pH8.1) + 10 mM EDTA (pH8.0) was added with a 10min incubation on ice. A Bioruptor Pico 
sonication device (Diagenode Cat# B01060001) was used for the sonication step. Chromatin 
concentration was measured, from a 1% of total sample, to equalize DNA content in each condition. 
After antibody titration (data not shown) 0.75μg H3K27ac antibody (Abcam) was used together with 
30μl of Dynabeads Protein G magnetic beads (10003D, Invitrogen). Bound complexes were eluted 
from the beads in 50 mM Tris-HCl, pH 8.0, 10 mM EDTA and 1% SDS by heating at 65°C for 1 hr with 
occasional vortexing and crosslinking was reversed by overnight incubation at 65°C. ChIP-seq sample 
preparation and sequencing was performed as in Chapter 2 of this thesis. 
ChIP-seq data analysis 
Most of the ChIP-seq analysis, after the first processing steps similar as in Chapter2 of this thesis, 
were performed using HOMER33 and BEDTOOLS34. Briefly, an input ChIP-seq dataset collected from 
18 hours in vitro was used as background control to identify significant peaks for each condition. 
After principal component analysis we decided to group samples in duos (early, switch and late). For 
every peak identified in any of the 6 conditions, we quantified the coverage of each grouped duos and 
compare it to the other two. We applied an algorithm to detect regions that were at least 3 fold higher 
from early to late or vice versa, or 3 fold higher from switch to early and late thus identifying 
enriched dynamic regions. After each list was completed, we proceed with analysis already described 
in Chapter 2 such as Gene Ontology cluster annotation, meta-peak profiles and motif recognition 
(using only known HOMER motifs).  
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In vivo expression annotation 
We retrieved genome expression data from the Allen developing mouse brain atlas27 focusing on 
telencephalic vesicle development and time-points comparable to the in vitro development steps in 
our cultures. We selected factors binding to the identified DNA motifs that presented clear dynamic 
expression and grouped them by the dynamic region they were found in. 
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Chapter 5 
GENERAL DISCUSSION 
Study of transcription through the neural lineage 
The scope of this thesis has been the study of one of the most fundamental determinants of life, gene 
expression control. We have studied transcription at several stages of development of the neural 
lineage. From the early neural induction events described in Chapter 3; to the more biochemistry 
focus studies in neural progenitors in Chapter 2; to the epigenetic characterization of maturating 
neurons in Chapter 4; we have covered different sides of transcription of a number of cellular states 
during neuronal development.  
Briefly, Chapter 2 contributes to the description of the uncharted core transcriptional network that 
dominates neural stem cells. In Chapter 3 we propose that Cggbp1 is not only a developmental 
transcription factor, but that it may act at promoters by a newly described mechanism. Finally, in 
Chapter 4, we have studied the phenomenon of cell maturation, a process that potentially all somatic 
cells undergo before they become functional, which is very important for neurons but surprisingly 
perhaps understudied. In neurons this process takes enough time to be able to study step by step 
reveling epigenetic switches that may relate to other systems. In other words, our endeavor to 
combine state of the art biochemistry and molecular cell techniques with the study of neural 
development has provided notable contributions to the general understanding of how transcription is 
regulated but also new factors involved in neurodevelopment. 
Through our studies we have defined several results that we found remarkable to discuss are explore 
further in this last section of my thesis. 
Mediator as a tool for discovery 
Since its initial discovery and the first purifications of the complex in the 90s, Mediator has proven to 
be a central piece not only for RNApol2 regulation but for nearly all aspects of gene transcription in 
eukaryotes1. Hence, the Mediator complex represents an excellent conduit in order to characterize the 
general transcriptional state of the cell. On one hand, Mediator purifications provide a wide list of 
chromatin factors acting both at enhancers and promoters. For example, we have identified several 
cofactors such as Carm1 and Jmjd1c as components of enhancer regulation in neural stem cells. In 
addition, we have identified Nfia/b, Sox2 and Tcf4/12 as candidates to be the core transcription factor 
network regulating this cell system. On the other hand, Mediator occupancy reveals active regions, 
super enhancers among them, which may define the cellular state. For example, we have identified a 
list of 450 genes candidates to define neural stem cell identity using Mediator ChIP-seq.  
We allege that Mediator-based screens could be extended to all eukaryotic model systems in order to 
identify the key transcriptional components in each situation.  
Several innovations could be added to increase the efficiency and clarity of this approach such as the 
development of models with endogenously tagged versions of Mediator subunits. We envision an 
example where CRISPR technology2 could be used to insert FLAG-V5 tag sequences at C- or N- 
terminal domains of one or several Mediator subunits in mouse embryonic stem cells or directly 
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injecting blastocysts3 with the aim to create transgenic Mediator-tagged mice. With this tool, the 
characterization of any cell type would be achievable implementing efficient protocols of cell isolation 
or cell culture differentiation. This approach would differ from other methods in delivering functional 
core chromatin networks instead of full proteomics or transcriptomic lists.  
Super enhancers 
In Chapter 2 of this thesis, we have described our work around super enhancers (for brief explanation 
see Chapter1 Box1), mostly due to our focus on new Mediator-based chromatin regulation processes. 
We have suggested that the Mediator complex is not only a marker but an organizer for assembling 
super enhancers.  
As mentioned, despite the variation in number and genomic assignation that can be explained by 
different empirical methods used; LCRs, COREs, stretch enhancers and super enhancers fall in the 
same conceptual and functional category. Nevertheless, despite a redundant description of a 
chromatin feature already found by other groups, the super enhancer term has reached high citation 
scores (a metascience topic on itself, Figure 1).  
Figure 1 | Citation graph of representative studies in transcription domains 
Since the rose of the super enhancer term there has been a debate about if they represent a 
mechanistically novel regulatory archetype or just a sum of features seen in classical enhancers4. Some 
studies suggested that in fact super enhancers (and synonyms) had specific properties. For example, 
they present specific enrichments for certain DNA motifs5. Another statement was that due to the 
significant higher accumulation of transcription factors and chromatin remodelers, they are more 
susceptible to perturbation representing potential therapeutic targets. For example they were claimed 
to be significantly more affected by inhibitors of Brd4, which are already in use to target super 
enhancer activated oncogenes such as Myc in leukemia6.  
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However, a new study from Ameres and Zuber’s labs, published during the preparation of this thesis 
manuscript, rebuts most of these claims. In an elegant approach combining fast 
degradation/inhibition of chromatin remodelers with newly synthesized mRNA labeling (SLAM-seq), 
the authors investigated the selective effects of Brd4 depletion. Rather than affecting the chromatin 
binding of factors such as Mediator or Cdk9, Brd4 inhibition led to a marked stall of RNA Pol II at 
TSS (including Ser5 phosphorylated forms). The usage of lower, more physiological doses of inhibitor 
than the used in previous studies revealed a selective inhibition in a subset of targets that correlated 
poorly with super enhancers. Combing published ChIP-seq data of chromatin binders it was shown 
that the effects on Brd4 depletion depend on locus specific regulators rather than a unifying 
chromatin domain7. 
Nevertheless, an accurate evaluation of super enhancer constituents by targeting either specific trans 
or cis components will determine their real separation from main enhancer characteristics. A recent 
study using CRISPR/Cas9-mediated DNA deletions has focused on evaluating super enhancers8. The 
results are still controversial due to high variation in the effects of deleting enhancer clusters. 
Interestingly, super enhancers did not present an increased regulatory activity compared to 
enhancers. However, partial redundancy between super enhancer components was observed, 
suggesting cooperativity between members of the same cluster8. 
About transcriptional factories and phase-separated transcriptional control 
In the introductory Chapter 1 we have seen that chromatin organization is an essential innovation in 
evolution not only to solve the space limitation that long genomes present but also as a regulatory 
mechanism to separate different functional domains. Indeed, a highly supported model suggests that 
nuclear transcription does not occur aimlessly throughout the nucleus but in distinct regions, termed 
transcription factories9,10. These structures would consist in localized domains where multiple active 
RNA polymerases and other chromatin factors are coordinated together, increasing the temporal and 
spatial availability of molecules involved in gene expression control11. Genes from the same or from 
different chromosomes associate with the same factory by looping into it12. Although representing a 
promising theory, it is not devoid of controversy, especially because the research of these structures 
requires innovative approaches to study their composition, assembly and mechanics13.  
Encouragingly, some studies have successfully adopted the concept of transcription factory in order 
to describe their particular working model. Such is the case of the β-globin locus control region (LCR), 
where a evolutionary conserved cluster of cis- and trans-regulatory DNA elements form an active 
chromatin hub (ACH) involved in the regulation of β-globin genes14,15.  
Although the first studies described transcription factories as fixed scaffolding structures11, recent 
advances in our understanding on biomolecular condensates may switch our concept of transcription 
factories to liquid–like phase separated nuclear compartments driven by macromolecular 
interactions16. Indeed, the application of thermodynamic laws of phase separation systems has been 
shown to cover many features associated with transcriptional control, from the formation of ACHs or 
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super enhancers, to the explanation of the transcriptional bursting pattern of enhancers or even the 
selective vulnerability to drugs17.  
An essential characteristic of biomolecular condensates is the enrichment in multivalent molecules, 
which provide multiple intra- or inter-molecular interactions16. Of course, central components in 
phase separation transcription would be RNA and DNA molecules harboring multiple cis-elements to 
recruit proteins. However, proteins composed of multiple modular interaction domains represent 
perfect affinity-scaffolds to promote the formation of large macro-complexes, reducing the solubility 
and isolating the condensate16. Our discoveries in Chapter 2 of this thesis point the Mediator complex 
as a central platform with the ability to coordinate a vast number of interactions, thus providing a 
highly multivalent component that favors the phase separation of the domain.   
While it is still not known if all active genes are entangled in transcription factories, it is believed that 
transcription factories would form de novo as the consequence of transcription of some highly active 
genes with strong active chromatin hubs, and that these factories, once formed, would be able to 
attract other genes to them18. As we have seen in Chapter 2, there is a subset of neural stem cell genes 
that not only are associated to super enhancers but also are marked with broad H3K4me3 signals into 
their promoters. We showed that these SE+Broad genes present the highest levels of RNApol2, 
Mediator and cofactors in addition to transcription factor occupancy. These findings, together with 
the fact that super enhancers are highly enriched among the most interacting TAD triplets19, and that 
broad promoters show enhanced DNA looping interactions with super enhancers20 makes us 
postulate that SE+Broad domains may represent the strongest transcription factories of the cell.  
Interestingly, in our cell model the core transcription network defining cell identity was regulated by 
SE+Broad domains. It would be interesting to further investigate a possible hierarchy in the formation 
of secondary factories associated to the targets of this transcriptional network.  
Taking into account that Mediator occupancy is ten orders of magnitude higher in SE+Broad 
compared to typical genes, we suggest that Mediator purifications provide an excel tool to study 
transcription factory proteomics. With the combination of better techniques for biomolecular 
condensates isolation21,22 and chromatin capture innovations19 further research should make possible 
the isolation and study of “frozen” factories revealing the native assembly of interactions between 
proteins and nucleic acids at these domains.  
About Mediator subunit composition 
An important characteristic of the Mediator complex is that its multi-subunit structure. While a 
Mediator core is needed to support the basic PIC assembly and transcription initiation, additional 
subunits can be lost or added affecting the biological function of the complex23. A clear example is the 
association to the Cdk8 kinase module, which changes the behavior of the complex. Moreover, 
variations in tail subunits influence the capacity of Mediator to bind recruiting transcription factors, 
thus making the cell “insensitive” to certain transcriptional responses24. Furthermore, with our 
discoveries in Chapter 2 of this thesis we could also extend this effect to the recruitment of chromatin 
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modifiers, which could depend on specific Mediator subunits to be recruited to the DNA. Despite few 
studies mainly focused on Mediator subunit expression alterations in malignancy25, the variation in 
Mediator subunit composition has not been characterized.  
To bring some light into this matter we purified and compare the Mediator complex subunit 
composition in ESCs and NSCs (ESC data from Dr. Debbie van den Berg unpolished data, Figure 2A). We 
immunoprecipitated endogenous Med12 instead of using our overexpressing Med15-Flag lines in 
order to maintain the physiological levels of all subunits. After identifying the peptide counts and 
emPAI scores by mass spectrometry, we calculated the relative contribution of each subunit to the 
complex. From the 30 subunits detected, we observe a big conservation in Mediator composition 
overall. Nevertheless, we identified several subunits with more than 1.5 fold difference in their 
relative contribution to the complex (Figure 2B). In order to evaluate if our findings were biologically 
relevant we extracted the gene expression levels of each subunit from a published study26. Strikingly, 
we observed that most of the subunits with a variable contribution to the complex had a correlating 
change in expression levels between ESCs and NSCs (Figure 2B).  
Interestingly, this implies that although the Mediator is an essential complex for transcription; its 
subunits do not behave as housekeeping genes, presenting significant changes among different cell 
types. Second, our findings suggest that Mediator complex composition can be explained in large part 
by the expression level of its subunits.  
Accordingly, we analyzed the mRNA levels of almost all Mediator subunits (33 subunits) across a 
wide palette of human tissues27 (Figure 2C). Strikingly, Mediator subunit expressions formed clusters 
between samples of similar tissues. For example, all neural tissues formed a well defined cluster 
characterized by high levels of CDK19. Interestingly, we observed most of the protein composition 
variation from ESCs to NSCs to correlate with these findings, although we have to take into account 
that neural progenitors differ significantly from adult tissues and the mouse-human extrapolation. 
CDK19 is the paralog of the cyclin-dependent kinase CDK8 and it has been mutated in patients 
suffering from microcephaly, congenital retinal folds and intellectual disability28. Both our protein 
purifications in Chapter 2 and the results above show the neural specificity of CDK19 and an 
explanation for its nervous system phenotype.  
Other well defined clusters were digestive system tissues such as intestines, colon and stomach. 
Interestingly, CDK8 is associated to colon cancer29,30 but also presented extremely high levels in 
healthy sigmoid colon. Reproductive system tissues such as uterus, cervix and fallopian tubes also 
cluster well together. Other interesting findings were the MED23 defining cluster of heart associated 
tissues and esophagus suggesting a novel role of this protein in this tissues. Finally, the inclusion of 
transformed malignant cells in the array reveled MED1 as a highly overexpressed outlier in the two 
cancer samples; a finding that concords with the already described oncogenic potential of this 
subunit31. 
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Figure 2 | Identification of Mediator subunit tissue specific variation 
A. Schematic representation of Mediator purifications in embryonic stem cells (ESCs) and neural stem cells 
(NSCs). B. Proteomic subunit contribution to Mediator complex was calculated as the relative emPAI of each 
subunit normalized to the total emPAI of the complex, calculated as the sum of all subunit emPAIs. Then, ESCs 
contribution values were used to calculate fold differences against NSCs subunits. Note that this experiment is 
n=1. Only subunits with more than 1.5 fold difference are presented. RNA expression was extracted from26and 
normalized to ESCs values. C. MeV (Artistic License 2.0) was used to cluster, using Euclidian distance, the 
normalized Mediator subunits expression profiles along tissues. Expression data extracted from27. 
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In summary, our preliminary data suggests that Mediator subunit composition varies significantly 
across tissues and that part of this variation can be explained by a regulation on the expression levels 
of several subunits. Nevertheless, little is known about the mechanisms regulating subunit exchange 
or the determinants of Mediator subunit composition. In relation to the transcriptional regulation of 
Mediator subunits we observed that not only several subunit of Mediator appear to be poised in 
ESCs, an indication of a developmental role, but also that both Retinoic acid receptor and Cggbp1, a 
neural inducer described in Chapter 3 of this thesis, bind to their promoters representing an example 
of a direct regulation by a transcription factor (Figure 3). 
Figure 3 | Cggbp1 binds Mediator subunit promoters 
Chip-seq tracks of Cggbp1, histone modifications H3K4me3, H3K4me1 from NSCs and H3K27me3 and RARa 
from ESCs at Cggbp1 locus. Range of reads per million per base pair is indicated on the y-axis. Scale bar is 
indicated.   
Before ending the discussion on this topic, it is worth mentioning the regulation of Mediator subunit 
levels post-translationally. As seen in the Chapter 2 of this thesis, Mediator purifications are rich in 
protein modifiers. One of the highest hits in Med15-Flag purifications is Trim11, an E3 ubiquitin 
ligase known to target many neural related proteins such as Humanin and Pax6 for degradation by 
the proteosome32. It is also described that it can target Med15 to the ubiquitin–proteasome 
degradation system representing a clear example of a Mediator subunit composition regulator33. 
Moreover, deeper analysis of our Med12 protein purifications showed an arginine dimethylation site 
(data not shown); a post-translation modifications regulated by Carm1/PRMT4, a Mediator interactor 
identified in Chapter 2. 
The further characterization of Mediator subunit composition and its regulation represent new layers 
on top of our expanding knowledge on transcriptional mechanics. Understanding the dynamics and 
effectors defining Mediator composition will provide new targets in order to alter transcriptional 
responses defective in disease.  
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Last but not least, recent advances in the proteomics field allow the study of specific interactions 
within a complex. For example, chemical cross-linking combined with mass spectrometry is being 
used to obtain 3-D structural information by detecting peptides that are in close spatial proximity34. 
This approach has been used to characterize Mediator subunit interactions and structure35. With 
advances in the cross-linked peptide-peptide recognizing algorithms, we anticipate an extension of 
this kind of approaches in order to identify the specific sites within the complex where each interactor 
is bound, hence providing the exact targets for drug discovery design.   
Brd4, the elephant in the room 
Bromodomain-containing protein 4 (Brd4) is a member of the eukaryotic BET family that contains two 
bromodomains (BDI and BDII) and an extraterminal (ET) domain. The bromodomain is a conserved 
sequence of ∼110 amino acids with the ability to bind acetyl-lysine residues in histones and many 
other proteins36,37. Ubiquitously expressed and with an almost 1400 amino acid length and a complex 
domain structure, this protein constitutes a docking platform for other chromatin regulators to target 
them to active open regions38. For example, Brd4 CTD interacts with the cyclin T1 and Cdk9, subunits 
of the positive transcription elongation factor b (pTEFb) complex39 centering the attention on its role 
in RNApol2 pause-release. Moreover, other interactions such as JMJD6 and NSD3 from Brd4 ET 
domain have been shown to be important for transcription activation40. 
Recently, its association with acetylated histones has pointed at Brd4 as an enhancer regulator. Brd4 
co-occupies with Mediator not only promoters but most enhancers, including super enhancers. 
Indeed, its relevance has risen exponentially since it has been discovered that the use of inhibitors for 
Brd4 selectivly disrupted super-enhancers associated to tumor oncogenes6. Thus, being part of the 
same macro regulatory structures in the genome may suggest that some interplay could exist between 
Brd4 and Mediator. However, the current evidence of a direct association is very controversial. On 
one hand, several groups have described Brd4-dependent Mediator binding to the DNA and that 
Brd4 inhibitors displace Mediator from chromatin6,41. On the other hand, biochemistry studies 
focusing on Brd4 purifications have not detected a physical link between these two entities40 and, as 
seen in Chapter 2 of this thesis, our Mediator purifications presented neither Brd4 nor Brd4-specific 
interactors.  
In an attempt to bring some clarity in this controversy, we decided to purify endogenous Brd4 in our 
NSC system. Our mass spectrometry data showed that we were able to detect almost all Brd4 
described interactors (Figure 4) but we detected minimal amounts of Mediator (data not shown). In 
the need of more experimental replicates we are not able to make a solid statement except that 
approaches similar to those in Chapter 2 (flag purification from DNA contamination controlled 
extracts) would be more suitable. In addition, label-free methods for mass spectrometry quantification 
such as iBAQ could be applied in order to normalize hit scores in several experiments42.  
We also performed a Mediator ChIP-seq in NSCs in the presence of Brd4 inhibitors, which removed 
Brd4 at all tested genomic locations. In contrast to results from other labs43, we found very little effect 
5 
Chapter 5 | Discussion
138
on Mediator genome-wide location (data not shown). One conclusion would be that the interaction 
between Brd4 and Mediator, if existing, is weak and does not appear required to target Mediator to 
the genome in NSCs. More extensive studies will have to be performed to resolve this puzzle. 
However, taking into account the phase-separation transcription model we could hypothesize that 
while not directly interacting with each other, Mediator and Brd4 are major multivalent complexes 
coordinating many components of the domain, thus interacting in an indirect manner. The removal of 
one of the two would create a great disturbance in the system leading at some point to the disruption 
of the other.  
Due to the privileged position of both Mediator and Brd4 at (super)enhancers and promoters, we 
argue that the construction of a combined protein network centered on these two entities would help 
to understand the mechanics of transcription assembly. In a preliminary approach, we have depicted 
the most significant chromatin complexes found in our Med12 and Brd4 purifications and the 
strength of their interaction (Figure 4). 
Our results show that while many complexes are shared between the two, other chromatin players 
appear to be highly specific for either Mediator or Brd4. As discussed above, cleaner approaches 
would narrow this overlap and provide new mechanistic insights in enhancer-promoter assembly.  
Figure 4 | Summary of Brd4-Mediator proteome in neural stem cells. 
Thickness of edges represents abundance (emPAI) corresponding to each purification. Note n=1. 
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About Cggbp1, an unfinished business 
In Chapter 3 of this thesis we have characterized Cggbp1 as a transcription factor regulating the 
transition from pluripotency to the neural lineage and neural stem cell homeostasis. As mention 
above, the identification of Cggbp1 constitutes another example on how Mediator-based screens 
could provide important transcription regulation candidates to study.  
Contemplating our work in progress, several aspects remain to be solved. First of all, we would like to 
properly characterize the expression of Cggbp1 in vivo as the only existing data does not include early 
developmental time points44. Our discovery of a direct retinoic acid regulation make us hypothesize 
that Cggbp1 could be involved in other RA-dependent developmental processes occurring later in 
development such as lung or limb formation45.  
In relation to that, a better characterization of the protein levels across tissues would give a better 
insight in the activity of the protein. Although Cggbp1 is described as ubiquitously expressed, its 
protein levels and nuclear localization depend on post-translation modifications produced by several 
signal cascades46. In particular, the EGF pathway, which is an essential growth signal to sustain NSCs, 
has been shown to phosphorylate Cggbp1 at tyrosine Y20 favoring its localization to the nucleus46. 
Hence, Cggbp1 activity could be restricted in different tissues due to a wide variety of regulatory 
steps (Figure 5A). Nonetheless, our results show a preference for the neural lineage justified in part, 
by the biased localization of the GCC motif in neural targets. 
Although we have provided evidence pointing to an activation role for this transcription factor, we 
have also found some signs that Cggbp1 may be also a repressor, the clearest example being the 
drastic mesodermal upregulation after Cggbp1 depletion in ESCs. In addition, as shown in Chapter 3, 
the mesodermal transcription factor Goosecoid (Gsc) appears to be bound by Cggbp1 in neural stem 
cells, where it is repressed. Further work will address the dual activity of Cggbp1 with special focus 
on developmental decisions (Figure 5B).  
Finally, despite the exploratory nature of our results, we recognize the exciting opportunity that 
Cggbp1 represents in characterizing Polycomb. The mechanisms of Polycomb regulation and 
recruitment are still very controversial, especially in mammals47. We hypothesize that Cggbp1 activity 
in development is linked to the Polycomb response. At the DNA sequence level, some studies 
associate large CpG islands depleted of activating factor motifs to Polycomb occupancy in ESCs48. We 
suggest that the GCC repeat of Cggbp1 may fall into these regions and passed unnoticed as a motif. In 
addition, Arabidopsis screens of Polycomb response elements identified GCC repeats as a recruiting cis 
candidate49. 
On top of that, our results show both an overlap of Cggbp1 occupancy with CpG islands and poised 
promoters. In parallel, our Cggbp1 interactome identified several members of Polycomb as interaction 
partners of Cggbp1. Finally, Cggbp1 regulates Polycomb subunits involved in the derepression 
switch of poised genes (Figure 5B). 
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Figure 5 | Cggbp1 and transcription regulation 
A. Schematic representation of Cggbp1 regulation. Red indicates speculative ideas. B. Cggbp1 modulation of the 
retinoic acid (RA) response in ESCs. Red indicates speculative ideas. C. Models of Cggbp1 mediated activation 
of poised promoters. TF_X refers to a trans-element binding similar sequences as Cggbp1. 
Taken together, we proposed two models explaining Cggbp1 regulation of poised promoters of the 
neural lineage (Figure 5C). The first model takes into account the Cggbp1 presence in ESCs and its 
Polycomb protein interactions. Signaling could trigger modification of Cggbp1 translating to a switch 
of interactors from Polycomb to activating complexes. The second model proposes that Cggbp1 
activity is only present after differentiation signals and its main role is to displace by competition an 
unidentified transcription factor from Polycomb response elements. Hence Cggbp1 would indirectly 
displace Polycomb and recruit the activation machinery. 
In a more opportunistic approach, we would like to extend our research of Cggbp1 to chromatin 
assembly. Despite the vast understanding in transcription factor mediated activation of enhancers, 
how enhancers recognize specific promoters is still poorly understood. The discovery of new 
promoter binders such Cggbp1 and the characterization of their mechanism of regulation should 
provide new insights in transcription assembly. 
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Neuronal maturation 
In addition to the massive success accomplished by the study of individual genes, in the last few 
decades genome-wide studies have provided new insights into the molecular basis of brain 
development, neural plasticity, and neurological diseases50. Neural maturation is an attractive field of 
study as discoveries found in one system such as hippocampal development can be easily 
extrapolated to other neural systems. While early differentiation and late synapse formation appear to 
be highly extrinsic regulated processes, maturation appears to be more cell-intrinsic51–53. Processes 
such as the nucleosome repeat shortening seem to occur across all neurons independent on their time 
of birth. We hypothesize that a conserved core transcriptional network must dictate the cell intrinsic 
response to reach maturity.  
In Chapter 4 of this thesis we have generated a map of the dynamic active chromatin regions during 
neuronal maturation. We suggest several candidate transcription factors acting in early, switch and 
late stages. We were particularly interested in the switch phase as the transition between neuronal 
differentiation transcription factors and synaptic activity-dependent ones had not been explored yet. 
Interestingly, while many of our candidates are validated by their in vivo expression profile, several of 
them have not been related to nervous system development. However, we have promising hints 
indicating to relevant physiological role of these candidates.  
For example, Spi-B has only been studied in lymphocytes and it has been shown to be a target of 
Ikaros family zing finger 1 (Ikzf1)54. Encouragingly, gene regulation in lymphocytes and neurons 
share many common players, Tcf4 (E2-2) being one example55,56. Indeed, Ikzf1 regulates neural 
differentiation57 by activating secondary transcription factors58. We hypothesize that Spi-B could be 
activated by this proneural factor.  
Another example is represented by Hepatic nuclear factors (HNF). In contrast to their name, these 
factors are not restricted to liver development, and new functions continuously appear for members 
of this transcription family59,60. Although we cannot rule out the possibility that other factors share the 
same motif, both Hnf4a and Hnf1b presented expression profiles correlated to the switch. 
Interestingly, deletion of the 17q12 locus where Hnf1b localizes causes a syndrome characterized by 
variable combinations of kidney and urinary tract abnormalities, maturity-onset diabetes and 
neurodevelopmental or neuropsychiatric disorders61. Additionally, the Hnf4a motif has been found 
significantly enriched at super enhancers of striatal neurons62 and has been related to depression and 
brain homeostasis63. Further research would consolidate these findings by testing the role in 
maturation of the identified candidates. For example, in addition to the proposed high-throughput 
screen (see Chapter 4), a more classical approach could be followed by in vivo electroporation of 
mouse embryos with shRNA constructs targeting the candidates and evaluating the neural 
maturation phenotype.  
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SUMMARY 
The scope of this thesis has been the study of one of the most fundamental determinants of life, gene 
expression control by transcription. We have studied transcription at several stages of development of 
the neuronal lineage. 
In Chapter 1 I have described how the process of transcription regulation is linked to the evolution of 
life, expanding in complexity as organisms develop more elaborated features. I have reviewed the 
fundamentals in the transcription process with a special focus on the Mediator complex, a versatile 
component of the core transcription machinery. In addition I describe the basic transcription 
regulators involved in mammal brain development representing a model to study chromatin 
regulation in high eukaryotes. 
Chapter 2 describes a transcriptional network that dominates neural stem cells. We have shown that 
Mediator complex represents a major interaction hub at enhancer-promoter assemblies and that by 
proteomic approaches it is possible to identify new Mediator interactors involved in transcription 
regulation at enhancers. Identified transcriptions factors dominate neural stem cell enhancers acting 
as putative Mediator recruiters. In addition, we have identified neural stem cell genes nearby super 
enhancers, which are prone to define cell identity, and showed that they are associated with high 
density of Mediator and its interactors. Combining new concepts such as “broad H3K4me3 
promoters” and super enhancers we have identified a core set of highly expressed genes where 
Mediator may play an essential role coordinating interactions and stabilizing their formation. Our 
data adds evidence to the concept of phase-separated chromatin domains, where high density of 
chromatin regulators would form biocondensates in order to efficiently regulate transcription at 
certain loci. 
In Chapter 3 we explore the functions of Cggbp1, one of the transcription factors identified in our 
Mediator purifications. We showed that Cggbp1 is a transcription activator acting at promotersof 
neural stem cell genes. Moreover, combining bioinformatics approaches with published data we 
suggest a role for Cggbp1 in early neural induction downstream of retinoic acid signaling.  
From the neural stem cell model in Chapter 2 we moved to embryonic stem cells in Chapter 3 in 
order to study early neural lineage developmental events. Fittingly, Chapter 4 of this thesis covers the 
last steps of neuronal development, neuronal maturation. By assessing active chromatin regions 
across several points in the development and maturation of ex-vivo hippocampal neurons we map 
regulatory regions involved in neuronal maturation. We identified candidate transcription factors 
that may regulate subsequent maturation steps by their binding motifs at active chromatin regions 
and their expression profiles during brain development.  
In summary, this thesis contains a collection of novel insights into the regulation of transcription in 
the neural lineage. In Chapter 5 I discuss several implications of the experiments described here and 
present preliminary work to support new hypothesess in future research.  
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SAMENVATTING 
De scope van dit proefschrift is de studie van één van de meest fundamentele eigenschappen van 
leven, de controle van genexpressie door transcriptie. We hebben transcriptie bestudeert in 
verschillende stadia van ontwikkeling van de neuronale lijn. 
In hoofdstuk 1 beschrijf ik hoe het proces van transcriptionele regulatie is verbonden met de evolutie 
van leven en complexer wordt wanneer organismen meer uitgebreide onwikkelingskenmerken 
krijgen. Ik bespreek fundamentele aspecten van het transcriptieproces met speciale aandacht voor het 
Mediator complex, een veelzijdige component van de centrale transcriptiemachinerie. Tevens 
beschrijf ik de transcriptionele regulators betrokken bij zoogdier-hersenontwikkeling als een model 
om chromatine regulators te bestuderen in hogere eukaryoten. 
Hoofdstuk 2 beschrijft een transcriptioneel netwerk wat neurale stamcellen domineert. We laten zien 
dat Mediator een significante interactie hub is voor promoter-enhancer complexen en dat het mogelijk 
is om met een proteomische benadering nieuwe Mediator interactoren te identificerendie betrokken 
zijn bij transcriptionele regulatie via enhancers.Geïdentificeerde transcriptiefactoren domineren 
neurale stamcel enhancers en zijn daar mogelijke recruiters van Mediator. Tevens hebben we genen 
geïdentificeerd nabij super-enhancers, welke waarschijnlijk zijn betrokken bij celidentiteit, en laten 
zien dat deze genen een hoge dichtheid hebben voor Mediator en zijn interactoren. We vinden dat 
genen met broad H3K4me3 promoters en super enhancers hoog tot expressie komen in neurale 
stamcellen en Mediator speelt waarschijnlijk een belangrijke rol bij het coördineren en stabiliseren van 
hun interacties. Onze data dragen bij aan het concept van fase-gescheiden chromatine-domeinen, 
waar de hoge dichtheid aan chromatine regulatoren leidt tot biocondensaten om de transcriptie van 
bepaalde loci efficiënt te kunnen reguleren. 
In hoofdstuk 3 bestuderen we de functies van Cggbp1, een van de transcriptiefactors geïdentificeerd 
als Mediator interactor. We laten zien dat Cggbp1 neurale stamcelgenen activeert via de promotor. 
Met een combinatie van bioinformatica en gepubliceerde data suggereren we een role voor Cggbp1 in 
de vroege neurale inductie via retinezuur signalering. 
Van het neurale stamcel model in hoofdstuk 2 gaan we naar embryonale stam cellen in hoofdstuk 3 
om vroege neurale ontwikkeling te bestuderen. Het is daarom passend dat in hoofdstuk 4 we de 
laatste stap van neuronale ontwikkeling behandelen, neuronale rijping. We bepalen actieve 
chromatine regionen in de ontwikkeling en rijping van ex-vivo hippocampale neuronen en bepalen 
daarmee de regulatiegebieden voor neuronale rijping. We identificeren kandidaat transcriptiefactoren 
die mogelijk betrokken zijn bij de achtereenvolgende rijpingsstappen door hun bindingsmotieven en 
expressieprofielen gedurende hersenontwikkeling. 
Samengevat bevat dit proefschrift een aantal nieuwe inzichten in de regulatie van transcriptie in de 
neurale lijn. In hoofdstuk 5 bediscussieer ik de verschillende implicaties van de beschreven 
experimenten en presenteer ik voorbereidend werk voor nieuwe hypotheses in toekomstig 
onderzoek.  
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all the best outside of it (with your partner, new house and your cutie doggo!). 
Erik, although we shared a small fraction of time in the lab I really appreciated your invitations to 
have some afternoon beers and your experienced advice on how to deal with supervisors. I wish you 
all the best in Germany. 
Ernie, you were always there to calm my inexperienced hands. Your patience and cheer were 
essential to balance the energy in the lab. You possess an extraordinary aura of vitality that inspired 
me every day. I hope that with your retirement you get to travel even more and to continue hiking 
and rowing.   
I also enjoyed to share the working space with the people from Harbour Antibodies; Dubi, Alex, Rien 
and Michael but specially Rick. You had always the will to stand any party we threw at you and I 
could always count on you for having a cocktail at Tiki’s. 
Working in academia has the bitter characteristic of meeting people always in transition. PhDs and 
Post-docs specially, we are a particular tribe of nomads in the 21st century. I met excellent people in 
the first years of my PhD that helped settle my tent in Rotterdam such as Maria, Ileana and Aristea to 
whom I send my sincere gratitude.  
Many people from floors 6th, 7th, 9th and 10th have contributed to the friendly environment. From the 
10th I would like to mention Silvia, which we have shared the same path in the PhD program and 
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Sreya, Valentina, Evelien and Mieke to keep the beer sessions going. From the 9th, I would like to 
specially thank Teresa not only as a bit of Catalan brought me home but also for the good times we 
shared. Also cheers to Ruben, my constant roommate at KWT, xd and Hegias and Cristina that 
would always have time to chat and as good Spaniards gossip a bit. 
I had the extraordinary luck of being introduced to the Italian clan of expats. I was charmed by your 
closeness, Andrea and your culinary expertise (I miss the Christmas dinners!). Thanks also for your 
experienced advice and to start the climbing movement in the department! Congratulations on your 
wedding and good luck with your future research. Enrico, thanks for being my paranimf. I wished 
we could have joined the PhD at the same time to spend a longer period together. I really enjoyed our 
guitar jams with the band and I am really happy you are getting into climbing (I spy the whatsup 
group, xd). Forza for the last sprint on your thesis! Finally, Luca; my partner in crime during the 
whole PhD. I am so glad we got the same fellowship and started so close together in time. I could 
always count on you to talk about my worries or to cheer with some beers. I found salvation in our 
sky runaways to Austria or our music jams with the band. I am really going to miss you for my 
defense date but I am not sad as I am certain we will meet either in Barcelona (you lucky bastard!) or 
in Sweden (we have pending a X-country expedition).  
My sincere gratitude to my other two paranimfs. Lize, I have seen you grow as a PhD student since 
you arrived and I am very happy how you are managing all the challenges. I am sure you will 
succeed in the path that lies ahead; it is less than 5c for sure! Judith, your energy and directness have 
been always a quality I loved. We are still missing a proper saxo-guitar jam! Thanks to both of you for 
the way you shape the wave of “new” students at the department. Your motivation for both research 
and partying has carried me on the last months where I was a social zombie.  
Talking about the next wave, thanks to Irene, Pablo, Rodrigo and Lukas for the climbing moments. I 
had always wished for a climbing group and you were a perfect fit! Also, thanks to Ilias and Jente for 
the good times partying.  
Besides climbing, what has kept me going in Rotterdam is music. In my mind I have assigned people 
to this category as we have met or befriended because of music. First of all, I would like to give 
special thanks to my guitar teachers in the Erasmusic initiative. Both Olmo Marín and Alvaro Rovira 
have brought me new flavors to add to my style and gave me hard homework to deviate my mind 
from the lab. Lennart, the remaining member of our rock band “The microtubules”. Thanks for 
brining the groove and being a “sharp dress man”, xd. Cristina, we met talking about Brazilian jazz at 
the cell culture room and since then I have enjoyed our music exchanges and your invites to DJ 
sessions. Yasemin, we shared the same fellowship and the same interests in music so it was inevitable 
to collide at some point. Luckily it was to make some nice music performances and to organize our 
own music jams where I met such as talented musicians such as Danny, Isabella and Carmen. I hope 
you keep the riffs going!  
Before I talked about mentorship, and during my PhD I had the opportunity to supervise two 
wonderful students. Adela; thanks for your time in the lab, I learnt a lot from your stay and I hope to 
have transmitted a bit as well, at least in the climbing side! You have a raw potential that I hope soon 
you will exploit. Isa, I could not have asked for a better student to be my first supervision duty. You 
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shined the lab with your good mood and crazy laughs. I hope you both all the best in your future 
work and PhD and hope to meet you both in Barcelona! 
I have been living in Umeå for almost 8 months now and I could not dismiss the opportunity to 
express my gratitude to several people that have welcomed me in the next step of my adventure. First 
of all, I would like to express my sincere gratitude to Prof. Strand for taking me into account and 
value my skills beyond background. I am looking forward to combine the best of our fields. Also I 
would like to thank your patience during the first phase of the project. I am extremely happy with the 
colleagues and friends I have met in my new group; Tamara, Xu, Tim, Nora, Yan, Qi, Nico and 
Jannek. In addition, I would like to specially thank Simon and Lucy for making me feel home even 
before I moved here. You guys are amazing! And also my thanks to the Spanish family we gather 
with Ruben and Sonia (and little Einar), Juan, and Enara and Jaime (and little June). 
The remaining lines will be in Catalan, to the most inner circle of my soul. 
Escric aquestes línies amb en Blai arraulit a sobre així que pot ser que passin dues coses; o em poso 
massa sentimental, o no m’expresso prou clarament; al cap i a la fi, espero expressar la meva gratitud 
en persona. El més important, però, és que sapigueu que tots vosaltres sou el veritable sostén de la 
meva felicitat. 
Sara, no em puc creure que haguem arribat tan lluny. Qui diria que els dos ens faríem doctors quan 
començàvem a descobrir la ciència amb la poliploïdia de les maduixes. Les nostres òrbites sempre han 
anat sincròniques, des de les nostres primers feines al parc científic, a l’experiència holandesa fins al 
punt de graduar-nos amb una setmana de diferència! Fora de la feina sempre he tingut una connexió 
especial amb tu. No tinc germans de sang però crec que puc saber el que se sent tenint-te a tu. Espero 
poder assistir a la teva tesi i transmetre’t aquests sentiments directament. Joan, des de que vam 
conèixer hem compartit les nostres ganes de gaudir del que la natura ens ofereix. M’encanta la teva 
energia i espero poder organitzar moltes més aventures amb tu. Encara recordo quan els dos em veu 
portar a navegar per dir-me que venia l´Ona. Em moro de ganes de trobar-nos tots sis (tots sis!!, que 
fort). 
I ja que estem posats a organitzar viatges, que menys que incloure a l’equació a la Laia i la Núria, les 
nostres companyes de viatge. No sabeu el que hem feu riure cada una a la vostre manera. Compartir 
amb vosaltres els moments de relax és la millor medicina per l’estrès. Una forta abraçada, ens veiem a 
París? 
Potser una de les persones que més me n’orgulleix de tenir com amic és l´Álvaro. Des de que ens vam 
conèixer m’has tractat no com la parella de la Marta sinó com un amic i amb el temps com família. La 
teva dedicació, bon humor i empenta m’inspiren cada dia. Per molt que la vida giri (i déu ni do com 
gira al voltant teu!) sempre tindràs un lloc amb nosaltres que pots anomenar casa. Sara, no saps que 
content estic de que hagis trobat feina a Hèlsinki. M’encanta veure com el vincle entre tots plegats no 
deixar de fer-se més fort. Us estimo! 
Del mateix grupet d’umpa-lumpas estic contentíssim d’haver-me trobat amb l’Albert. Tot i els mals 
principis, els quals em conclòs que es un fenotip crònic teu xd, m´encanta haver-me apropat i establir 
una gran amistat amb tu. Em commou la teva fluïdesa d’interacció i les ganes de menjar-te la vida. 
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Estic impressionat amb la teva aventura californiana, et desitjo el més gran dels èxits! Una forta 
abraçada també per la Carla, espero que trobis en Blai tant “niño teletienda” com em vas trobar a mi. 
Segueix amb la teva força i il·lusió tant característiques. Jordi, tinc moltíssimes ganes de presentar-te 
en Blai i veure el teu jo pedagògic interior que encara no he pogut veure en acció! Si el tractes la 
meitat de bé que a mi serà increïble. No sabeu com espero amb ànsia veure’s a tots junts. 
Com he dit, no tinc germans però la meva família no sanguínia és extraordinària. Oriol, sempre et 
porto en els meus pensaments! Et trobo moltíssim a faltar, però em tranquil·litzo amb la certesa que 
aviat podrem començar a organitzar unes bones excursions amb els dos “pimpollos” a l’esquena, a 
poder ser als Alps prop de casa teva. Ets la proba de que la distància no importa quan el vincle és 
prou fort. Una abraçada per les teves xurris, la Laura i la petita Emma. 
Parlant de família! Ara sí que podem dir que ja sou família oficial (amb boda i nen en menys de 15 
dies!) tot i sempre m’hi heu fet sentir en aquests 10 anys. Conxita, Joan, Laura i Helena; moltes 
gràcies pel vostre amor i tota l’ajuda que ens doneu contínuament. 
Papa i mama, pare i mare, Manel i Marta, (i aviat abu i iaia). Resumir en paraules escrites tots el 
sentiments que floreixen quan penso en vosaltres és una gran simplificació. Deixeu-me dir però, que 
sempre heu estat i sereu el meu més gran referent de la meva vida. No sabeu l’afortunat que em sento 
de tenir una relació tant directa i honesta amb vosaltres. Gràcies per tota paciència, sacrificis, lliçons i 
sobretot tot l’amor que m’heu donat per poder esdevenir la persona que sóc ara. I què bé que ens ho 
hem passat arribant fins aquí! Ben endins porto un gran sac d’experiències magnífiques que de tant en 
tant obro per il·luminar els dies grisos en països estrangers. Em moro de ganes de seguir-lo omplint 
amb noves aventures, ara amb un participant més. Us estimo tant que fa mal!  
Blai, ara mateix dorms plàcidament en el caliu dels meus braços. El rítmic tecleig de l’ordinador actua 
de soroll blanc mentre el sol de primavera t’acaricia els peus. Esperar la teva arribada ha sigut el 
millor refugi on la meva ment trobava aixopluc durant els tempestuosos mesos finals de tesi. Cada 
dia amb tu és un milió d’experiments esplèndids. 
I parlant d’experiments! Portem més de 10 anys rebutjant la hipòtesi nul·la amb tu Marta, i cada cop 
ens dona més significatiu. En altres paraules, cada cop t’estimo més i segueixo enamorant-me cada 
dia del teu somriure i de la teva mirada. Sembla estrany donar-te gràcies ara, quan en tot el temps que 
portem junts no has parat de transmetre’m el teu amor i la teva força. Quan tot s’enfosqueix i la nit 
m’envolta sempre trobo el camí buscant la llum de la teva estrella. Endavant ens queden infinitat de 
camins per explorar junts amb el nostre xipironet.  
I si la nit no es torna clara 
em tindràs al teu costat 
per creuar el camp de batalla. 
And if the night doesn’t turn bright 
you will have me on your side 
to cross the battlefield. 
Camp de batalla (Txarango) 
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